Released this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\\n\\n
We wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
IntechOpen is proud to announce that 191 of our authors have made the Clarivate™ Highly Cited Researchers List for 2020, ranking them among the top 1% most-cited.
\n\n
Throughout the years, the list has named a total of 261 IntechOpen authors as Highly Cited. Of those researchers, 69 have been featured on the list multiple times.
\n\n\n\n
Released this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\n\n
We wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
Note: Edited in March 2021
\n'}],latestNews:[{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"},{slug:"introducing-intechopen-book-series-a-new-publishing-format-for-oa-books-20210915",title:"Introducing IntechOpen Book Series - A New Publishing Format for OA Books"}]},book:{item:{type:"book",id:"7016",leadTitle:null,fullTitle:"Cardiovascular Risk Factors in Pathology",title:"Cardiovascular Risk Factors in Pathology",subtitle:null,reviewType:"peer-reviewed",abstract:"This book provides a broad overview of the molecular mechanisms associated with relevant and significant cardiovascular conditions that continue to plague humanity. It also discusses potential and promising therapeutic avenues targeted at addressing these conditions. The overarching goal of this multifaceted work is to entice future and current members of the scientific community to direct their endeavors towards improving our current knowledge of cardiovascular disease conditions and curb their impact on our everyday lives.",isbn:"978-1-83881-950-7",printIsbn:"978-1-83881-949-1",pdfIsbn:"978-1-83881-951-4",doi:"10.5772/intechopen.73773",price:119,priceEur:129,priceUsd:155,slug:"cardiovascular-risk-factors-in-pathology",numberOfPages:142,isOpenForSubmission:!1,isInWos:null,isInBkci:!1,hash:"7937d2c640c7515de372282c72ee5635",bookSignature:"Alaeddin Abukabda, Maria Suciu and Minodora Andor",publishedDate:"April 21st 2021",coverURL:"https://cdn.intechopen.com/books/images_new/7016.jpg",numberOfDownloads:3746,numberOfWosCitations:0,numberOfCrossrefCitations:1,numberOfCrossrefCitationsByBook:0,numberOfDimensionsCitations:3,numberOfDimensionsCitationsByBook:0,hasAltmetrics:1,numberOfTotalCitations:4,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"August 20th 2019",dateEndSecondStepPublish:"March 5th 2020",dateEndThirdStepPublish:"May 4th 2020",dateEndFourthStepPublish:"July 23rd 2020",dateEndFifthStepPublish:"September 21st 2020",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"307873",title:"Ph.D.",name:"Alaeddin",middleName:null,surname:"Abukabda",slug:"alaeddin-abukabda",fullName:"Alaeddin Abukabda",profilePictureURL:"https://mts.intechopen.com/storage/users/307873/images/system/307873.png",biography:"Dr. Abukabda graduated from Al Fateh Dental College, Libya, in 2007. He obtained a master`s degree in Molecular Biology from Clarion University, Pennsylvania, in 2011. He later obtained a Ph.D. in Cellular Physiology from West Virginia University in 2018 and a Certification in Biostatistics from the West Virginia University School of Public Health. In 2018, Dr. Abukabda worked as a postdoctoral research associate at the Vascular Medicine Institute at the University of Pittsburgh. He has been involved in the submission and writing of several National Institutes of Health (NIH) and National Science Foundation (NSF) grants and intramural seed grants. Dr. Abukabda has published and presented many papers in immunology, toxicology, and cardiovascular physiology. He has also served as a reviewer for many journals in his field of expertise.",institutionString:"Lake Erie College of Osteopathic Medicine",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Lake Erie College of Osteopathic Medicine",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:{id:"198005",title:"Dr.",name:"Maria",middleName:null,surname:"Suciu",slug:"maria-suciu",fullName:"Maria Suciu",profilePictureURL:"https://mts.intechopen.com/storage/users/198005/images/system/198005.jpeg",biography:'Dr. Maria Suciu is Assistant Professor of Pharmacology and Clinical Pharmacy in the Faculty of Pharmacy, \\"Victor Babes\\" University of Medicine and Pharmacy Timisoara, Romania. She received an MD in Family Medicine in 2003, an MPharm in 2011, and an MD in Cardiology in 2013, all from \\"Victor Babes\\" University of Medicine and Pharmacy Timisoara. Dr. Suciu has published one book chapter, eight scientific papers, and seventeen abstracts in international journals. She has also co-authored five books.',institutionString:"Victor Babeș University of Medicine and Pharmacy",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Victor Babeș University of Medicine and Pharmacy Timișoara",institutionURL:null,country:{name:"Romania"}}},coeditorTwo:{id:"219242",title:"Dr.",name:"Minodora",middleName:null,surname:"Andor",slug:"minodora-andor",fullName:"Minodora Andor",profilePictureURL:"https://mts.intechopen.com/storage/users/219242/images/system/219242.jpg",biography:"Assistant Professor Minodora Andor, Ph.D., graduated from the University of Medicine and Pharmacy “Victor Babes” Timisoara, Romania, in 1997. She completed her studies with a Ph.D. thesis addressing negative prognostic factors in the evolution of patients with acute myocardial infarction. Over the last twenty-three years, her personal research activity has focused on the study of cardiovascular pathology, particularly early diagnosis of atherosclerotic cardiovascular disease as well as the evolution of cardiac diseases in different pathological contexts. Her research interests include cardiovascular risk factors and endothelial dysfunction. Her professional work includes activities as a member of Timis College of Physicians and an expert with the European Commission for evaluating scientific projects within the Horizon 2020 frame.",institutionString:"Victor Babeș University of Medicine and Pharmacy",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Victor Babeș University of Medicine and Pharmacy Timișoara",institutionURL:null,country:{name:"Romania"}}},coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"170",title:"Cardiology and Cardiovascular Medicine",slug:"cardiology-and-cardiovascular-medicine"}],chapters:[{id:"71921",title:"Endothelial Dysfunction and Disruption in Pulmonary Hypertension",doi:"10.5772/intechopen.92177",slug:"endothelial-dysfunction-and-disruption-in-pulmonary-hypertension",totalDownloads:695,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:0,abstract:"A number of systemic diseases lead to pulmonary hypertension (PH), a serious disorder with a high morbidity and mortality rate. Irrespective of the underlying disease, endothelial dysfunction or disruption plays a key role in the initiation and progression of PH. Endothelial dysfunction and disruption result in impaired vascular relaxation response, activation of proliferative pathways leading to medial hypertrophy and PH. Endothelial cells (EC) play a crucial role in regulating vascular tone and maintaining homeostasis. Caveolin-1, a 21-22 kD membrane protein, interacts with a number of transducing factors and maintains them in a negative conformation. Disruption of EC results in endothelial caveolin-1 loss and reciprocal activation of proliferative pathways leading to PH, and the accompanying loss of PECAM1 and vascular endothelial cadherin results in barrier dysfunction. These changes lead to the irreversibility of PH. Hypoxia-induced PH is not accompanied by endothelial disruption or caveolin-1 loss but is associated with caveolin-1 dysfunction and the activation of proliferative pathways. Removal of hypoxic exposure results in the reversal of the disease. Thus, EC integrity is an important factor that determines irreversibility vs. reversibility of PH. This chapter will discuss normal EC function and the differences encountered in PH following EC disruption and EC dysfunction.",signatures:"Rajamma Mathew",downloadPdfUrl:"/chapter/pdf-download/71921",previewPdfUrl:"/chapter/pdf-preview/71921",authors:[{id:"65828",title:"Dr.",name:"Rajamma",surname:"Mathew",slug:"rajamma-mathew",fullName:"Rajamma Mathew"}],corrections:null},{id:"71452",title:"Pathogenesis of Abdominal Aortic Aneurysm",doi:"10.5772/intechopen.91670",slug:"pathogenesis-of-abdominal-aortic-aneurysm",totalDownloads:574,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:1,abstract:"Abdominal aortic aneurysms (AAAs) are encountered by many healthcare providers such as interventional radiologists, vascular surgeons, cardiologists, and general practitioners. Much effort has been placed in the screening, diagnosis, and treatment of AAA with somewhat little understanding of its pathophysiology. AAA is a complex disease typically segmented into a process of proteolysis, inflammation, and vascular smooth muscle cell (VSMC) apoptosis with oxidative stress balancing its components. AAA and other aortic syndromes such as aortic dissection share this same process. On the other hand, AAA formation and aortic pathology may be acquired through infection like in mycotic aneurysm or may be genetic in origin such as seen with Ehlers-Danlos and Marfan syndromes.",signatures:"Michael Patel, Daniel Braga, Brad Money, Andres Pirela, Adam Zybulewski, Brandon Olivieri and Robert Beasley",downloadPdfUrl:"/chapter/pdf-download/71452",previewPdfUrl:"/chapter/pdf-preview/71452",authors:[{id:"311726",title:"Dr.",name:"Michael",surname:"Patel",slug:"michael-patel",fullName:"Michael Patel"},{id:"311728",title:"Dr.",name:"Robert",surname:"Beasley",slug:"robert-beasley",fullName:"Robert Beasley"},{id:"312400",title:"BSc.",name:"Brad",surname:"Money",slug:"brad-money",fullName:"Brad Money"},{id:"312403",title:"Dr.",name:"Daniel",surname:"Braga",slug:"daniel-braga",fullName:"Daniel Braga"},{id:"312905",title:"Dr.",name:"Andres",surname:"Pirella",slug:"andres-pirella",fullName:"Andres Pirella"},{id:"315077",title:"Dr.",name:"Brandon",surname:"Olivieri",slug:"brandon-olivieri",fullName:"Brandon Olivieri"},{id:"315078",title:"Dr.",name:"Adam",surname:"Zybulewski",slug:"adam-zybulewski",fullName:"Adam Zybulewski"},{id:"412210",title:"Dr.",name:"Michael",surname:"Patel",slug:"michael-patel",fullName:"Michael Patel"},{id:"412211",title:"Dr.",name:"Daniel",surname:"Braga",slug:"daniel-braga",fullName:"Daniel Braga"},{id:"412212",title:"Dr.",name:"Brad",surname:"Money",slug:"brad-money",fullName:"Brad Money"},{id:"412213",title:"Dr.",name:"Andres",surname:"Pirela",slug:"andres-pirela",fullName:"Andres Pirela"},{id:"412214",title:"Dr.",name:"Adam",surname:"Zybulewski",slug:"adam-zybulewski",fullName:"Adam Zybulewski"},{id:"412215",title:"Dr.",name:"Brandon",surname:"Olivieri",slug:"brandon-olivieri",fullName:"Brandon Olivieri"},{id:"412216",title:"Dr.",name:"Robert",surname:"Beasley",slug:"robert-beasley",fullName:"Robert Beasley"}],corrections:null},{id:"72533",title:"The Importance of Autophagy and Proteostasis in Metabolic Cardiomyopathy",doi:"10.5772/intechopen.92727",slug:"the-importance-of-autophagy-and-proteostasis-in-metabolic-cardiomyopathy",totalDownloads:576,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Metabolic cardiomyopathy and other heart disorders are associated with proteostasis derailment and subsequent autophagy. Proteostasis is a process of protein homeostasis, and autophagy is a mechanism of self-degradation for surviving cells facing stressful conditions. Metabolic challenges have been linked to excess reactive oxygen species. Cardiomyocyte proteotoxicity, an important underlying pathologic mechanism in cardiac disease, is characterized by chronic accumulation of misfolded or unfolded proteins that can lead to proteotoxic formation or aggregation of soluble peptides. Autophagic processes are mediated by the ubiquitin-proteasome and autophagy-lysosome systems, fundamental for cardiac adaptation to physiological and pathological stress. Cellular proteostasis alterations in cardiomyopathy are represented by myocardial remodeling and interstitial fibrosis with reduced diastolic function and arrhythmias. Autophagy regulation may be a potential therapeutic strategy for metabolic cardiomyopathy necessary for the treatment of fibrosis and cardiac tissue remodeling alterations. Furthermore, autophagy has been shown to be active in the perimeter of cardiovascular fibrotic tissue as mechanism of fibrosis recovery and scarring secondary to cell apoptosis. In the present work, we review the current knowledge on the role of autophagy and proteostasis in the pathogenesis of heart failure to resolve the ever-expanding epidemic of metabolic cardiomyopathy and heart failure associated with substantial morbidity and mortality.",signatures:"María Cristina Islas-Carbajal, Ana Rosa Rincón-Sánchez, Cesar Arturo Nava-Valdivia and Claudia Lisette Charles-Niño",downloadPdfUrl:"/chapter/pdf-download/72533",previewPdfUrl:"/chapter/pdf-preview/72533",authors:[{id:"84149",title:"Dr.",name:"Ana Rosa",surname:"Rincon Sanchez",slug:"ana-rosa-rincon-sanchez",fullName:"Ana Rosa Rincon Sanchez"},{id:"317039",title:"Prof.",name:"Claudia Lisette",surname:"Charles Niño",slug:"claudia-lisette-charles-nino",fullName:"Claudia Lisette Charles Niño"},{id:"317040",title:"Prof.",name:"Cesar Arturo",surname:"Nava Valdivia",slug:"cesar-arturo-nava-valdivia",fullName:"Cesar Arturo Nava Valdivia"},{id:"317056",title:"Dr.",name:"María Cristina",surname:"Islas-Carbajal",slug:"maria-cristina-islas-carbajal",fullName:"María Cristina Islas-Carbajal"}],corrections:null},{id:"72726",title:"Familial Hypercholesterolemia: Three “under” (Understood, Underdiagnosed, and Undertreated) Disease",doi:"10.5772/intechopen.93042",slug:"familial-hypercholesterolemia-three-under-understood-underdiagnosed-and-undertreated-disease",totalDownloads:256,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Familial hypercholesterolemia (FH) is one of the most prevalent genetic disorders leading to premature atherosclerosis and coronary heart disease. The main cause of FH is a mutation in the LDL-receptor gene that leads to loss of function of these receptors causing high levels of blood cholesterol. The diagnosis of FH is not very easy. Wide screenings are needed to reveal high levels of LDL cholesterol among “healthy” population. If the patient has MI or stroke at an early age, high levels of LDL cholesterol, and tendon xanthomas, the diagnosis of FH becomes much more clear. Genetic testing is a gold standard in the diagnosis of FH. There are several factors, influencing the time course of FH. Smoking males with low levels of HDL cholesterol have an extremely higher risk of death than nonsmoking females with high HDL cholesterol. Management of FH includes low cholesterol diet, statin and ezetimibe treatment, PCSK inhibitors, and LDL aphaeresis. Early and effective treatment influences much the prognosis in FH patients.",signatures:"Vladimir O. Konstantinov",downloadPdfUrl:"/chapter/pdf-download/72726",previewPdfUrl:"/chapter/pdf-preview/72726",authors:[{id:"317670",title:"Prof.",name:"Vladimir O.",surname:"Konstantinov",slug:"vladimir-o.-konstantinov",fullName:"Vladimir O. Konstantinov"}],corrections:null},{id:"71227",title:"Statin Therapy in Children",doi:"10.5772/intechopen.91367",slug:"statin-therapy-in-children",totalDownloads:627,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:"Landmark studies such as the Bogalusa Heart study, Pathobiological Determinants of Atherosclerosis in Youth study, and Muscatine and Young Finns studies established that the atherosclerotic process begins in childhood. Early precursors of atherosclerosis may increase risk of cardiovascular morbidity in adulthood. Follow-up studies of children with familial homozygous hypercholesterolemia showed that initiation of statin therapy slowed the progression of carotid intima-media thickness and reduced cardiovascular disease risk. Despite the growing evidence on the efficacy of statins and a rising prevalence of dyslipidemia, there are concerns regarding long-term safety and efficacy. Moreover, data on statin use in children with secondary dyslipidemia are sparse. This chapter provides a comprehensive review of the current state of literature on the indications, contraindications, efficacy and safety data on the use of statins in pediatric dyslipidemia.",signatures:"Bhuvana Sunil and Ambika Pallikunnath Ashraf",downloadPdfUrl:"/chapter/pdf-download/71227",previewPdfUrl:"/chapter/pdf-preview/71227",authors:[{id:"314228",title:"Prof.",name:"Ambika Pallikunnath",surname:"Ashraf",slug:"ambika-pallikunnath-ashraf",fullName:"Ambika Pallikunnath Ashraf"},{id:"314519",title:"Dr.",name:"Bhuvana",surname:"Sunil",slug:"bhuvana-sunil",fullName:"Bhuvana Sunil"},{id:"411782",title:"Dr.",name:"Bhuvana",surname:"Sunil",slug:"bhuvana-sunil",fullName:"Bhuvana Sunil"},{id:"411783",title:"Dr.",name:"Ambika Pallikunnath",surname:"Ashraf",slug:"ambika-pallikunnath-ashraf",fullName:"Ambika Pallikunnath Ashraf"}],corrections:null},{id:"71581",title:"Pharmacokinetic Aspects of Statins",doi:"10.5772/intechopen.91910",slug:"pharmacokinetic-aspects-of-statins",totalDownloads:1018,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"Statins are the most used therapeutic group in the treatment of hypercholesterolemia and reduce the risk of cardiovascular events and mortality. Long prescription periods and their pharmacokinetic characteristics increase the possibility of interactions, especially at the metabolism level. Simvastatin, lovastatin, and atorvastatin are metabolized by CYP3A4 isoenzymes, so they will have more significant interactions than fluvastatin, pitavastatin, and rosuvastatin that require CYP2C9. The main interactions are with macrolides, azole antifungals, antiretrovirals, platelet antiaggregants, anticoagulants, oral antidiabetics, calcium channel blockers, immunosuppressants, and other hypolipidemic agents, among others. A review of all medications that are taken by patients treated with statins should be performed at each medical consultation and during all healthcare transitions.",signatures:"Lucía Cid-Conde and José López-Castro",downloadPdfUrl:"/chapter/pdf-download/71581",previewPdfUrl:"/chapter/pdf-preview/71581",authors:[{id:"171329",title:"Dr.",name:"José",surname:"López-Castro",slug:"jose-lopez-castro",fullName:"José López-Castro"},{id:"313205",title:"Mrs.",name:"Lucía",surname:"Cid Conde",slug:"lucia-cid-conde",fullName:"Lucía Cid Conde"},{id:"412474",title:"Dr.",name:"Lucía",surname:"Cid-Conde",slug:"lucia-cid-conde",fullName:"Lucía Cid-Conde"},{id:"412475",title:"Dr.",name:"José",surname:"López-Castro",slug:"jose-lopez-castro",fullName:"José López-Castro"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"6209",title:"Endothelial Dysfunction",subtitle:"Old Concepts and New Challenges",isOpenForSubmission:!1,hash:"f6e76bbf7858977527679a6e6ad6a173",slug:"endothelial-dysfunction-old-concepts-and-new-challenges",bookSignature:"Helena Lenasi",coverURL:"https://cdn.intechopen.com/books/images_new/6209.jpg",editedByType:"Edited by",editors:[{id:"68746",title:"Dr.",name:"Helena",surname:"Lenasi",slug:"helena-lenasi",fullName:"Helena Lenasi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7220",title:"Congenital Heart Disease",subtitle:null,isOpenForSubmission:!1,hash:"f59bacfffcccc636ec3082869d10a82e",slug:"congenital-heart-disease",bookSignature:"David C. Gaze",coverURL:"https://cdn.intechopen.com/books/images_new/7220.jpg",editedByType:"Edited by",editors:[{id:"71983",title:"Dr.",name:"David C.",surname:"Gaze",slug:"david-c.-gaze",fullName:"David C. Gaze"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6752",title:"Cholesterol",subtitle:"Good, Bad and the Heart",isOpenForSubmission:!1,hash:"599b1f8bc760449a4ee6ecd816a1df93",slug:"cholesterol-good-bad-and-the-heart",bookSignature:"Madan L. Nagpal",coverURL:"https://cdn.intechopen.com/books/images_new/6752.jpg",editedByType:"Edited by",editors:[{id:"182681",title:"Dr.",name:"Madan L.",surname:"Nagpal",slug:"madan-l.-nagpal",fullName:"Madan L. Nagpal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6777",title:"Advances in Extra-corporeal Perfusion Therapies",subtitle:null,isOpenForSubmission:!1,hash:"1e52fb6e834ada962495c512111f684e",slug:"advances-in-extra-corporeal-perfusion-therapies",bookSignature:"Michael S. Firstenberg",coverURL:"https://cdn.intechopen.com/books/images_new/6777.jpg",editedByType:"Edited by",editors:[{id:"64343",title:"Dr.",name:"Michael S.",surname:"Firstenberg",slug:"michael-s.-firstenberg",fullName:"Michael S. Firstenberg"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6373",title:"Myocardial Infarction",subtitle:null,isOpenForSubmission:!1,hash:"10bca0bf18d68ec3c1641dbc3a1ae899",slug:"myocardial-infarction",bookSignature:"Burak Pamukçu",coverURL:"https://cdn.intechopen.com/books/images_new/6373.jpg",editedByType:"Edited by",editors:[{id:"70686",title:"Dr.",name:"Burak",surname:"Pamukçu",slug:"burak-pamukcu",fullName:"Burak Pamukçu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8629",title:"Visions of Cardiomyocyte",subtitle:"Fundamental Concepts of Heart Life and Disease",isOpenForSubmission:!1,hash:"1cae2b319d6f3c230849834f10715701",slug:"visions-of-cardiomyocyte-fundamental-concepts-of-heart-life-and-disease",bookSignature:"Angelos Tsipis",coverURL:"https://cdn.intechopen.com/books/images_new/8629.jpg",editedByType:"Edited by",editors:[{id:"77462",title:"Dr.",name:"Angelos",surname:"Tsipis",slug:"angelos-tsipis",fullName:"Angelos Tsipis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7556",title:"Dyslipidemia",subtitle:null,isOpenForSubmission:!1,hash:"dfd1faefe925f0f8335c42cdb36256c1",slug:"dyslipidemia",bookSignature:"Samy I. McFarlane",coverURL:"https://cdn.intechopen.com/books/images_new/7556.jpg",editedByType:"Edited by",editors:[{id:"53477",title:"Prof.",name:"Samy I.",surname:"McFarlane",slug:"samy-i.-mcfarlane",fullName:"Samy I. McFarlane"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7055",title:"Angiography",subtitle:null,isOpenForSubmission:!1,hash:"20638a6ce5e042484cc33b5b510cdca6",slug:"angiography",bookSignature:"Burak Pamukçu",coverURL:"https://cdn.intechopen.com/books/images_new/7055.jpg",editedByType:"Edited by",editors:[{id:"70686",title:"Dr.",name:"Burak",surname:"Pamukçu",slug:"burak-pamukcu",fullName:"Burak Pamukçu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6311",title:"Blood Pressure",subtitle:"From Bench to Bed",isOpenForSubmission:!1,hash:"2e393b1d66ff57ba49a6e00a6f50714d",slug:"blood-pressure-from-bench-to-bed",bookSignature:"Aise Seda Artis",coverURL:"https://cdn.intechopen.com/books/images_new/6311.jpg",editedByType:"Edited by",editors:[{id:"99453",title:"Dr.",name:"Aise Seda",surname:"Artis",slug:"aise-seda-artis",fullName:"Aise Seda Artis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7842",title:"Basic and Clinical Understanding of Microcirculation",subtitle:null,isOpenForSubmission:!1,hash:"a57d5a701b51d9c8e17b1c80bc0d52e5",slug:"basic-and-clinical-understanding-of-microcirculation",bookSignature:"Kaneez Fatima Shad, Seyed Soheil Saeedi Saravi and Nazar Luqman Bilgrami",coverURL:"https://cdn.intechopen.com/books/images_new/7842.jpg",editedByType:"Edited by",editors:[{id:"31988",title:"Prof.",name:"Kaneez",surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{},chapter:{},book:{}},ofsBook:{item:{type:"book",id:"11474",leadTitle:null,title:"Quality of Life Interventions - Magnitude of Effect and Transferability",subtitle:null,reviewType:"peer-reviewed",abstract:"
\r\n\tThe Quality of Life for an individual and society at large is determined by both personal and state-level decisions. The magnitude of the effect of interventions that modify one Quality Adjusted Life Years (QALYs) will be compared, and the transferability of these interventions globally will be investigated by comparison between different socio-economic countries with different government structures (from socialist to autocratic). The reproducibility and cost of the lifestyle interventions (e.g., exercise, sleep, nutritious diet, national child care, pollution limitations) on QALYs will also be documented. The ratio of (QALY/Cost) weighted by reproducibility and transferability should give a rank-ordered list of actions humans can take to increase the quality years of human consciousness. Differences in the optimized list of rank-ordered interventions to maximize the quality of life between nation-states with varying GDP and government types (i.e., the lack of transferability) will be discussed. These local maximums for QALY optimization will be discussed in light of possible avenues that allow countries to overcome national hurdles that allow them to reach greater QALY global maximums.
\r\n
\r\n\tThis book welcomes topics related to the quality of life measurements (QALYs) both within a community and between disparate societies, as well as the transferability/durability of these QALY gains.
",isbn:"978-1-80356-609-2",printIsbn:"978-1-80356-608-5",pdfIsbn:"978-1-80356-610-8",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,isSalesforceBook:!1,isNomenclature:!1,hash:"5a6bcdaf5ee144d043bcdab893ff9e1c",bookSignature:"Ph.D. Sage Arbor",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/11474.jpg",keywords:"Health, Lifespan, Obesity, Pollution, Culture, Government, Demographics, Race, GDP, Age, Rate of Change, Automation",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"May 5th 2022",dateEndSecondStepPublish:"July 7th 2022",dateEndThirdStepPublish:"September 5th 2022",dateEndFourthStepPublish:"November 24th 2022",dateEndFifthStepPublish:"January 23rd 2023",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"7 days",secondStepPassed:!1,areRegistrationsClosed:!1,currentStepOfPublishingProcess:2,editedByType:null,kuFlag:!1,biosketch:"A computational biologist that has worked across a broad biomedical spectrum to optimize human health, Dr. Arbor combines research from academia (Duke, Washington University) and companies (Pfizer, Dupont) to deliver datasets to the wider scientific community. His recent focus includes quality of life modifiers and bioethical versus religious standards.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"245319",title:"Ph.D.",name:"Sage",middleName:null,surname:"Arbor",slug:"sage-arbor",fullName:"Sage Arbor",profilePictureURL:"https://mts.intechopen.com/storage/users/245319/images/system/245319.png",biography:"Sage Arbor is a computational biologist whose research includes fields ranging from drug design, systems biology, and epigenetic database creation to fitness app development. His work spans a broad biomedical spectrum from drug design to clinical trial analysis, including being a medical school professor and researcher, project management of developers/analysts of globally distributed labs, electronic medical record data mining (SQL and NoSQL), Python/pandas coding, data segmentation, 6σ improvement, pathway mapping, and computational drug design and synthesis. Having worked at multiple academic institutions (Duke, Marian University) and companies (e.g., Pfizer and Dupont), his research has been on both proprietary and open-access datasets for publication to the wider scientific community. His recent publication topics include quality of life modifiers, therapeutic interventions for Alzheimer\\'s disease, bioethical versus religious standards, and scientific training in those deciding public policy.",institutionString:"Duke University School of Medicine",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Duke University School of Medicine",institutionURL:null,country:{name:"United States of America"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"23",title:"Social Sciences",slug:"social-sciences"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"429339",firstName:"Jelena",lastName:"Vrdoljak",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/429339/images/20012_n.jpg",email:"jelena.v@intechopen.com",biography:"As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6926",title:"Biological Anthropology",subtitle:"Applications and Case Studies",isOpenForSubmission:!1,hash:"5bbb192dffd37a257febf4acfde73bb8",slug:"biological-anthropology-applications-and-case-studies",bookSignature:"Alessio Vovlas",coverURL:"https://cdn.intechopen.com/books/images_new/6926.jpg",editedByType:"Edited by",editors:[{id:"313084",title:"Dr.",name:"Alessio",surname:"Vovlas",slug:"alessio-vovlas",fullName:"Alessio Vovlas"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6942",title:"Global Social Work",subtitle:"Cutting Edge Issues and Critical Reflections",isOpenForSubmission:!1,hash:"222c8a66edfc7a4a6537af7565bcb3de",slug:"global-social-work-cutting-edge-issues-and-critical-reflections",bookSignature:"Bala Raju Nikku",coverURL:"https://cdn.intechopen.com/books/images_new/6942.jpg",editedByType:"Edited by",editors:[{id:"263576",title:"Dr.",name:"Bala",surname:"Nikku",slug:"bala-nikku",fullName:"Bala Nikku"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"314",title:"Regenerative Medicine and Tissue Engineering",subtitle:"Cells and Biomaterials",isOpenForSubmission:!1,hash:"bb67e80e480c86bb8315458012d65686",slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/314.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"65172",title:"Oocyte Activation Failure: Physiological and Clinical Aspects",doi:"10.5772/intechopen.83488",slug:"oocyte-activation-failure-physiological-and-clinical-aspects",body:'\n
\n
1. Introduction
\n
In vitro fertilization (IVF) techniques enabled conception outside the body and led to the birth of the first child conceived in vitro in 1978 [1]. The first laboratory technique used for conception in vitro was “classic” IVF where a suspension of prepared sperm cells is added to oocytes surrounded by cumulus cells and fertilization occurs naturally. The most discouraging result of such assisted reproduction technology (ART) treatment was fertilization failure, occurring often with the male infertility factor or unexplained infertility. The development of a micromanipulation technique named intracytoplasmic sperm injection (ICSI) in 1990 [2] enabled new treatment possibilities for many couples. Bypassing initial steps in the process of natural fertilization, a single spermatozoon is inserted directly into the cytoplasm. Successful fertilization is thus also achieved with low sperm numbers, surgically retrieved sperm, or frozen sperm samples. ICSI was soon globally accepted as a reliable technique leading to successful fertilization, pregnancy, and healthy offspring. Although ICSI can overcome some fertilization problems, total fertilization failure (TFF) still occurs in some ICSI cycles. In some patients, this failure can repeat in several ART cycles. Some patients have extremely low fertilization rates, which consequently lowers their chances for successful treatment.
\n
Studies of etiology of fertilization failure after ICSI revealed that the predominant cause is oocyte activation failure [3, 4]. In humans, oocyte activation is the transition of the oocyte into a zygote where a series of intracellular calcium (Ca2+) oscillations following the fusion of the gametes play an essential role. Calcium ions are released from intracellular storage in the endoplasmic reticulum; free in the cytosol, they are intracellular messengers and act as modulators of processes in the early steps of fertilization and embryo development. In humans, oocyte activation thus describes a cascade of events that lead to completion of the meiosis, cortical granule exocytosis for prevention of polyspermy, formation of the male and female pronuclei and progression in the first embryonic cell cycle. Both sperm and oocyte defects can cause failed activation.
\n
Artificial oocyte activation (AOA) methods can be used in clinical practice in reproductive medicine in rare cases of TFF or low fertilization. AOA tries to reproduce elevations of calcium ion concentration in cytosol, which are necessary for triggering downstream processes in oocyte activation.
\n
\n
\n
2. Total fertilization failure (TFF) after ICSI
\n
Total fertilization failure after ICSI is complete lack of fertilization at the standard checking time of 17 ± 1 h post ICSI. This means that the obvious sign, female and male pronuclei, is not visible in any of the injected mature oocytes in the metaphase of meiosis II (MII) of the patient.
\n
According to data from the literature, complete fertilization failure occurs in: 2 [5], 1.3 [6], 3 [7], 3 [8], 5.6 [9], and 4.3% [10] of ICSI cycles.
\n
Complete fertilization failure after ICSI is directly correlated with the number of mature oocytes available [9], so the definition is needed. TFF is not surprising in cases of poor ovarian response, nonmotile spermatozoa, or poor sperm morphology. But even if we have a sufficient number of mature oocytes of normal morphology and sperm of good quality, TFF happens and can reoccur in subsequent cycles.
\n
Another problem that also lowers the chances for successful treatment of infertility is an extremely low fertilization rate.
\n
\n
2.1 Results of retrospective analysis of data from our center
\n
We analyzed all consecutive ICSI cycles in the period between years 2011 and 2016. Results are presented in Table 1. In this period, we performed 7474 ART cycles (IVF and ICSI) in our center. The majority of these cycles were stimulated with gonadotropins (recombinant FSH or highly purified human menopausal gonadotropin) with pituitary suppression using agonists or antagonists, followed by hCG administration for 36–37 h before ultrasound-guided follicle aspiration. Some of these cycles were natural cycles, as previously described in [11].
\n
\n
\n
\n
\n
\n
\n\n
\n
\n
Cycles with ≥3MII
\n
Cycles with <3MII
\n
Cycles with >0% and <30% fertilization (≥3MII)
\n
Cycles with >70% fertilization (≥3MII)
\n
\n\n\n
\n
N of all cycles
\n
3550
\n
983
\n
175
\n
1980
\n
\n
\n
N of TFF cycles (%)
\n
76 (2.14%)
\n
171 (17.4%)
\n
/
\n
/
\n
\n
\n
Woman age (years)
\n
35.62 ± 4.42
\n
37.26 ± 4.69
\n
34.70 ± 4.96
\n
34.14 ± 4.65
\n
\n
\n
Stimulation protocol
\n
\n
\n
• Natural cycles
\n
/
\n
35 (20.5%)
\n
/
\n
/
\n
\n
\n
• Long protocol with agonists GnRHa
\n
26 (34.2%)
\n
23 (13.5%)
\n
58 (33.1%)
\n
595 (30.6%)
\n
\n
\n
• Short protocol with antagonists antGnRH
\n
45 (59.2%)
\n
101 (59.1%)
\n
105 (60.0%)
\n
1297 (65.1%)
\n
\n
\n
• Other
\n
5
\n
12
\n
12
\n
88
\n
\n
\n
Duration of stimulation
\n
10.40 ± 1.95
\n
8.77 ± 4.85
\n
9.96 ± 1.76
\n
9.98 ± 1.8
\n
\n
\n
Gonadotropin dose (ampoules)
\n
32.80 ± 11.84
\n
31.53 ± 20.72
\n
28.86 ± 10.75
\n
27.34 ± 9.92
\n
\n
\n
N oocytes
\n
8.04 ± 6.10
\n
2.02 ± 2.46
\n
10.16 ± 5.4
\n
10.16 ± 5.95
\n
\n
\n
MII
\n
5.80 ± 4.13
\n
1.25 ± 0.44
\n
7.91 ± 4.41
\n
8.51 ± 5.07
\n
\n
\n
2PN
\n
0
\n
0
\n
1.35 ± 1.21
\n
7.37 ± 4.33
\n
\n
\n
1PN
\n
0.07 ± 0.25
\n
0.09 ±0.30
\n
0.16 ± 0.40
\n
0.12 ± 0.37
\n
\n
\n
3PN
\n
0.16 ± 0.49
\n
0.26 ± 1.11
\n
0.22 ± 0.64
\n
0.10 ± 0.35
\n
\n
\n
Damaged
\n
0.29 ± 0.82
\n
0.26 ± 1.11
\n
0.57 ± 1.06
\n
0.22 ± 0.55
\n
\n
\n
Male diagnosis
\n
\n
\n
\n
\n
\n
\n
• Normozoospermia (% of TFF cycles)
\n
15 (19.74%)
\n
61 (35.67%)
\n
31 (17.7%)
\n
371 (18.7%)
\n
\n
\n
• Krypto- and azoospermia (% of TFF cycles)
\n
18 (23.68%)
\n
17 (9.94%)
\n
45 (25.7%)
\n
214 (10.8%)
\n
\n
\n
ET
\n
0
\n
0
\n
1.04 ± 0.76
\n
1.57 ± 0.69
\n
\n
\n
Clinical pregnancy
\n
/
\n
/
\n
39/220 17.7%
\n
702/1822 38.5%
\n
\n
\n
Birth rate
\n
/
\n
/
\n
13.2%
\n
30.5%
\n
\n\n
Table 1.
Analysis of all consecutive ICSI cycles performed in our clinic in the period between years 2011 and 2016 (N = 4533); cycles with at least one mature oocyte in the metaphase stage of meiosis II (MII) are included. Data are presented in means ± SD or number of cases (percentage of all cases in a group).
\n
In this period, we performed 4533 ICSI cycles with at least one mature oocyte in the metaphase stage of meiosis II (MII) available. Complete fertilization failure (TFF) occurred in 247 (5.5%) of ICSI cycles.
\n
We compared standard characteristics of these cycles regarding the number of oocytes. There were 3550 cycles with 3 or more MII oocytes, TFF occurred in 76 among the (2.14%) cycles. There were 983 cycles with 1 or 2 MII oocytes available, TFF occurred in 171 among them (17.4%). A total of 35 of these TFF cycles were natural cycles.
\n
We also analyzed the characteristics of cycles with 3 or more MII oocytes and low fertilization; in doing so, we took into account cycles with more than 0% and less than 30% MII oocytes fertilized. There were 175 such cycles (3.9%).
\n
Woman’s age is greater in cycles with fewer oocytes, which can be explained with lower ovarian reserve in greater age. Regarding the stimulation protocol of the ART cycles, there were 35 natural cycles in the group with <3 MII oocytes. In our center, natural cycles are mainly performed in patients with extremely low ovarian response, where increasing gonadotropin dosage does not increase the chance to obtain more oocytes.
\n
In TFF cases where 3 or more MII oocytes are available, there is a higher proportion of severe male infertility cases (22.68%) compared to the cycles with less than 3 MII oocytes (9.94%). When there are more oocytes available, there is statistically less probability for TFF, and more cases of TFF are due to gamete defects. A similar proportion of low fertilization cycles are those with severe male infertility (25.7%). Severe male infertility is described as diagnosis of cryptozoospermia and azoospermia, where individual sperms have to be extracted from semen sediments or testis aspirates/biopsies.
\n
In cases where only one mature oocyte was available, total fertilization failure occurred more often (30.8%) than in those with more oocytes.
\n
In Figure 1, the correlation between the number of available mature oocytes and occurrence of TFF is presented. With more oocytes available, there is less probability for TFF.
\n
Figure 1.
Number of available oocytes and incidence of TFF. The proportion of ICSI cycles with total fertilization failure regarding the number of mature oocytes available; x = number of injected MII oocytes; y = % of cycles with TFF. 4533 ICSI cycles analysed.
\n
\n
\n
\n
3. Etiology of failed fertilization after ICSI
\n
Soon after implementation of the ICSI technique, some investigations of possible reasons for unsuccessful fertilization began. It was first speculated that perhaps the proportion of unfertilized oocytes arises from technical limitations of the method itself that cannot deliver the sperm in the cytoplasm, or ejection of the sperm from the cytoplasm occurs after injection. It was established that in only 7 [12], 16.7 [7], 10.6 [13], and 12.6% [14] of unfertilized oocytes after ICSI the sperm DNA was outside the oocytes.
\n
With different staining techniques, visualization of the chromatin, spindle, and other structures was possible, and this enabled a better understanding of at what stage unfertilized oocytes are (Table 2). It soon became evident that the majority of unfertilized oocytes are arrested in the metaphase of the meiosis II with different levels of sperm chromatin decondensation, which suggested that oocyte activation and sperm decondensation run independently [15]. In the majority of these oocytes, sperm chromatin is in a decondensed state, which indicates that protamines are usually successfully replaced by histones [14], so unsuccessful decondensation of sperm chromatin can be the underlying cause for only a relatively small proportion of unfertilized oocytes. Premature chromosome condensation (PCC) is a condition when sperm chromosomes are getting condensed in the cytoplasm of oocyte too early and the right synchronization between sperm and oocyte genetic material is compromised. Up to 33% of studied unfertilized oocytes had PCC [15], but it is difficult to conclude whether this indicates sperm- or oocyte-borne defect.
Giemsa: stain for adenine-thymine rich regions in DNA
\n
n = 82 NF MII
\n
93% oocytes having sperm in cytoplasm and MII chromosomes of the oocyte present; of these 51% SC, 41% intact SC, 8% premature chromosome condensation (PCC)
Chromomycin A3: binds to G-C rich DNA regions, does not bind to DNA coupled with protamines Propidium iodide: fluorescent DNA stain
\n
n = 93 NF MII
\n
74.8% metaphase MII oocytes; of these 63.6% decondensed SC, 23.4% condensed SC, and 13% no sperm in the cytoplasm. In majority of spermatozoa, successful replacement of protamines with histones took place.
\n
\n
\n
Rawe VY, Olmedo SB, Nodar FN, Doncel GD, Acosta AA, and Vitullo AD [16]
\n
Immunofluorescence analysis with immunoglobulins and monoclonal antibodies
\n
n = 150 NF MII
\n
13.3% oocytes with no sperm, 39.9% activation failure, 22.6% defects of pronuclear formation/migration, 13.3% arrest in metaphase of the 1st mitotic division
On the basis of the studies listed in Table 2, we can conclude that failed oocyte activation seems to be the predominant reason for fertilization failure. However, it is unclear whether the cause is sperm or oocyte defect, since proteins, organelles, and metabolic paths of both gametes are involved in the activation.
\n
Oocyte activation failure being the main problem was also confirmed by electron microscopy, where unreleased cortical granule at periphery, maternal chromosomes in the metaphase plate, and paternal intact or partially decondensed chromatin were found [3]. These are all signs of failed activation, but it is difficult to conclude on which level in the cascade there is a failure.
\n
Perhaps, in the future, genetic data will give us more information on the etiology of fertilization failure. An interesting case report where researchers investigated possible reasons for fertilization failure on genetic levels analyzed gene expression profiles in unfertilized oocytes of a patient with previous TFF history [17].
\n
\n
\n
4. Oocyte activation
\n
Oocyte activation is a downstream cascade triggered by sperm that causes progression of the oocyte from meiosis arrested in metaphase II toward its completion and beginning of embryonic development. It is a serial of biochemical reactions, organelle redistribution, changes in metabolism, transmembrane potentials, mRNA translation, gene transcription, and cytoskeletal rearrangements.
\n
The role of calcium in fertilization was established very early with a series of experiments on sea urchin eggs where the amount of bound and free calcium was measured in fertilized and nonfertilized eggs [18]. Later, calcium-specific light-emitting protein aequorin injected in fish oocytes enabled visualization of light flash after fusion of oocyte and sperm [19]. It soon became evident that calcium ions play an essential role in activation of the animal oocyte and that the frequencies and amplitudes of these elevations of calcium ions in cytoplasm are species-specific [20].
\n
The term “oocyte activation” probably evolved on the basis of these evident sudden changes that happen during the transition from oocyte to embryo. It describes not only calcium waves that occur but also other processes and morphological changes that happen during fertilization. Intracytoplasmic calcium elevation is essential for fertilization, but it is not always the sperm that triggers it. In some animal species such as fruit flies (Drosophila) the calcium wave occurs prior to oocyte-sperm fusion, during ovulation [21]. The focus of our text will be human oocyte activation, but since nonhuman biological material is usually more available or even easier to study, many data on fertilization come from studies on sea organisms such as starfish and sea urchins or different mammalian species. Early studies of the role of calcium in the process of fertilization and even use of ionophores are well documented in the review of Epel [22]. The source of an intracellular rise of calcium ion concentration can be external—calcium enters the cell by influx through calcium channels in the plasma membrane or can be released in cytoplasm from intracellular stores in the endoplasmic reticulum [23].
\n
But it is important to understand that the details vary a lot through the animal kingdom and that these differences can be the reason why the ICSI method can be successful in humans but not in other species. However, the animal studies are the foundation for the development of assisted reproduction techniques in human medicine.
\n
Early studies of fertilization in mammals are well reviewed by Miyazaki [24]; in sum, there is the first hyperpolarization of membrane potential as a result of a change in potassium conductivity across the plasma membrane. This coincides with an increase of free calcium in cytosol; there is no electrical block of polyspermy and a serial of intracytoplasmic rises of calcium concentration follow continuously (oscillations) at intervals of different frequencies and amplitudes, which depends on the species studied. Intracellular calcium first rises near the site of the sperm attachment and spreads like a wave over the entire egg [24]. The model of generating calcium spikes from intracellular stores in the endoplasmic reticulum was described by Igusa and Miyazaki [25]. The techniques used for revealing these processes were measurements with calcium-sensitive microelectrodes, the voltage-clamp technique, aequorin injections, injection of calcium ion chelators, and injection of different compounds that interact with the calcium-releasing system.
\n
The first study of calcium measurements at fertilization in human oocytes showed that the first rise in intracytoplasmic calcium concentration appears 20–35 min after adding sperm suspension in a chamber with oocytes; spikes appear every 10–35 min, with a single spike of amplitude up to 2.25 μM calcium concentration and duration of 100–120 s [26].
\n
Other researchers studied changes of membrane potential across the plasma membrane in human oocytes at fertilization and showed that the increase of potassium ion conductivity of the plasma membrane and outward current of ions, which causes hyperpolarization, is calcium dependent [27]. A study on bovine oocytes gave more information about the relationship between hyperpolarization of the plasma membrane potential and calcium release from intracellular stores and targeted calcium-activated potassium channels as membrane proteins involved in the process [28].
\n
Soon after introducing ICSI, it was of great interest to compare these responses with the classic IVF method, where events such as sperm capacitation and activation, acrosome reaction, and sperm-oocyte membrane fusion happen first. From the work of Tesarik et al. [29], we can see that when performing ICSI in human oocytes, the first intracytoplasmic rise of calcium ion concentration happens immediately; the peak is 10–15 s after penetration with the needle. Sperm then evokes intracellular calcium oscillations. They described that oscillations follow the lag period that lasts 4–12 h. Oscillations are in the form of spikes that last 20 s; the intervals between spikes are 1–5 min. The duration of the oscillatory phase is 30 min–1 h; at the end of the period, the amplitude of calcium spikes gets smaller.
\n
The proposed mechanism through which calcium oscillations are maintained is through the phosphoinositide signaling pathway, where inositol 1,4,5-trisphosphate (InsP3) is generated from phosphatidylinositol 4,5-bisphosphate (PIP2) [23]. The positive feedback cycle involving calcium-dependent InsP3 generation and InsP3-induced calcium release seem to be responsible for the oscillations [23]. The main protein is InsP3 receptor (InsP3R), a ligand-gated channel found in the membrane of the endoplasmic reticulum that allows calcium release from the ER [30].
\n
That calcium oscillations have a role in long-term embryonic events and provide more than merely a stimulus for meiotic resumption was shown in experiments with different activating agents and subsequent measurements of cell mass of the blastocyst [31].
\n
\n
4.1 The role of free calcium ions in cytoplasm
\n
Calcium is the secondary messenger that regulates different events during fertilization, such as progression of the cell cycle from metaphase II arrest toward chromatid segregation, extrusion of the second polar body and completion of the second meiotic division, and cortical granule exocytosis [32]. The role of calcium in reproduction is preserved through evolution; it is important in plants and animals. Species-specific calcium signatures, like oscillations in mammals, have evolved, which are optimal for activation and development of a specific type of organism [33]. The variations in amplitude, duration, and frequency of oscillations over time are coordinated with the cell cycle, and experimentally changing them also affects development in the later stages when blastocyst forms [31]. Experiments with injecting calcium (Ca2+) chelators in the cytosol of frog eggs demonstrated the blockage of activation [34].
\n
Calcium rises in cytosol are converted in different cellular responses.
\n
\n
4.1.1 Ca2+-dependent process of cortical granule exocytosis
\n
Cortical granule exocytosis enables polyspermy block by altering the zona pellucida with the content of the granule (proteases, peroxidases, and glycosaminoglycans) and prevent more sperms from fertilizing oocytes. The proposed model is that calcium stimulates Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) and myosin light-chain kinase (MLCK) that phosphorylate a vesicle targeting protein and myosin II to promote exocytosis [33]. It is a quick response; in mouse oocytes, exocytosis starts 15 min after exposure to capacitated sperm, and 30 min after insemination, 78% of cortical granules disappear from cytoplasm [35]. It is proposed that each calcium oscillation cycle moves cortical granule one step closer to the egg plasma membrane toward the fusion with the plasma membrane and exocytosis of the contents [33].
\n
\n
\n
4.1.2 Ca2+ is a trigger for cell cycle progression
\n
The completion of meiosis means that the extrusion of the chromatids in the second polar body enables the formation of haploid oocytes that can form a female pronucleus that will be able to combine genetic material with the male pronucleus.
\n
Meiosis is the ground of sexual reproduction where homologous chromosomes recombine—exchange genetic material through chiasmata and generate new genetic combinations that are unique to the offspring. Mammalian oocytes progress through meiosis very slowly; first, the cell cycle is arrested in the dictyate phase of prophase I during the fetal life of a girl and stays in this phase up to 40–50 years. During the menstrual cycle, the recruited oocytes in the ovary progress through the cell cycle under the influence of the hormones. But the meiosis is again arrested at the metaphase of the second meiotic division (metMII). Calcium oscillations at fertilization activate calmodulin-dependent protein kinase II (CaMKII) and switch on the anaphase-promoting complex/cyclosome (APC/C) that leads to securin and cyclin B1 degradation necessary for cell cycle progression and segregation of sister chromatids [33].
\n
Ca2+ also plays a role in pronuclear formation by decreasing MAP kinase (MAPK) activity responsible for nuclear envelope assembly [33]. Oscillations terminate with PN formation, and PLCζ localizes into PN [36]. The mechanism by which Ca2+ recruits maternal mRNA for translation and genome activation is not well understood at the moment. There are some data indicating that calcium oscillations and mRNA translation are coupled [37]. Not only in cytosol, calcium can also diffuse to the nucleus and control different cell functions by direct nuclear calcium signaling [38].
\n
\n
\n
\n
4.2 Electrophysiology and fertilization
\n
Fertilization potential is a change in the membrane potential across the plasma membrane (PM) of the oocyte that is first observed after oocyte-sperm interaction. In many invertebrates, this is in the form of depolarization of the plasma membrane and is proposed to provide a fast block to polyspermy, described in some invertebrates and only a few vertebrates (such as frogs), but not present in mammals [39]. Lately, there have been some discussions about the nature of electrical block in preventing polyspermy [40]. The role of electrical events in the form of depolarization or hyperpolarization of the plasma membrane at fertilization remains unclear.
\n
In mammals, there is hyperpolarization of membrane potential as a result of change in potassium conductivity across the plasma membrane [24]. In human oocytes, outward current and long-lasting hyperpolarization of the plasma membrane were described [27]. The channels responsible for this hyperpolarization are calcium-activated potassium channels [41]. Species-specific differences in the channels involved in early electrical responses at fertilization are reviewed in [42].
\n
During oocyte maturation, the composition of the channels in the plasma membrane changes, as described in bovine oocytes [28]. The factors regulating the composition of channels in the plasma membrane, the conductance for different ions, depending on the specificity, gating, and sensitivity of the channels at different stages, are still unclear. The conditions during gamete maturation are very important, and we can imagine that diet and changes in metabolic pathways can affect the performance. It is not just cytoplasmic maturity of the oocyte that is important, but also maturity of the plasma membrane.
\n
The conditions in which gametes are matured are important; the diet and especially taking some medicines in this period can affect the infertility treatment outcome. There are some data from studies of calcium channel blockers used as therapy in various cardiovascular conditions. They affect the movement of free calcium ions across membranes, and dose-dependent reduction in sperm mobility and viability in vitro that can affect fertility treatment was demonstrated [43].
\n
\n
\n
4.3 Sperm factors
\n
Data from studies of fertilization pointed to a sperm component that has to trigger response in the form of calcium oscillations. But the exact component, its nature, and mechanism were long unknown.
\n
There were four main hypotheses, reviewed in [44]. The first one assumed that sperm delivers calcium to the oocyte that further stimulates release of calcium from intracellular stores. The conduit hypothesis assumed that sperm increases the permeability of the plasma membrane for calcium that enters the oocyte with influx from the surroundings. The contact hypothesis predicts that sperm interacts with a receptor on the plasma membrane that causes calcium release from intracellular stores. But success of the ICSI method revealed that there is no need for interaction of sperm and receptors in the plasma membrane for fertilization. The fourth is the sperm factor hypothesis that assumes that there is a component in the sperm cell delivered in cytosol with sperm and that this factor causes calcium release from intracellular stores.
\n
Experiments where soluble sperm extracts are injected into the oocyte coupled with different biochemical approaches enabled the search for unknown sperm factor and were in favor of the sperm factor hypothesis [45, 46].
\n
There were many candidates such as oscillin, a cytosolic sperm factor related to prokaryote glucosamine phosphate deaminase [47]. In nonmammalian species, PLCγ was identified [48] and the role of nitric oxide in fertilization was investigated [49]. In mammals post-acrosomal WW domain-binding protein (PAWP) was described, which is located in the post-acrosomal region of the sperm, from the stage of elongated spermatids onwards, that causes meiosis resumption and PN formation [50].
\n
\n
4.3.1 PLCζ
\n
When it was demonstrated that sperm extracts were related to InsP3 concentrations in cell and PLC activity [51], phospholipases were under investigation. Genetic data from the testis’ cDNA library revealed some new isoform of PLC [23] and soon a novel sperm-specific phospholipase C, PLCζ was identified as a trigger of calcium oscillations in mouse eggs [52]. In the work of Saunders et al., it was experimentally demonstrated that PLCζ content in a single sperm evoked oscillations and normal embryonic development [52]. They also prepared PLCζ complementary RNA (cRNA) for injection into MII oocytes that triggered the same effect. When they removed PLCζ from sperm extracts, they no longer induced calcium oscillations.
\n
Important evidence that PLCζ is the necessary trigger for calcium oscillations comes also from the studies of Dpy19l2 knockout mice that have globozoospermic sperm phenotype and absence of or extremely reduced PLC ζ and no ability to trigger calcium oscillations [53]. But proof in the form of the knockout mouse model was missing. By using RNA interference technology that prevents translation of PLCζ mRNA and that reduces the amount of PLCζ protein in transgenic mouse sperm, altered calcium oscillation patterns, lower egg activation, and no transgenic offspring [54] were observed.
\n
A study where whole exome sequencing was performed in patients with previous TFF, homozygous missense mutation in PLCζ was established [55].
\n
PLCζ was identified in many mammalian and nonmammalian species [56, 57] and can act across species. But there are differences in solubility of PLCζ in cytosol that can contribute to differences between species. It is proven in the mouse oocyte activation test (MOAT) that human PLCζ exhibits greater response in mouse oocytes than mouse PLCζ.
\n
The amount of PLCζ measured in a single mouse sperm cell is in the same range as the amount required to cause oscillations experimentally [52]. This can explain why altered frequency of oscillations was established when more than one sperm fertilized an oocyte [58]. PLCζ has to diffuse through cytosol to trigger spatiotemporal response in the form of a calcium wave that spreads from the point of sperm entry to the other pole.
\n
Recently, the knockout mouse model was prepared using CRISPR/Cas9 gene editing [59] and revealed interesting facts: PLCζ-null mouse males have normal spermatogenesis and normal sperm parameters (motility, capacitation, and acrosome reaction) but their sperm cannot elicit calcium oscillations after ICSI. Still, some oocytes can undergo activation in abnormal form or even develop to blastocyst stage. But mating knockout males with normal females shows that they can still produce offspring without PLCζ as a physiological trigger. Males are not infertile, rather subfertile, so there is possibility that apart from PLCζ, there is a second calcium releasing factor delivered to oocyte by sperm, perhaps an alternative that is used only when PLCζ is missing.
\n
Calcium oscillations are normal physiological stimuli for oocyte activation but from parthenogenetic activation at ICSI and from the use of artificial oocyte activation techniques we already know that they are not always necessary to activate oocytes. They can be bypassed on some levels.
\n
There are still many facts about calcium oscillations triggering that are not well understood. The proposed mechanism of activation is reviewed in [23] and represented in a schematic diagram (Figure 2): PLCζ diffuses from the sperm head into egg cytosol and hydrolyses the PIP2 (phosphatidylinositol 4,5-bisphosphate) in the membrane of the vesicle compartment into products InsP3 (inositol 1,4,5-trisphosphate) and DAG (diacylglycerol). InsP3 binds to the receptor InsP3R on the endoplasmic reticulum membrane. The conformation of the channel is changed and it becomes permeable for Ca2+ ions that are released from intracellular storage in the endoplasmic reticulum into cytosol. Oscillations are generated through a positive feedback loop.
\n
Figure 2.
Schematic diagram of the proposed model of sperm triggered oocyte activation at fertilization in mammals: after the fusion of sperm and oocyte plasma membrane PLCζ diffuses from sperm into oocyte cytosol. Vesicles baring PIP2 are present in cytosol and PLCζ hydrolyzes PIP2 into products DAG and InsP3. InsP3 binds to the InsP3R present in the membrane of ER. InsP3R is a ligand-gated Ca2+ release channel and Ca2+ is released from intracellular stores in ER into the cytosol. In mammals, repetitive Ca2+ oscillations occur, and several rises of calcium concentration in cytosol take place. Ca2+ ions play an essential role in oocyte activation. They enable block of polyspermy by chemically altering zona pellucida with the content of cortical granules that are released in the perivitelline space. Ca2+ ions enable cell cycle progression—resumption of meiosis II. Ca2+-dependent inactivation of factors that hold cell cycle in arrested state takes place, by degradation of cyclinB1 and securin and MPF inactivation of cell cycle eventually progresses. Ca2+ ions play a role in recruitment of mRNAs and affect their translation. Ca2+ can diffuse in the nucleus and play a role in embryonic gene activation. Ca2+ oscillations terminate when female pronucleus is formed and PLCζ relocalizes in the pronucleus. PLCζ—phospholipase C zeta, PIP2—phosphatidylinositol 4,5-bisphosphate, InsP3—inositol 1,4,5-trisphosphate, DAG—diacylglycerol, InsP3R—inositol 1,4,5-trisphosphate receptor, Ca2+—calcium ions, ZP—zona pellucida (the glycoprotein envelope surrounding mammalian oocyte), PV—perivitelline space (space between ZP and plasma membrane of oocyte), PM—plasma membrane, cg—cortical granules, and PN—pronucleus.
\n
In a series of experiments on mouse oocytes injected with RNA encoding PLCζ and tagged with a fluorescent protein, it was established that at the time when calcium oscillations terminate and pronucleus is formed, PLCζ protein translocates from the cytosol to the pronucleus [36]. Authors also demonstrated that it is again released in the cytosol in the first mitotic division of an embryo at the time of nuclear envelope breakdown and observed also in the second mitotic division. This suggests the possible role of calcium oscillations not only in oocyte activation but also in early embryonic development.
\n
All together there is a lot of accumulating evidence that points toward PLCζ as a trigger of oocyte activation cascade in mammals. Soon the idea of using recombinant PLCζ in clinical practice emerged that will be discussed later among other methods for artificial oocyte activation. But still there are many data missing that are needed to fully understand oocyte activation.
\n
\n
\n
4.3.2 Other sperm-related factors that affect oocyte activation
\n
Spermatozoon has to go through many changes in order to be able to fertilize an oocyte naturally. First, the mechanism of chemotaxis between the gametes plays an important role; capacitation is the process of altering the sperm plasma membrane so that it becomes more permanent for calcium ions, then changes in sperm movements in the form of hyperactivation help to bring the spermatozoon closer to the oocyte. Finally, at acrosome reaction the content of acrosomes (enzymes) facilitates the fusion between the plasma membrane of the oocyte and spermatozoon so that the paternal genetic material can enter the oocyte. Sperm also delivers a centriole into the oocyte that duplicates and forms centrosome, a microtubule-organizing center responsible for mitotic divisions in a growing embryo. ICSI bypasses many of these events and enables fertilization and successful development, but there are still sperm factors other than PLCζ that can contribute to failure of oocyte activation.
\n
Successful sperm chromatin decondensation is a necessary condition for fertilization. The chromatin of the spermatozoon is uniquely packaged in such a way that histones become replaced by protamines during the spermatogenesis. Protamines provide more structural stability but after the entry of the spermatozoon into the oocyte the chromatin of the spermatozoon must be uncoiled and protamines must be replaced by histones. Proteins and other factors in the cytosol of an oocyte play a role in the correct decondensation of male genetic material.
\n
Mitosis-promoting factor (MPF) in the cytosol of an oocyte can cause premature chromosome condensation (PCC), but perhaps it is not only an oocyte-related problem. It was established that protamine-deficient sperm seems to be related to a higher proportion of PCC independent of oocyte cytoplasmic maturity [60, 61]. The cell cycle of spermatozoa is related to chromatin status and protamine-histone remodeling must be synchronized with the oocyte.
\n
\n
\n
\n
4.4 Oocyte factors
\n
If PLCζ depletion in sperm is a good candidate for explaining fertilization failure of male origin, less is known about different oocyte defects that cause unsuccessful activation. It is obvious that oocyte maturation is crucial and competent oocytes of good quality with all the necessary elements in the downstream cascade must be available. In the process of oocyte maturation, not only the elements responsible for generating calcium oscillations must develop but also all other elements such as those responsible for exocytosis of cortical granules, the necessary actin cortical cytoskeleton, and energy resources must be available.
\n
The direct proof of oocyte-borne defects is the results of the mouse oocyte activation test (MOAT) that will be discussed in detail later. It is a heterologous model where mouse oocytes are fertilized with the patient’s sperm. Successful fertilization of mouse oocytes points toward oocyte defects that are the underlying cause of previous fertilization failure in ART treatments in a specific couple.
\n
\n
4.4.1 Organelle distribution
\n
Studies of the ultrastructure of unfertilized oocytes with transmission or scanning electron microscopy revealed differences in oocyte ultrastructure that can reflect different stages in oocyte maturation [62].
\n
Cortical granule migration toward the plasma membrane is an important step in cytoplasmic maturation and it is a cytoskeleton-dependent process [63].
\n
Some studies have investigated the relationship between mitochondrial function and fertilization. Unfertilized oocytes exhibit a higher proportion of mtDNA deletions that may contribute to their malfunction and ATP production [64]. As the early embryo requires a lot of energy, it is important that during oocyte maturation a sufficient number and functionality of the mitochondria are prepared.
\n
Reorganization of the endoplasmic reticulum (ER) during maturation seems to play an important role in oocyte competence to generate calcium oscillations. Visualization of the ER in mouse oocytes revealed that in prophase I (in the germinal vesicle stage) the ER is in the form of a fine network with patch-like accumulations in the inner cytoplasm. After the resumption of meiosis, the ER accumulates in the form of a dense ring in the center of the oocyte, around the meiotic apparatus; later the ER rings move together with a meiotic spindle toward the oocyte cortex [65]. In oocytes in metaphase II, the ER ring transforms into clusters in the cortical region; in the central cytoplasm the reticular form is present [65]. These researchers also showed that these relocalizations happen independently from meiotic progression and that microtubules, dyneins, and actins are responsible for the movements.
\n
During oocyte maturation, the Ins3R receptors responsible for calcium release from the endoplasmic reticulum achieve their functionality. In a mouse model, it was demonstrated that increase in IP3R1 sensitivity is underpinned, at least in part, by increases in calcium concentrations within the endoplasmic reticulum and receptor phosphorylation but not by changes in IP3R1 distribution [66].
\n
Distribution of vesicles with PIP2 is also important. PLCζ diffuses from the sperm head into egg cytosol and acts on PIP2 that is present in the membrane of small vesicles in the cytoplasm. Defects or deficits of PIP2 or vesicles could contribute to fertilization failure [30].
\n
\n
\n
4.4.2 Cytoplasmic maturation
\n
Evaluation of oocyte maturity relies on the presence of the first polar body, but it is difficult to evaluate in daily IVF laboratory practice whether the oocyte cytoplasm is mature.
\n
Cytoplasmic maturity is an important factor determining the ability of the oocyte to activate. During oocyte cytoplasmic maturation, the mechanisms responsible for sperm-induced calcium oscillations and oocyte activation develop and are reviewed in [67].
\n
It was experimentally shown in LT/Sv mouse strain (that has abnormal oocyte nuclear maturation arrested at metaphase I) that the ability of these oocytes to be activated by sperm develops gradually during cytoplasmic maturation independent of nuclear maturation [68].
\n
Oocyte cytoplasmic maturity also plays a role in decondensation of the sperm genetic material that is tightly packed with protamines. Oocyte immaturity is correlated to the occurrence of premature chromosome condensation (PCC) of the male pronucleus [69].
\n
Evaluation of cytoplasmic maturity with immunocytochemical methods revealed that metaphase plate rearrangements are more frequent in oocytes showing immaturity [70]. Another study investigated abnormal maturation in patients with a high proportion of immature oocytes [71].
\n
It is obvious that the conditions in which oocytes mature are important and beside patient-related factors there are also cycle-specific factors that have an impact on oocyte maturity, quality, and fertilization. Little is known about the cellular mechanisms of how diet, medicament uptake, or tobacco/alcohol intake affect oocyte quality. In a review of [72], the environmental impact on oocyte function through mitochondrial level is discussed.
\n
\n
\n
\n
\n
5. Artificial oocyte activation (AOA)
\n
Artificial oocyte activation methods try to induce oocyte activation by using physiological properties of the gametes and in this way interfere in different levels of the cascade of events during fertilization. In general, they try to alleviate intracellular calcium concentration and mimic oscillations. As we are well aware by now that there is big species-specific variability in the mechanisms of oocyte activation, it is not surprising that different AOA methods can be successful in one species, but not in another.
\n
By influencing gamete physiological properties such as electrical excitability and plasma membrane conductivity, the aim is to increase intracytoplasmic calcium concentrations and mimic the frequency and amplitude of the oscillations.
\n
Basically, there are three types of AOA methods: electrical, chemical, and mechanical.
\n
\n
5.1 Electrical methods
\n
By applying direct electrical current within a Petri dish with oocytes, the electrical field stimulates charged proteins to move toward the plasma membrane, and by this, the number of pores in the plasma membrane increases [30]. Calcium conductivity increases, and more calcium enters the oocyte from the surroundings. There is only one large calcium concentration increase.
\n
In the prospective randomized study of [73], an electrical pulse in a special chamber with electrodes 30 minutes after ICSI in 0.3 M glucose drops was used to activate oocytes, and a small increase in the fertilization rate after ICSI was achieved. Successful pregnancy and birth were achieved and reported in the case report [74].
\n
In a study with round spermatid injection coupled with electrostimulation, the electrical pulse triggered not only a single calcium concentration increase, but a series of calcium spikes after spermatid injection [75].
\n
\n
\n
5.2 Chemical methods
\n
Chemical activation is the most commonly used method. Oocytes are exposed to chemical agents that lead to an increase in intracellular calcium concentration in the oocyte. Some agents, such as calcium ionophores cause a single, prolonged calcium transient, while others cause multiple oscillations.
\n
\n
5.2.1 Ionophores
\n
Calcium ionophores, such as ionomycin, A23187 (calcimycin), and gm508 are molecules soluble in lipids, synthesized by microorganisms; today several synthetic compounds are known. They can transport ions across lipid bilayers. They increase membrane permeability for Ca2+ ions, thus allowing calcium influx in the oocyte from the surrounding medium and intracytoplasmic rise of calcium concentration. It has been recently established that intracytoplasmic rise of calcium concentration in human and mouse oocytes is not only the consequence of the influx from the surroundings but also from intracellular stores, since this rise appears also in calcium-free medium. However, they are not able to induce calcium oscillations typical for mammalian species but a single rise. Different protocols are described in the literature, regarding different concentrations used, and intervals of ionophore exposition [76, 77, 78, 79].
\n
They are used in cases of repeating TFF or low fertilization, oligoteratoasthenospermia cases, globozoospermia, in vitro maturation of oocytes (IVM), unexplained female infertility, and low ovarian reserve, with patients with Kartagener’s syndrome with no response on theophylline, at primary ciliary dyskinesia. They are the most widely used chemical agents for artificial oocyte activation.
\n
\n
\n
5.2.2 Strontium chloride (SrCl2)
\n
It is reported as very efficient in mice and induces not only single calcium concentration elevation, but oscillations [80]. The mechanism by which it induces oscillations is not fully understood.
\n
A study that investigated efficacy of SrCl2 in human oocytes showed significantly increased fertilization rates, when compared with conventional ICSI or calcium ionophore treatment [81].
\n
\n
\n
5.2.3 PLCζ
\n
Soon after the discovery of the role of PLCζ as a trigger of oocyte activation, the ideas of using the protein as an artificial activator emerged. The synthesis of the first recombinant human PLCζ protein was published [82]; when injected into mouse oocytes, calcium oscillations were evoked that closely resembled those initiated by the sperm after fertilization. Later, a study where human recombinant PLCζ was used on human and mouse oocytes was published [83] describing dose-dependent manner of calcium oscillations. These authors also showed that by injecting recombinant human PLCζ the next day in oocytes that failed to fertilize after ICSI, five of eight oocytes were rescued.
\n
Earlier, it was established that PLCζ complementary RNA (cRNA) injection in MII oocytes also triggered oscillations [52] with a time lag that enables protein to synthesize.
\n
The commercial use of recombinant human PLCζ still has to be validated in terms of safety.
\n
\n
\n
5.2.4 Ethanol
\n
In veterinary medicine, ethanol is often used for parthenogenetic oocyte activation. Parthenogenesis is development of an embryo from an unfertilized oocyte, naturally occurring in invertebrates or even some vertebrates. By inhibiting the second polar body extrusion, diploid parthenotes with two maternal genomes can be created and embryos can develop normally for several days, but later die. In several species, artificial parthenogenetic activation was described to be caused by ethanol [84].
\n
\n
\n
\n
5.3 Mechanical methods
\n
Some data from the literature suggest that the modified ICSI technique can give better fertilization in patients with a history of TFF or low fertilization [85, 86]. Vigorous aspiration of cytoplasm and a different position of the pipette tip when ejecting sperm in the oocyte is supposed to increase calcium levels during injection and enable better contact of sperm with intracellular storage of calcium.
\n
\n
\n
\n
6. Diagnostic tools for assessing sperm- or oocyte-dependent activation defects
\n
A proper diagnostic procedure is very important prior to the decision to use artificial oocyte activation, and oocyte or sperm donation is a reasonable treatment option for some couples [87].
\n
There are several diagnostic methods available, but not always accessible to all clinics since legislation can prohibit the use of heterologous human-animal models.
\n
The mouse oocyte activation test (MOAT) is a heterologous ICSI model where mouse oocytes are fertilized with the patient’s sperm [78]. As a negative control, mouse oocytes are injected with the medium and as a positive control, they are injected with donor sperm with proven fertilizing ability. It allows discrimination between sperm- and oocyte-borne causes for fertilization failure. According to the ratio of fertilized mouse oocytes, three groups are described: MOAT1 indicating sperm-borne defects, MOAT2 fertilization failure of unknown origin, MOAT3 sperm defects are excluded indicating oocyte defects.
\n
In some patients from groups MOAT2 or MOAT3, capacity to activate mouse oocytes is demonstrated but later ICSI-AOA results in TFF. In these cases, assessment of calcium oscillations can give better answers as to whether the underlying reason is the presence of human sperm activation deficiencies or oocyte-related activation deficiency. Mouse oocyte Ca2+ analysis (M-OCA) or even more sensitive human oocyte Ca2+ analysis (H-OCA) can be performed before using AOA [88]. In the M-OCA test, the patient’s sperm is used and frequency patterns of calcium oscillations are analyzed. H-OCA yields higher sensitivity than M-OCA to detect the presence of human sperm activation deficiencies. It helps detect cases with suspected oocyte-related activation deficiency.
\n
\n
\n
7. Success rates of AOA
\n
The systematic review and meta-analysis of RCTs that compared ICSI-AOA and conventional ICSI first established that there is insufficient evidence available from RCTs to judge the efficacy and safety of ICSI-AOA for couples with previous fertilization failure [89]. A total of 14 articles were assessed and 9 included in meta-analysis. It cannot be concluded that the outcomes are improved using ICSI followed by artificial oocyte activation compared with conventional ICSI. The fertilization rate, cleavage rate, and likelihood of blastocyst formation seem to improve according to some studies, but it is difficult to make a general conclusion.
\n
Recently, important evidence appeared that the conditions in which activation takes place are very important for the success rate and can vary a lot. Varying concentrations of both ionomycin and calcium ions in culture media used during AOA can have significant effects on calcium release and further embryonic developmental potential .
\n
\n
\n
8. Safety of AOA methods
\n
Although AOA methods have been proven efficient to overcome some cases of TFF, the concern around using them in clinical practice is quite big. By artificially increasing intracellular calcium levels we interfere with cellular mechanisms that normally would not occur. Nature has regulatory mechanisms to eliminate errors and when we force events that would not happen spontaneously it is always important to verify all possible negative effects of such procedures.
\n
The number of children born after AOA is relatively small for statistical analysis, but there are accumulating data on the safety of these methods. The study from Ghent analyzed neonatal and neurodevelopmental outcomes of 21 children born after cycles with AOA [90]. For all tests and questionnaires, the mean outcomes lay within the expected ranges, but since the number of studied cases is small, the authors state that AOA should still be performed only in selected couples. In another study, 79 children born following AOA-ICSI and 89 born by ICSI were compared in terms of intrauterine fetal death, preterm delivery, birth weight, growth rate, hospitalization in neonatal intensive care units, abnormal behavior according to age, and the physical and mental health of children born and no significant differences were found [91].
\n
In a study, genetic content of donated oocytes in metaphase II artificially activated with calcium-ionophore was analyzed. By using array comparative genomic hybridization, single-nucleotide polymorphism genotyping and maternal haplotyping chromosome segregation errors in meiosis II were not increased compared to the control group [92].
\n
There are concerns about the effects of AOA on gene expression and later embryonic development coming from animal studies [33, 93]. In the case of the use of SrCl2 for AOA, data in mice show that birth weight of male pups is reduced [80].
\n
\n
\n
9. Conclusions
\n
The problem of failed fertilization is a big burden for patients and clinicians and the pressure to help these patients is enormous. Today, ART methods are generally easily accessible and patients’ expectations are very high. In Europe alone, there have been 1,308,289 children born from IVF treatments between the years 1997 and 2013 according to data collected in European IVF monitoring [94]. Global data collection on IVF is a difficult task, but there are reports that in a three-year period, more than a million babies are born worldwide [95]. Despite the great success of ART, there are always some patients facing fertilization failure and the emotional burden of inability to achieve pregnancy is great for these couples. For successful fertilization, sperm must activate a quiescent oocyte to complete meiosis and progress toward embryonic development characterized with repeated mitotic divisions. Oocyte activation is a complex cascade of intracellular processes. Sperm or oocyte abnormalities can contribute to activation failure. In clinical practice, there is a need for safe methods of artificial oocyte activation based on the physiological properties of the gametes that closely imitate calcium oscillations triggered naturally by sperm.
\n
\n
Conflict of interest
The authors confirm that there are no known “conflicts of interest” associated with this publication.
\n
Notes/thanks/other declarations
\n
The publication is a part of research program P3-0327 and research project J3-7177 funded by the Slovenian Research Agency.
\n
\n',keywords:"oocyte activation, total fertilization failure (TFF), calcium oscillations, artificial oocyte activation (AOA), gamete maturation, ion channels, ion currents, calcium signaling, meiosis, intracytoplasmic sperm injection (ICSI), PLCζ, calcium ionophores",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/65172.pdf",chapterXML:"https://mts.intechopen.com/source/xml/65172.xml",downloadPdfUrl:"/chapter/pdf-download/65172",previewPdfUrl:"/chapter/pdf-preview/65172",totalDownloads:1710,totalViews:4,totalCrossrefCites:1,totalDimensionsCites:3,totalAltmetricsMentions:8,impactScore:2,impactScorePercentile:82,impactScoreQuartile:4,hasAltmetrics:1,dateSubmitted:"May 1st 2018",dateReviewed:"December 11th 2018",datePrePublished:"February 7th 2019",datePublished:"August 28th 2019",dateFinished:"January 12th 2019",readingETA:"0",abstract:"Despite successful treatment of infertility with assisted reproductive technology (ART), total fertilization failure (TFF) after in vitro fertilization (IVF) and even after intracytoplasmic sperm injection (ICSI) still occurs. In the current chapter, the incidence and etiology of TFF after ICSI are described. The literature on physiology of oocyte activation, electrical properties of gametes’ membranes, and ion currents is reviewed. Calcium oscillations play an essential role in fertilization, and calcium ions act as secondary messengers in different metabolic pathways and cellular processes during oocyte activation. The contribution of oocyte- and sperm-related causes of fertilization failure is discussed. Many studies on the physiology of fertilization in mammals have shown that oocyte activation is triggered by the sperm factor. Methods for artificial oocyte activation (AOA) try to bypass fertilization failure by influencing physiological processes that are crucial for successful fertilization. Activation can be induced with the use of electrical, mechanical, or chemical stimuli that elevate intracellular concentrations of calcium ions. Different AOA methods and their success and safety are presented.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/65172",risUrl:"/chapter/ris/65172",book:{id:"6977",slug:"embryology-theory-and-practice"},signatures:"Nina Hojnik and Borut Kovačič",authors:[{id:"257108",title:"Prof.",name:"Borut",middleName:null,surname:"Kovačič",fullName:"Borut Kovačič",slug:"borut-kovacic",email:"borut.kov63@gmail.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null},{id:"257110",title:"MSc.",name:"Nina",middleName:null,surname:"Hojnik",fullName:"Nina Hojnik",slug:"nina-hojnik",email:"hojnina@ukc-mb.si",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Total fertilization failure (TFF) after ICSI",level:"1"},{id:"sec_2_2",title:"2.1 Results of retrospective analysis of data from our center",level:"2"},{id:"sec_4",title:"3. Etiology of failed fertilization after ICSI",level:"1"},{id:"sec_5",title:"4. Oocyte activation",level:"1"},{id:"sec_5_2",title:"4.1 The role of free calcium ions in cytoplasm",level:"2"},{id:"sec_5_3",title:"4.1.1 Ca2+-dependent process of cortical granule exocytosis",level:"3"},{id:"sec_6_3",title:"4.1.2 Ca2+ is a trigger for cell cycle progression",level:"3"},{id:"sec_8_2",title:"4.2 Electrophysiology and fertilization",level:"2"},{id:"sec_9_2",title:"4.3 Sperm factors",level:"2"},{id:"sec_9_3",title:"4.3.1 PLCζ",level:"3"},{id:"sec_10_3",title:"4.3.2 Other sperm-related factors that affect oocyte activation",level:"3"},{id:"sec_12_2",title:"4.4 Oocyte factors",level:"2"},{id:"sec_12_3",title:"4.4.1 Organelle distribution",level:"3"},{id:"sec_13_3",title:"4.4.2 Cytoplasmic maturation",level:"3"},{id:"sec_16",title:"5. Artificial oocyte activation (AOA)",level:"1"},{id:"sec_16_2",title:"5.1 Electrical methods",level:"2"},{id:"sec_17_2",title:"5.2 Chemical methods",level:"2"},{id:"sec_17_3",title:"5.2.1 Ionophores",level:"3"},{id:"sec_18_3",title:"5.2.2 Strontium chloride (SrCl2)",level:"3"},{id:"sec_19_3",title:"5.2.3 PLCζ",level:"3"},{id:"sec_20_3",title:"5.2.4 Ethanol",level:"3"},{id:"sec_22_2",title:"5.3 Mechanical methods",level:"2"},{id:"sec_24",title:"6. Diagnostic tools for assessing sperm- or oocyte-dependent activation defects",level:"1"},{id:"sec_25",title:"7. Success rates of AOA",level:"1"},{id:"sec_26",title:"8. Safety of AOA methods",level:"1"},{id:"sec_27",title:"9. Conclusions",level:"1"},{id:"sec_31",title:"Conflict of interest",level:"1"},{id:"sec_28",title:"Notes/thanks/other declarations",level:"1"}],chapterReferences:[{id:"B1",body:'Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet. 1978;2(8085):366\n'},{id:"B2",body:'Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992;340(8810):17-18\n'},{id:"B3",body:'Sousa M, Tesarik J. Ultrastructural analysis of fertilization failure after intracytoplasmic sperm injection. Human Reproduction. 1994;9(12):2374-2380\n'},{id:"B4",body:'Flaherty SP, Payne D, Swann NJ, Matthews CD. Aetiology of failed and abnormal fertilization after intracytoplasmic sperm injection. Human Reproduction. 1995;10(10):2623-2629\n'},{id:"B5",body:'Bhattacharya S, Hamilton MPR, Shaaban M, Khalaf Y, Seddler M, Ghobara T, et al. Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: A randomised controlled trial. Lancet. 2001;357(9274):2075-2079\n'},{id:"B6",body:'Esfandiari N, Javed MH, Gotlieb L, Casper RF. Complete failed fertilization after intracytoplasmic sperm injection--analysis of 10 years’ data. International Journal of Fertility and Women\'s Medicine. 2005;50(4):187-192\n'},{id:"B7",body:'Flaherty SP, Payne D, Matthews CD. Fertilization failures and abnormal fertilization after intracytoplasmic sperm injection. Human Reproduction. 1998;13(suppl. 1):155-164\n'},{id:"B8",body:'Liu J, Nagy Z, Joris H, Tournaye H, Smitz J, Camus M, et al. Analysis of 76 total fertilization failure cycles out of 2732 intracytoplasmic sperm injection cycles. Human Reproduction. 1995;10(10):2630-2636\n'},{id:"B9",body:'Yanagida K, Morozumi K, Katayose H, Hayashi S, Sato A. Successful pregnancy after ICSI with strontium oocyte activation in low rates of fertilization. Reproductive Biomedicine Online. 2006;13(6):801-806\n'},{id:"B10",body:'Shinar S, Almog B, Levin I, Shwartz T, Amit A, Hasson J. Total fertilization failure in intra-cytoplasmic sperm injection cycles-classification and management. Gynecological Endocrinology. 2014;30(8):593-596\n'},{id:"B11",body:'Vlaisavljević V, Kovacic B, Reljic M, Lovrec VG, Sajko MC. Results of intracytoplasmic sperm injection of single oocyte in 362 unstimulated cycles. Journal of Assisted Reproduction and Genetics. 2002;19(3):127-131\n'},{id:"B12",body:'Dozortsev D, Sutter PD, Dhont M. Fertilization and early embryology: Behaviour of spermatozoa in human oocytes displaying no or one pronucleus after intracytoplasmic sperm injection. Human Reproduction. 1994;9(11):2139-2144\n'},{id:"B13",body:'Yanagida K. Complete fertilization failure in ICSI. Human Cell. 2004;17(4):187-193\n'},{id:"B14",body:'Pitsos MA, Nicolopoulou-Stamati P. DNA spatial distribution in unfertilized human oocytes by confocal laser scanning microscope. Molecular Reproduction and Development. 2002;62(3):368-374\n'},{id:"B15",body:'Kovacic B, Vlaisavljevic V. Configuration of maternal and paternal chromatin and pertaining microtubules in human oocytes failing to fertilize after intracytoplasmic sperm injection. Molecular Reproduction and Development. 2000;55(2):197-204\n'},{id:"B16",body:'Rawe VY, Olmedo SB, Nodar FN, Doncel GD, Acosta AA, Vitullo AD. Cytoskeletal organization defects and abortive activation in human oocytes after IVF and ICSI failure. Molecular Human Reproduction. 2000;6(6):510-516\n'},{id:"B17",body:'Gasca S, Reyftmann L, Pellestor F, Rème T, Assou S, Anahory T, et al. Case report: Total fertilization failure and molecular abnormalities in metaphase II oocytes. Reproductive Biomedicine Online. 2008;17(6):772-781\n'},{id:"B18",body:'Mazia D. The release of calcium in Arbacia eggs on fertilization. Journal of Cellular and Comparative Physiology. 1937;10:291-304\n'},{id:"B19",body:'Ridgway EB, Gilkey JC, Jaffe LF. Free calcium increases explosively in activating medaka eggs. Proceedings of the National Academy of Sciences of the United States of America. 1977;74(2):623-627\n'},{id:"B20",body:'Stricker SA. Comparative biology of calcium signaling during fertilization and egg activation in animals. Developmental Biology. 1999;211(2):157-176\n'},{id:"B21",body:'Kaneuchi T, Sartain CV, Takeo S, Horner VL, Buehner NA, Aigaki T, et al. Calcium waves occur as Drosophila oocytes activate. Proceedings of the National Academy of Sciences. 2015;112(3):791-796\n'},{id:"B22",body:'Epel D. Mechanisms of activation of sperm and egg during fertilization of sea urchin gametes. Current Topics in Developmental Biology. 1978;12(C):185-246\n'},{id:"B23",body:'Swann K, Lai FA. Egg activation at fertilization by a soluble sperm protein. Physiological Reviews. 2016;96(1):127-149\n'},{id:"B24",body:'Miyazaki S. Fertilization potential and calcium transients in mammalian eggs. Development, Growth & Differentiation. 1988;30(6):603-610\n'},{id:"B25",body:'Igusa Y, Miyazaki S. Effects of altered extracellular and intracellular calcium concentration on hyperpolarizing responses of hamster egg. Journal of Physiology. 1983;340:611-632\n'},{id:"B26",body:'Taylor CT, Lawrence YM, Kingsland CR, Biljan MM, Cuthbertson KSR. Fertilization and early embryology: Oscillations in intracellular free calcium induced by spermatozoa in human oocytes at fertilization. Human Reproduction. 1993;8(12):2174-2179\n'},{id:"B27",body:'Gianaroli L, Tosti E, Magli C, Iaccarino M, Ferraretti AP, Dale B. Fertilization current in the human oocyte. Molecular Reproduction and Development. 1994;38(2):209-214\n'},{id:"B28",body:'Tosti E, Boni R, Cuomo A. Fertilization and activation currents in bovine oocytes. Reproduction. 2002;124(6):835-846\n'},{id:"B29",body:'Tesarik J, Sousa M, Testart J. Human oocyte activation after intracytoplasmic sperm injection. Human Reproduction. 1994;9(3):511-518\n'},{id:"B30",body:'Yeste M, Jones C, Amdani SN, Patel S, Coward K. Oocyte activation deficiency: A role for an oocyte contribution? Human Reproduction Update. 2016;22(1):23-47\n'},{id:"B31",body:'Bos-Mikich A, Whittingham DG, Jones KT. Meiotic and mitotic Ca2+ oscillations affect cell composition in resulting blastocysts. Developmental Biology. 1997;182(1):172-179\n'},{id:"B32",body:'Jones KT. Mammalian egg activation: From Ca2+ spiking to cell cycle progression. Reproduction. 2005;130(6):813-823\n'},{id:"B33",body:'Ducibella T, Schultz RM, Ozil JP. Role of calcium signals in early development. Seminars in Cell & Developmental Biology. 2006;17(2):324-332\n'},{id:"B34",body:'Kline D. Calcium-dependent events at fertilization of the frog egg: Injection of a calcium buffer blocks ion channel opening, exocytosis, and formation of pronuclei. Developmental Biology. 1988;126(2):346-361\n'},{id:"B35",body:'Fukuda Y. The time of cortical granule breakdown and sperm penetration in mouse and hamster eggs inseminated in vitro. Biology of Reproduction. 1978;19:261-266\n'},{id:"B36",body:'Sone Y, Ito M, Shirakawa H, Shikano T, Takeuchi H, Kinoshita K, et al. Nuclear translocation of phospholipase C-zeta, an egg-activating factor, during early embryonic development. Biochemical and Biophysical Research Communications. 2005;330(3):690-694\n'},{id:"B37",body:'Ducibella T, Huneau D, Angelichio E, Xu Z, Schultz RM, Kopf GS, et al. Egg-to-embryo transition is driven by differential responses to Ca2+ oscillation number. Developmental Biology. 2002;250(2):280-291\n'},{id:"B38",body:'Oliveira AG, Guimaraes ES, Andrade LM, Menezes GB, Fatima LM. Decoding calcium signaling across the nucleus. Physiology. 2014;29(5):361-368\n'},{id:"B39",body:'Santella L, Lim D, Moccia F. Calcium and fertilization: The beginning of life. Trends in Biochemical Sciences. 2004;29(8):400-408\n'},{id:"B40",body:'Dale B. Is the idea of a fast block to polyspermy based on artifact? Biochemical and Biophysical Research Communications. 2014;450(3):1159-1165\n'},{id:"B41",body:'Dale B, Wilding M, Coppola G, Tosti E. How do spermatozoa activate oocytes? Reproductive Biomedicine Online. 2010;21(1):1-3\n'},{id:"B42",body:'Tosti E, Boni R. Electrical events during gamete maturation and fertilization in animals and humans. Human Reproduction Update. 2004;10(1):53-65\n'},{id:"B43",body:'Brezina PR, Yunus FN, Zhao Y. Effects of pharmaceutical medications on male fertility. Journal of Reproduction & Infertility. 2012;13(1):3-11\n'},{id:"B44",body:'Nomikos M, Swann K, Lai FA. Starting a new life: Sperm PLC-zeta mobilizes the Ca2+ signal that induces egg activation and embryo development: An essential phospholipase C with implications for male infertility. BioEssays. 2012;34(2):126-134\n'},{id:"B45",body:'Swann K. A cytosolic sperm factor stimulates repetitive calcium increases and mimics fertilization in hamster eggs. Development. 1990;110(4):1295-1302\n'},{id:"B46",body:'Stricker SA. Intracellular injections of a soluble sperm factor trigger calcium oscillations and meiotic maturation in unfertilized oocytes of a marine worm. Developmental Biology. 1997;186(2):185-201\n'},{id:"B47",body:'Parrington J, Swann K, Shevchenko VI, Sesay AK, Lai FA. Calcium oscillations in mammalian eggs triggered by a soluble sperm protein. Nature. 1996;379:364\n'},{id:"B48",body:'Carroll DJ, Albay DT, Terasaki M, Jaffe LA, Foltz KR. Identification of PLC y-dependent and -independent events during fertilization of eggs. Developmental Biology. 1999;206(2):232-247\n'},{id:"B49",body:'Kuo RC, Baxter GT, Thompson SH, Stricker SA, Patton C, Bonaventura J, et al. NO is necessary and sufficient for egg activation at fertilization. Nature. 2000;406(6796):633-636\n'},{id:"B50",body:'Wu ATH, Sutovsky P, Manandhar G, Xu W, Katayama M, Day BN, et al. PAWP, a sperm-specific WW domain-binding protein, promotes meiotic resumption and pronuclear development during fertilization. The Journal of Biological Chemistry. 2007;282(16):12164-12175\n'},{id:"B51",body:'Rice A, Parrington J, Jones KT, Swann K. Mammalian sperm contain a Ca2+−sensitive phospholipase C activity that can generate InsP3from PIP2associated with intracellular organelles. Developmental Biology. 2000;228(1):125-135\n'},{id:"B52",body:'Saunders CM, Larman MG, Parrington J, Cox LJ, Royse J, Blayney LM, et al. PLC zeta: A sperm-specific trigger of Ca(2+) oscillations in eggs and embryo development. Development. 2002;129(15):3533-3544\n'},{id:"B53",body:'Escoffier J, Yassine S, Lee HC, Martinez G, Delaroche J, Coutton C, et al. Subcellular localization of phospholipase Cζ in human sperm and its absence in DPY19L2-deficient sperm are consistent with its role in oocyte activation. MHR: Basic Science of Reproductive Medicine. 2015;21(2):157-168\n'},{id:"B54",body:'Knott JG, Kurokawa M, Fissore RA, Schultz RM, Williams CJ. Transgenic RNA interference reveals role for mouse sperm phospholipase Cζ in triggering Ca2+ oscillations during Fertilization1. Biology of Reproduction. 2005;72(4):992-996\n'},{id:"B55",body:'Escoffier J, Lee HC, Yassine S, Zouari R, Martinez G, Karaouzène T, et al. Homozygous mutation of PLCZ1 leads to defective human oocyte activation and infertility that is not rescued by the WW-binding protein PAWP. Human Molecular Genetics. 2016;25(5):878-891\n'},{id:"B56",body:'Kashir J, Heindryckx B, Jones C, de Sutter P, Parrington J, Coward K. Oocyte activation, phospholipase C zeta and human infertility. Human Reproduction Update. 2010;16(6):690-703\n'},{id:"B57",body:'Kashir J, Deguchi R, Jones C, Coward K, Stricker SA. Comparative biology of sperm factors and fertilization-induced calcium signals across the animal kingdom. Molecular Reproduction and Development. 2013;80(10):787-815\n'},{id:"B58",body:'Faure JE, Myles DG, Primakoff P. The frequency of calcium oscillations in mouse eggs at fertilization is modulated by the number of fused sperm. Developmental Biology. 1999;213(2):370-377\n'},{id:"B59",body:'Hachem A, Godwin J, Ruas M, Lee HC, Ferrer Buitrago M, Ardestani G, et al. PLCζ is the physiological trigger of the Ca2+ oscillations that induce embryogenesis in mammals but conception can occur in its absence. Development. 2017;144(16):2914-2924\n'},{id:"B60",body:'Nasr-Esfahani MH, Razavi S, Mardani M, Shirazi R, Javanmardi S. Effects of failed oocyte activation and sperm protamine deficiency on fertilization post-ICSI. Reproductive Biomedicine Online. 2007;14(4):422-429\n'},{id:"B61",body:'Nasr-Esfahani MH, Naghshizadian N, Imani H, Razavi S, Mardani M, Kazemi S, et al. Can sperm protamine deficiency induce sperm premature chromosomal condensation? Andrologia. 2006;38(3):92-98\n'},{id:"B62",body:'Motta PM, Nottola SA, Micara G, Familiari G. Ultrastructure of human unfertilized oocytes and Polyspermic embryos in an IVF-ET program. Annals of the New York Academy of Sciences. 1988;541(1):367-383\n'},{id:"B63",body:'Liu M. The biology and dynamics of mammalian cortical granules. Reproductive Biology and Endocrinology. 2011;9(1):149\n'},{id:"B64",body:'Hsieh RH, Tsai NM, Au HK, Chang SJ, Wei YH, Tzeng CR. Multiple rearrangements of mitochondrial DNA in unfertilized human oocytes. Fertility and Sterility. 2002;77(5):1012-1017\n'},{id:"B65",body:'FitzHarris G, Marangos P, Carroll J. Changes in endoplasmic reticulum structure during mouse oocyte maturation are controlled by the cytoskeleton and cytoplasmic dynein. Developmental Biology. 2007;305(1):133-144\n'},{id:"B66",body:'Wakai T, Vanderheyden V, Yoon S-Y, Cheon B, Zhang A, Parys JB, et al. Regulation of inositol 1,4,5-trisphosphate receptor function during mouse oocyte maturation. Journal of Cellular Physiology. 2012;227(2):705-717\n'},{id:"B67",body:'Ajduk A, Małagocki A, Maleszewski M. Cytoplasmic maturation of mammalian oocytes: Development of a mechanism responsible for sperm-induced Ca2+ oscillations. Reproductive Biology. 2008;8(1):3-22\n'},{id:"B68",body:'Archacka K, Ajduk A, Pomorsiki P, Szczepanska K, Maleszewski M, Ciemerych MA. Defective calcium release during in vitro fertilization of maturing oocytes of LT/Sv mice. International Journal of Developmental Biology. 2008;52(7):903-912\n'},{id:"B69",body:'Calafell JM, Badenas J, Egozcue J, Santaló J. Premature chromosome condensation as a sign of oocyte immaturity. Human Reproduction. 1991;6(7):1017-1021\n'},{id:"B70",body:'Sedó CA, Miguens M, Andreucci S, Ortiz N, Lorenzi D, Papier S, et al. Correlation between cytoplamic oocyte maturation and chromosomal aneuploidies—Impact on fertilization, embryo quality and pregnancy. JBRA Assisted Reproduction. 2015;19(2):59-65\n'},{id:"B71",body:'Lu Y, Ferrer-Buitrago M, Popovic M, Neupane J, De Vos WH, Lierman S, et al. Patients with a high proportion of immature and meiotically resistant oocytes experience defective nuclear oocyte maturation patterns and impaired pregnancy outcomes. Reproductive Biomedicine Online. 2018;36(4):396-407\n'},{id:"B72",body:'Grindler NM, Moley KH. Maternal obesity, infertility and mitochondrial dysfunction: Potential mechanisms emerging from mouse model systems. Molecular Human Reproduction. 2013;19(8):486-494\n'},{id:"B73",body:'Mansour R, Fahmy I, Tawab NA, Kamal A, El-Demery Y, Aboulghar M, et al. Electrical activation of oocytes after intracytoplasmic sperm injection: A controlled randomized study. Fertility and Sterility. 2009;91(1):133-139\n'},{id:"B74",body:'Egashira A, Murakami M, Haigo K, Horiuchi T, Kuramoto T. A successful pregnancy and live birth after intracytoplasmic sperm injection with globozoospermic sperm and electrical oocyte activation. Fertility and Sterility. 2009;92(6):2037.e5-2037.e9\n'},{id:"B75",body:'Tanaka A, Nagayoshi M, Takemoto Y, Tanaka I, Kusunoki H, Watanabe S, et al. Fourteen babies born after round spermatid injection into human oocytes. Proceedings of the National Academy of Sciences. 2015;112(47):14629-14634\n'},{id:"B76",body:'Nikiforaki D, Vanden Meerschaut F, De Roo C, Lu Y, Ferrer-Buitrago M, De Sutter P, et al. Effect of two assisted oocyte activation protocols used to overcome fertilization failure on the activation potential and calcium releasing pattern. Fertility and Sterility. 2016;105(3):798-806e2\n'},{id:"B77",body:'Tesarik J, Nagy ZP, Mendoza C, Greco E. Chemically and mechanically induced membrane fusion: Non-activating methods for nuclear transfer in mature human oocytes. Human Reproduction. 2000;15(5):1149-1154\n'},{id:"B78",body:'Heindryckx B, Van der Elst J, De Sutter P, Dhont M. Treatment option for sperm- or oocyte-related fertilization failure: Assisted oocyte activation following diagnostic heterologous ICSI. Human Reproduction. 2005;20(8):2237-2241\n'},{id:"B79",body:'Nakagawa K, Yamano S, Moride N, Yamashita M, Yoshizawa M, Aono T. Effect of activation with Ca ionophore A23187 and puromycin on the development of human oocytes that failed to fertilize after intracytoplasmic sperm injection. Fertility and Sterility. 2001;76(1):148-152\n'},{id:"B80",body:'Vanden Meerschaut F, Nikiforaki D, De Roo C, Lierman S, Qian C, Schmitt-John T, et al. Comparison of pre-and post-implantation development following the application of three artificial activating stimuli in a mouse model with round-headed sperm cells deficient for oocyte activation. Human Reproduction. 2013;28(5):1190-1198\n'},{id:"B81",body:'Kim J-W, Kim S-D, Yang S-H, Yoon S-H, Jung J-H, Lim J-H. Successful pregnancy after SrCl2 oocyte activation in couples with repeated low fertilization rates following calcium ionophore treatment. Systems Biology in Reproductive Medicine. 2014;60(3):177-182\n'},{id:"B82",body:'Kashir J, Jones C, Lee HC, Rietdorf K, Nikiforaki D, Durrans C, et al. Loss of activity mutations in phospholipase C zeta (PLCzeta) abolishes calcium oscillatory ability of human recombinant protein in mouse oocytes. Human Reproduction. 2011;26(12):3372-3387\n'},{id:"B83",body:'Yoon S-Y, Eum JH, Lee JE, Lee HC, Kim YS, Han JE, et al. Recombinant human phospholipase C zeta 1 induces intracellular calcium oscillations and oocyte activation in mouse and human oocytes. Human Reproduction. 2012;27(6):1768-1780\n'},{id:"B84",body:'Grabiec A, Max A, Tischner M. Parthenogenetic activation of domestic cat oocytes using ethanol, calcium ionophore, cycloheximide and a magnetic field. Theriogenology. 2007;67(4):795-800\n'},{id:"B85",body:'Ebner T, Moser M, Sommergruber M, Jesacher K, Tews G. Complete oocyte activation failure after ICSI can be overcome by a modified injection technique. Human Reproduction. 2004;19(8):1837-1841\n'},{id:"B86",body:'Tesarik J, Rienzi L, Ubaldi F, Mendoza C, Greco E. Use of a modified intracytoplasmic sperm injection technique to overcome sperm-borne and oocyte-borne oocyte activation failures. Fertility and Sterility. 2002;78(3):619-624\n'},{id:"B87",body:'Combelles CMH, Morozumi K, Yanagimachi R, Zhu L, Fox JH, Racowsky C. Diagnosing cellular defects in an unexplained case of total fertilization failure. Human Reproduction. 2010;25(7):1666-1671\n'},{id:"B88",body:'Ferrer-Buitrago M, Dhaenens L, Lu Y, Bonte D, Vanden Meerschaut F, De Sutter P, et al. Human oocyte calcium analysis predicts the response to assisted oocyte activation in patients experiencing fertilization failure after ICSI. Human Reproduction. 2018;33(3):416-425\n'},{id:"B89",body:'Sfontouris IA, Nastri CO, Lima MLS, Tahmasbpourmarzouni E, Raine-Fenning N, Martins WP. Artificial oocyte activation to improve reproductive outcomes in women with previous fertilization failure: A systematic review and meta-analysis of RCTs. Human Reproduction. 2015;30(8):1831-1841\n'},{id:"B90",body:'Vanden Meerschaut F, D’Haeseleer E, Gysels H, Thienpont Y, Dewitte G, Heindryckx B, et al. Neonatal and neurodevelopmental outcome of children aged 3-10 years born following assisted oocyte activation. Reproductive Biomedicine Online. 2014;28(1):54-63\n'},{id:"B91",body:'Deemeh MR, Tavalaee M, Nasr-Esfahani MH. Health of children born through artificial oocyte activation: A pilot study. Reproductive Sciences. 2015;22(3):322-328\n'},{id:"B92",body:'Capalbo A, Ottolini CS, Griffin DK, Ubaldi FM, Handyside AH, Rienzi L. Artificial oocyte activation with calcium ionophore does not cause a widespread increase in chromosome segregation errors in the second meiotic division of the oocyte. Fertility and Sterility. 2016;105(3):807-814e2\n'},{id:"B93",body:'Ozil J-P, Banrezes B, Toth S, Pan H, Schultz RM. Ca2+ oscillatory pattern in fertilized mouse eggs affects gene expression and development to term. Developmental Biology. 2006;300(2):534-544\n'},{id:"B94",body:'Calhaz-Jorge C, De Geyter C, Kupka MS, De Mouzon J, Erb K, Mocanu E, et al. Assisted reproductive technology in Europe, 2013: Results generated from European registers by ESHRE. Human Reproduction. 2017;32(10):1957-1973\n'},{id:"B95",body:'Dyer S, Chambers GM, De Mouzon J, Nygren KG, Zegers-Hochschild F, Mansour R, et al. International committee for monitoring assisted reproductive technologies world report: Assisted reproductive technology 2008, 2009 and 2010. Human Reproduction. 2016;31(7):1588-1609\n'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Nina Hojnik",address:"hojnina@ukc-mb.si",affiliation:'
Department of Reproductive Medicine and Gynecological Endocrinology, University Medical Centre Maribor, Maribor, Slovenia
Department of Reproductive Medicine and Gynecological Endocrinology, University Medical Centre Maribor, Maribor, Slovenia
'}],corrections:null},book:{id:"6977",type:"book",title:"Embryology",subtitle:"Theory and Practice",fullTitle:"Embryology - Theory and Practice",slug:"embryology-theory-and-practice",publishedDate:"August 28th 2019",bookSignature:"Bin Wu and Huai L. Feng",coverURL:"https://cdn.intechopen.com/books/images_new/6977.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-78985-306-3",printIsbn:"978-1-78985-305-6",pdfIsbn:"978-1-78985-639-2",reviewType:"peer-reviewed",numberOfWosCitations:2,isAvailableForWebshopOrdering:!0,editors:[{id:"108807",title:"Ph.D.",name:"Bin",middleName:null,surname:"Wu",slug:"bin-wu",fullName:"Bin Wu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:{id:"251607",title:"Dr.",name:"Huai L.",middleName:null,surname:"Feng",slug:"huai-l.-feng",fullName:"Huai L. Feng"},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1065"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"68249",type:"chapter",title:"Introductory Chapter: New Theory and Technology in Early Clinical Embryogenesis",slug:"introductory-chapter-new-theory-and-technology-in-early-clinical-embryogenesis",totalDownloads:979,totalCrossrefCites:0,signatures:"Bin Wu",reviewType:"peer-reviewed",authors:[{id:"108807",title:"Ph.D.",name:"Bin",middleName:null,surname:"Wu",fullName:"Bin Wu",slug:"bin-wu"}]},{id:"65216",type:"chapter",title:"Background Proteins in Human Chorionic Gonadotropin Pharmaceutical Formulations of Different Origins",slug:"background-proteins-in-human-chorionic-gonadotropin-pharmaceutical-formulations-of-different-origins",totalDownloads:1069,totalCrossrefCites:0,signatures:"Tanja Panić-Janković and Goran Mitulović",reviewType:"peer-reviewed",authors:[{id:"212804",title:"Dr.",name:"Goran",middleName:null,surname:"Mitulović",fullName:"Goran Mitulović",slug:"goran-mitulovic"},{id:"256238",title:"Dr.",name:"Tanja",middleName:null,surname:"Panić-Janković",fullName:"Tanja Panić-Janković",slug:"tanja-panic-jankovic"}]},{id:"67832",type:"chapter",title:"Clinical Application of In Vitro Maturation of Oocytes",slug:"clinical-application-of-in-vitro-maturation-of-oocytes",totalDownloads:1295,totalCrossrefCites:0,signatures:"Xiaolin La, Jing Zhao and Zhihui Wang",reviewType:"peer-reviewed",authors:[{id:"291066",title:"Dr.",name:"Xiaolin",middleName:null,surname:"La",fullName:"Xiaolin La",slug:"xiaolin-la"},{id:"291067",title:"Dr.",name:"Jing",middleName:null,surname:"Zhao",fullName:"Jing Zhao",slug:"jing-zhao"},{id:"308602",title:"Dr.",name:"Zhihui",middleName:null,surname:"Wang",fullName:"Zhihui Wang",slug:"zhihui-wang"}]},{id:"65172",type:"chapter",title:"Oocyte Activation Failure: Physiological and Clinical Aspects",slug:"oocyte-activation-failure-physiological-and-clinical-aspects",totalDownloads:1710,totalCrossrefCites:1,signatures:"Nina Hojnik and Borut Kovačič",reviewType:"peer-reviewed",authors:[{id:"257108",title:"Prof.",name:"Borut",middleName:null,surname:"Kovačič",fullName:"Borut Kovačič",slug:"borut-kovacic"},{id:"257110",title:"MSc.",name:"Nina",middleName:null,surname:"Hojnik",fullName:"Nina Hojnik",slug:"nina-hojnik"}]},{id:"64456",type:"chapter",title:"Human Blastocyst Formation and Development",slug:"human-blastocyst-formation-and-development",totalDownloads:1661,totalCrossrefCites:0,signatures:"Hilma Putri Lubis and Binarwan Halim",reviewType:"peer-reviewed",authors:[{id:"257685",title:"Dr.",name:"Hilma Putri",middleName:null,surname:"Lubis",fullName:"Hilma Putri Lubis",slug:"hilma-putri-lubis"},{id:"258506",title:"Dr.",name:"Binarwan",middleName:null,surname:"Halim",fullName:"Binarwan Halim",slug:"binarwan-halim"}]},{id:"64133",type:"chapter",title:"Bovine Embryonic Development to Implantation",slug:"bovine-embryonic-development-to-implantation",totalDownloads:2012,totalCrossrefCites:2,signatures:"Loide Valadão, Helena Moreira da Silva and Fernando Moreira da Silva",reviewType:"peer-reviewed",authors:[{id:"191057",title:"Prof.",name:"Fernando",middleName:null,surname:"Moreira Da Silva",fullName:"Fernando Moreira Da Silva",slug:"fernando-moreira-da-silva"},{id:"259013",title:"Dr.",name:"Helena",middleName:null,surname:"Moreira Da Silva",fullName:"Helena Moreira Da Silva",slug:"helena-moreira-da-silva"},{id:"262761",title:"Dr.",name:"Loide",middleName:null,surname:"Valadão",fullName:"Loide Valadão",slug:"loide-valadao"}]},{id:"67826",type:"chapter",title:"The Role of Neuroendocrine in Embryo Implantation",slug:"the-role-of-neuroendocrine-in-embryo-implantation",totalDownloads:1026,totalCrossrefCites:2,signatures:"Fenting Liu and Rong Li",reviewType:"peer-reviewed",authors:[{id:"307568",title:"Dr.",name:"Rong",middleName:null,surname:"Li",fullName:"Rong Li",slug:"rong-li"},{id:"307576",title:"Dr.",name:"Fen-Ting",middleName:null,surname:"Liu",fullName:"Fen-Ting Liu",slug:"fen-ting-liu"}]},{id:"63808",type:"chapter",title:"The Present and Future of Embryo Cryopreservation",slug:"the-present-and-future-of-embryo-cryopreservation",totalDownloads:1532,totalCrossrefCites:0,signatures:"Iavor K. Vladimirov, Desislava Tacheva and Vladislav Dobrinov",reviewType:"peer-reviewed",authors:[{id:"253947",title:"Dr.",name:"Iavor K.",middleName:null,surname:"Vladimirov",fullName:"Iavor K. Vladimirov",slug:"iavor-k.-vladimirov"},{id:"254692",title:"Dr.",name:"Desislava",middleName:null,surname:"Tacheva",fullName:"Desislava Tacheva",slug:"desislava-tacheva"},{id:"254693",title:"MSc.",name:"Vladislav",middleName:null,surname:"Dobrinov",fullName:"Vladislav Dobrinov",slug:"vladislav-dobrinov"}]},{id:"68013",type:"chapter",title:"Effect of Assisted Reproductive Technology (ART) on Babies Born: Compared by IVF Laboratories of Two Countries",slug:"effect-of-assisted-reproductive-technology-art-on-babies-born-compared-by-ivf-laboratories-of-two-co",totalDownloads:1090,totalCrossrefCites:0,signatures:"Linda Wu, Jinzhou Qin, Dikai Zhang, Minqi Zhang, Suzhen Lu, Jennifer Howell, Timothy J. Gelety and Bin Wu",reviewType:"peer-reviewed",authors:[{id:"108807",title:"Ph.D.",name:"Bin",middleName:null,surname:"Wu",fullName:"Bin Wu",slug:"bin-wu"},{id:"287545",title:"Ms.",name:"Linda",middleName:null,surname:"Wu",fullName:"Linda Wu",slug:"linda-wu"},{id:"287546",title:"Dr.",name:"Jinzhou",middleName:null,surname:"Qin",fullName:"Jinzhou Qin",slug:"jinzhou-qin"},{id:"288012",title:"Dr.",name:"Dikai",middleName:null,surname:"Zhang",fullName:"Dikai Zhang",slug:"dikai-zhang"},{id:"288013",title:"Dr.",name:"Minqi",middleName:null,surname:"Zhang",fullName:"Minqi Zhang",slug:"minqi-zhang"},{id:"288014",title:"Ms.",name:"Suzhen",middleName:null,surname:"Lu",fullName:"Suzhen Lu",slug:"suzhen-lu"},{id:"288015",title:"Dr.",name:"Timothy",middleName:null,surname:"Gelety",fullName:"Timothy Gelety",slug:"timothy-gelety"},{id:"288016",title:"Dr.",name:"Jennifer",middleName:null,surname:"Howell",fullName:"Jennifer Howell",slug:"jennifer-howell"}]}]},relatedBooks:[{type:"book",id:"1577",title:"Advances in Embryo Transfer",subtitle:null,isOpenForSubmission:!1,hash:"b9d06c4d4736cf2bd3394ce91e8d3031",slug:"advances-in-embryo-transfer",bookSignature:"Bin Wu",coverURL:"https://cdn.intechopen.com/books/images_new/1577.jpg",editedByType:"Edited by",editors:[{id:"108807",title:"Ph.D.",name:"Bin",surname:"Wu",slug:"bin-wu",fullName:"Bin Wu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"32051",title:"Advances in Embryo Transfer",slug:"advances-in-embryo-transfer",signatures:"Bin Wu",authors:[{id:"108807",title:"Ph.D.",name:"Bin",middleName:null,surname:"Wu",fullName:"Bin Wu",slug:"bin-wu"}]},{id:"32052",title:"Minimal and Natural Stimulations for IVF",slug:"minimal-and-natural-stimulations-for-ivf",signatures:"Jerome H. Check",authors:[{id:"138125",title:"Dr.",name:"Jerome H.",middleName:null,surname:"Check",fullName:"Jerome H. Check",slug:"jerome-h.-check"}]},{id:"32053",title:"Does the Number of Retrieved Oocytes Influence Pregnancy Rate After Day 3 and Day 5 Embryo Transfer?",slug:"does-the-number-of-retrieved-oocytes-influence-pregnancy-rate-after-day-3-and-day-5-embryo-transfer-",signatures:"Veljko Vlaisavljević, Jure Knez and Borut Kovačič",authors:[{id:"83022",title:"Prof.",name:"Veljko",middleName:null,surname:"Vlaisavljevic",fullName:"Veljko Vlaisavljevic",slug:"veljko-vlaisavljevic"},{id:"114682",title:"Dr.",name:"Borut",middleName:null,surname:"Kovačič",fullName:"Borut Kovačič",slug:"borut-kovacic"},{id:"120078",title:"Dr.",name:"Jure",middleName:null,surname:"Knez",fullName:"Jure Knez",slug:"jure-knez"}]},{id:"32054",title:"Prevention and Treatment of Ovarian Hyperstimulation Syndrome",slug:"prevention-and-treatment-of-ovarian-hyperstimulation-syndrome",signatures:"Ivan Grbavac, Dejan Ljiljak and Krunoslav Kuna",authors:[{id:"117482",title:"Prof.",name:"Krunoslav",middleName:null,surname:"Kuna",fullName:"Krunoslav Kuna",slug:"krunoslav-kuna"},{id:"118458",title:"MSc.",name:"Dejan",middleName:null,surname:"Ljiljak",fullName:"Dejan Ljiljak",slug:"dejan-ljiljak"},{id:"118706",title:"Dr.",name:"Ivan",middleName:null,surname:"Grbavac",fullName:"Ivan Grbavac",slug:"ivan-grbavac"}]},{id:"32055",title:"Sperm Cell in ART",slug:"sperm-cell-in-art",signatures:"Dejan Ljiljak, Tamara Tramišak Milaković, Neda Smiljan Severinski, Krunoslav Kuna and Anđelka Radojčić Badovinac",authors:[{id:"117482",title:"Prof.",name:"Krunoslav",middleName:null,surname:"Kuna",fullName:"Krunoslav Kuna",slug:"krunoslav-kuna"},{id:"112998",title:"MSc",name:"Dejan",middleName:null,surname:"Ljiljak",fullName:"Dejan Ljiljak",slug:"dejan-ljiljak"},{id:"117484",title:"MSc.",name:"Tamara",middleName:null,surname:"Tramišak Milaković",fullName:"Tamara Tramišak Milaković",slug:"tamara-tramisak-milakovic"},{id:"117485",title:"Prof.",name:"Neda",middleName:null,surname:"Smiljan Severinski",fullName:"Neda Smiljan Severinski",slug:"neda-smiljan-severinski"},{id:"118703",title:"Prof.",name:"Anđelka",middleName:null,surname:"Radojčić Badovinac",fullName:"Anđelka Radojčić Badovinac",slug:"andjelka-radojcic-badovinac"}]},{id:"32056",title:"Meiotic Chromosome Abnormalities and Spermatic FISH in Infertile Patients with Normal Karyotype",slug:"meiotic-chromosome-abnormalities-and-spermatic-fish-in-infertile-patients-with-normal-karyotype",signatures:"Simón Marina, Susana Egozcue, David Marina, Ruth Alcolea and Fernando Marina",authors:[{id:"117513",title:"Dr.",name:"Simón",middleName:null,surname:"Marina",fullName:"Simón Marina",slug:"simon-marina"}]},{id:"32057",title:"New Advances in Intracytoplasmic Sperm Injection (ICSI)",slug:"new-advances-in-intracytoplasmic-sperm-injection-icsi-",signatures:"Lodovico Parmegiani, Graciela Estela Cognigni and Marco Filicori",authors:[{id:"90056",title:"Dr.",name:"Lodovico",middleName:null,surname:"Parmegiani",fullName:"Lodovico Parmegiani",slug:"lodovico-parmegiani"}]},{id:"32058",title:"Advances in Fertility Options of Azoospermic Men",slug:"advances-in-fertility-options-of-azoospermic-men",signatures:"Bin Wu, Timothy J. Gelety and Juanzi Shi",authors:[{id:"108807",title:"Ph.D.",name:"Bin",middleName:null,surname:"Wu",fullName:"Bin Wu",slug:"bin-wu"}]},{id:"32059",title:"Increasing Pregnancy by Improving Embryo Transfer Techniques",slug:"increasing-pregnancy-by-improving-embryo-transfer-techniques",signatures:"Tahereh Madani and Nadia Jahangiri",authors:[{id:"115849",title:"Dr.",name:"Tahereh",middleName:null,surname:"Madani",fullName:"Tahereh Madani",slug:"tahereh-madani"}]},{id:"32060",title:"Optimizing Embryo Transfer Outcomes: Determinants for Improved Outcomes Using the Oocyte Donation Model",slug:"optimizing-embryo-transfer-outcomes-determinants-for-improved-outcomes-using-the-oocyte-donation-mod",signatures:"Alan M. Martinez and Steven R. Lindheim",authors:[{id:"115167",title:"Dr.",name:"Steven",middleName:null,surname:"Lindheim",fullName:"Steven Lindheim",slug:"steven-lindheim"},{id:"126542",title:"Dr.",name:"Alan",middleName:null,surname:"Martinez",fullName:"Alan Martinez",slug:"alan-martinez"}]},{id:"32061",title:"Importance of Blastocyst Morphology in Selection for Transfer",slug:"importance-of-blastocyst-morphology-in-selection-for-transfer",signatures:"Borut Kovačič and Veljko Vlaisavljević",authors:[{id:"83022",title:"Prof.",name:"Veljko",middleName:null,surname:"Vlaisavljevic",fullName:"Veljko Vlaisavljevic",slug:"veljko-vlaisavljevic"},{id:"114682",title:"Dr.",name:"Borut",middleName:null,surname:"Kovačič",fullName:"Borut Kovačič",slug:"borut-kovacic"}]},{id:"32062",title:"Pregnancy Rates Following Transfer of Cultured Versus Non Cultured Frozen Thawed Human Embryos",slug:"pregnancy-rates-following-transfer-of-cultured-versus-non-cultured-frozen-thawed-human-embryos",signatures:"Bharat Joshi, Manish Banker, Pravin Patel, Preeti Shah and Deven Patel",authors:[{id:"112484",title:"Mr.",name:"Bharat",middleName:"Vishnu",surname:"Joshi",fullName:"Bharat Joshi",slug:"bharat-joshi"},{id:"116500",title:"Dr.",name:"Manish",middleName:null,surname:"Banker",fullName:"Manish Banker",slug:"manish-banker"},{id:"116501",title:"Dr.",name:"Pravin",middleName:null,surname:"Patel",fullName:"Pravin Patel",slug:"pravin-patel"},{id:"116503",title:"Ms.",name:"Preeti",middleName:null,surname:"Shah",fullName:"Preeti Shah",slug:"preeti-shah"},{id:"116504",title:"Dr.",name:"Deven",middleName:null,surname:"Patel",fullName:"Deven Patel",slug:"deven-patel"}]},{id:"32063",title:"Intercourse and ART Success Rates",slug:"intercourse-and-art",signatures:"Abbas Aflatoonian, Sedigheh Ghandi and Nasim Tabibnejad",authors:[{id:"115320",title:"Prof.",name:"Abbas",middleName:null,surname:"Aflatoonian",fullName:"Abbas Aflatoonian",slug:"abbas-aflatoonian"},{id:"128461",title:"Dr.",name:"Sedigheh",middleName:null,surname:"Ghandi",fullName:"Sedigheh Ghandi",slug:"sedigheh-ghandi"},{id:"128462",title:"Dr.",name:"Nasim",middleName:null,surname:"Tabibnejad",fullName:"Nasim Tabibnejad",slug:"nasim-tabibnejad"},{id:"128463",title:"Dr.",name:"Mahmoud",middleName:null,surname:"Fazel",fullName:"Mahmoud Fazel",slug:"mahmoud-fazel"}]},{id:"32064",title:"Implantation of the Human Embryo",slug:"implantation-of-the-embryo",signatures:"Russell A. Foulk",authors:[{id:"118294",title:"Dr.",name:"Russell",middleName:"A.",surname:"Foulk",fullName:"Russell Foulk",slug:"russell-foulk"}]},{id:"32065",title:"Biomarkers Related to Endometrial Receptivity and Implantation",slug:"endometrial-receptivity-and-implantation",signatures:"Mark P. Trolice1 and George Amyradakis",authors:[{id:"108852",title:"Dr.",name:"Mark",middleName:null,surname:"Trolice",fullName:"Mark Trolice",slug:"mark-trolice"},{id:"111873",title:"Dr.",name:"George",middleName:null,surname:"Amyradakis",fullName:"George Amyradakis",slug:"george-amyradakis"}]},{id:"32066",title:"Fertility Cryopreservation",slug:"fertility-cryopreservation",signatures:"Francesca Ciani, Natascia Cocchia, Luigi Esposito and Luigi Avallone",authors:[{id:"32033",title:"Dr.",name:"Natascia",middleName:null,surname:"Cocchia",fullName:"Natascia Cocchia",slug:"natascia-cocchia"},{id:"117666",title:"Prof.",name:"Francesca",middleName:null,surname:"Ciani",fullName:"Francesca Ciani",slug:"francesca-ciani"},{id:"117668",title:"Prof.",name:"Luigi",middleName:null,surname:"Avallone",fullName:"Luigi Avallone",slug:"luigi-avallone"},{id:"117670",title:"Prof.",name:"Luigi",middleName:null,surname:"Esposito",fullName:"Luigi Esposito",slug:"luigi-esposito"}]}]}],publishedBooks:[{type:"book",id:"700",title:"The Human Embryo",subtitle:null,isOpenForSubmission:!1,hash:"86474f84fc2e891369f79e859bd84d44",slug:"the-human-embryo",bookSignature:"Shigehito Yamada and Tetsuya Takakuwa",coverURL:"https://cdn.intechopen.com/books/images_new/700.jpg",editedByType:"Edited by",editors:[{id:"114031",title:"Dr.",name:"Shigehito",surname:"Yamada",slug:"shigehito-yamada",fullName:"Shigehito Yamada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"702",title:"Recent Advances in Research on the Human Placenta",subtitle:null,isOpenForSubmission:!1,hash:"2ec960f95ad477086c54b65993d58c49",slug:"recent-advances-in-research-on-the-human-placenta",bookSignature:"Jing Zheng",coverURL:"https://cdn.intechopen.com/books/images_new/702.jpg",editedByType:"Edited by",editors:[{id:"89898",title:"Dr.",name:"Jing",surname:"Zheng",slug:"jing-zheng",fullName:"Jing Zheng"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2586",title:"Skeletal Muscle",subtitle:"From Myogenesis to Clinical Relations",isOpenForSubmission:!1,hash:"39cac55a7eca71b41c2a28933c1e2d4d",slug:"skeletal-muscle-from-myogenesis-to-clinical-relations",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/2586.jpg",editedByType:"Edited by",editors:[{id:"135579",title:"Dr.",name:"Julianna",surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7175",title:"Placenta",subtitle:null,isOpenForSubmission:!1,hash:"447d49d62164c5437461f3b0aae7a67f",slug:"placenta",bookSignature:"Ahmed R. G.",coverURL:"https://cdn.intechopen.com/books/images_new/7175.jpg",editedByType:"Edited by",editors:[{id:"138555",title:"Prof.",name:"R.G.",surname:"Ahmed",slug:"r.g.-ahmed",fullName:"R.G. Ahmed"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6191",title:"Selected Topics in Breastfeeding",subtitle:null,isOpenForSubmission:!1,hash:"3334b831761ffa52e78de6fc681e33b3",slug:"selected-topics-in-breastfeeding",bookSignature:"R. Mauricio Barría P.",coverURL:"https://cdn.intechopen.com/books/images_new/6191.jpg",editedByType:"Edited by",editors:[{id:"88861",title:"Dr.",name:"R. Mauricio",surname:"Barría",slug:"r.-mauricio-barria",fullName:"R. Mauricio Barría"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],publishedBooksByAuthor:[]},onlineFirst:{chapter:{type:"chapter",id:"81570",title:"Prenatal Diagnosis of Diaphragmatic Hernia",doi:"10.5772/intechopen.104103",slug:"prenatal-diagnosis-of-diaphragmatic-hernia",body:'
1. Introduction
Congenital diaphragmatic hernia (CDH) is a congenital malformation of diaphragm, which leads to a defect in separation between the thoracic and abdominal cavities [1, 2]. It appears to be due to an error in the development of the pleuro-peritoneal canals and therefore develops around 6 weeks of gestation [1]. Its incidence is 1:3000 live births. Progress in the management of these patients has significantly increased survival rates (up to 90% [3]), but disease-related morbidity remains very high: the main problem is the compression exerted by the herniated viscera on the developing lungs, development, which causes pulmonary hypoplasia and hypertension [4].
2. Classification
CDH can be classified, depending on the location of the defect, into postero-lateral, or Bochdalek’s hernia (70–75%), anterior or Morgagni’s hernia (23–28%) and central or hiatal hernia (2–7%) [4]. Morgagni’s hernia is often discovered incidentally in older children, as it rarely causes such a mass effect on the thoracic level as to compromise the development of the lungs. Bochdalek’s hernia is the form that is classically referred to when talking about this pathology and to which we will refer accordingly in the next paragraphs (26). Most often it is located on the left side (85%), but it can also be right (13%) or bilateral (2%) [4].
3. Pathogenesis
The pathogenesis of CDH is complex and currently still little known. Some studies have shown that pulmonary hypoplasia in these patients arises before the development of the diaphragm itself. This discovery opened the door to the so-called “double hit theory” which sees pulmonary hypoplasia as the result of two insults: the first, affecting both lungs, would be due to genetic and environmental factors (for example alcohol, smoking, obesity, low intake of retinoids during pregnancy); the second, which would affect only the lung ipsilateral to the defect, would consist of the compressive effect of the herniated viscera and their interference with normal fetal respiratory movements. Multiple studies have demonstrated the importance of the genetic component in the pathogenesis of ECD: they often fall within syndromic pictures, and about 40% of cases are associated with other congenital anomalies, especially cardiovascular (11–15% of ECD) [4].
4. Antenatal management
Given the potential severity of the disease, prenatal counseling represents a fundamental phase of the diagnostic-therapeutic process of CDH: parents must be adequately informed about all the steps to be taken and the risks in terms of mortality and morbidity.
4.1 Antenatal diagnosis
Ultrasound currently represents the gold standard in CDH diagnosis, although it has been calculated that less than two-thirds of CDHs are detected on prenatal screening ultrasound scans. The mean gestational age at diagnosis is 24–25 weeks, more advanced in cases of isolated defects than in CDHs associated with other anomalies. The typical ultrasound sign is the presence of abdominal organs (intestinal loops, stomach, liver) in the chest. Indirect signs of CDH can be changes in the heart axis, polyhydramnios, mediastinal shift. The differential diagnosis includes all congenital pulmonary malformations, bronchial atresia, intestinal duplications and mediastinal masses [5, 6]. The execution of genetic tests and second-level imaging tests is essential for defining the prenatal management strategy, whether it is inclined towards termination of pregnancy, or whether it is oriented towards fetal therapies. One of the main prognostic factors is represented by the lung to head ratio (LHR), which by measuring the length of the lung contralateral to the hernia normalized for the head circumference, provides an indirect estimate of pulmonary hypoplasia. More specifically, since the LHR changes with advancing gestational age, we prefer to use the ratio between observed LHR and expected LHR (observed/expected LHR or o/and LHR).
One or/and LHR <25% is indicative of severe hypoplasia, while one/and LHR of 25–35% or an LHR of 35–45% with herniated liver are indicative of moderate hypoplasia. In fact, another prognostic factor is represented by the position of the liver: since the liver and the fetal lung are poorly distinguishable ultrasonographically, there may be an indication to perform a fetal magnetic resonance [3, 4, 5, 6]. It allows to evaluate not only the presence or absence of liver in the thoracic cavity, but also to quantify the observed/expected total fetal lung volume (or/and TFLV), which was a better predictor in terms of postnatal survival. As an alternative to magnetic resonance evaluation of the or/and TFLV, some authors have demonstrated a close relationship between the liver herniation, the position of the stomach (which being anechoic is much more easily identifiable) and the postnatal outcome. Finally, given the high frequency with which EDC is associated with cardiovascular anomalies, there is an indication to perform fetal echocardiography [7, 8].
4.2 Antenatal therapies
The prenatal management of fetuses affected by CDH essentially provides for an ultrasound monitoring of the ultrasound parameters described above, associated in doubtful cases with second level examinations such as resonance. In recent years, however, fetal therapy has become increasingly popular on the international scene, indicated in cases where negative prognostic factors are detected in screening investigations (liver herniation, LHR <1.0). The purpose of these interventions is essentially to stop the mechanisms that induce the onset of complications such as pulmonary hypoplasia and pulmonary hypertension as early as possible. The technique currently most used is fetal tracheal occlusion (FETO): it is based on the principle that the occlusion of the trachea prevents the leakage of fluids, increasing the pressure in the airways and promoting lung growth. However, animal models have shown that tracheal occlusion reduces the maturation of type II pneumocytes, inducing a surfactant deficiency: for this reason the so-called “plug-unplug” sequence was devised, in which the patency of the trachea is first interrupted by the introduction of a balloon (or plug) and then re-established before delivery to allow lung maturation. This procedure can be performed percutaneously under ultrasound guidance or fetoscopy, typically between 27 and 32 weeks of gestational age, with the plug removed at 34 weeks. This procedure appears to be associated with increased survival in children with moderate and severe CDH, although further risk-benefit studies are certainly needed.
In children with CDH, the only medical treatment for which there is evidence of efficacy is corticosteroid therapy: maternal administration of one or two doses of corticosteroids at 34–36 weeks of gestation appears to be correlated with a reduction in respiratory morbidity at birth. Promising studies are also underway on the prenatal use of retinoids and phosphodiesterase inhibitors (Sildenafil) and on the use of stem cells from amniotic fluid in combination with FETO [4].
5. Postnatal management
The optimal timing and modality of delivery for children with CDH are still under discussion today. There seem to be no indications for induced delivery before 38 weeks of gestation, as well as there do not seem to be any advantages in performing a cesarean section. On the other hand, a unanimous consensus was found on the importance of planning the birth in a third-level center, where a multidisciplinary group (gynecologists, neonatologists, surgeons and pediatric anesthetists) is available, capable of managing the disease [4].
At birth, the main objective must be to ensure adequate ventilatory support (without triggering a vasospasm or further lung damage) and induce not too deep sedation (which would further compromise respiratory function). In case of respiratory distress, endotracheal intubation is carried out directly: in fact, ventilation with a facial mask must be avoided, as it would lead to distension of the stomach and intestinal loops, worsening the respiratory dynamics.
For the same principle, the positioning of a nasogastric tube is indicated at the same time, in order to decompress the stomach as much as possible. It is considered acceptable to maintain reduced saturation levels and a certain degree of hypercapnia, as long as the pH is kept above 7.2: in the presence of acidosis, in fact, vascular resistance would increase and consequently the risk of pulmonary hypertension. Another major problem in these patients is hemodynamic instability: to assess the need for inotropic support, these patients must be continuously monitored from a pressure point of view and postnatal echocardiography (within 48 h of life) must be performed if necessary repeated at 2–3 weeks. The indication for the ECMO, as a bridge to surgery in the most compromised patients, is still much debated. One of the biggest challenges remains the management of pulmonary hypertension: currently the most widely used treatment is inhaled nitric oxide, although encouraging new studies are underway on the use of Sildenafil [2, 4, 5].
Surgical treatment of CDH should be planned in election, after the achievement of hemodynamic stability. The only case in which it is acceptable to perform an emergency operation is when there are signs of ischemia of the herniated intestinal loops. As for the surgical technique, this can be performed openly (in thoracotomy or laparotomy) or by minimally invasive techniques. The intervention consists in the repositioning of the herniated organs within the abdomen and consequently in the closure of the defect, which can be primary or with a patch depending on the size of the defect. Minimally invasive techniques and the use of a patch were associated with a higher relapse rate [3, 4].
6. Long-term outcomes
In light of the increased survival of newborns with CDH, long-term outcomes, especially in terms of quality of life, have assumed increasing importance over time. The most compromised organs are certainly the lungs: in addition to the well-known pulmonary hypertension, these children experience alterations both in a restrictive sense (due to pulmonary hypoplasia) and in an obstructive sense (similar to bronchodysplasia of the premature infant) [8]. Pulmonary function seems to gradually restore during childhood, but recent studies have shown a slight deterioration of the same from childhood to adulthood. The respiratory system is not the only one affected by this disease. Gastroesophageal reflux is present in 45–89% of children with CDH and appears to be correlated with the size of the defect. Stunted growth is also a frequent finding, affecting 69% of these children at 1 year of age. Neurological alterations (in terms of delay in neurodevelopment but also sensorineural deafness) represent one of the most feared and also most frequent complications of CDH, with incidence rates ranging from 12 to 77%, especially in children undergoing ECMO. Finally, musculoskeletal deformities (chest anomalies, hemithorax asymmetries, scoliosis) were reported in 21–48% of patients treated for CDH [3].
All this, together with the fact that a good percentage of CDHs fall into syndromic pictures or are associated with other congenital anomalies, justifies the importance of a long-term follow-up program.
\n',keywords:"lung hypoplasia, pulmonary hypertension, extracorporeal membrane oxygenation, prenatal diagnosis",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/81570.pdf",chapterXML:"https://mts.intechopen.com/source/xml/81570.xml",downloadPdfUrl:"/chapter/pdf-download/81570",previewPdfUrl:"/chapter/pdf-preview/81570",totalDownloads:19,totalViews:0,totalCrossrefCites:0,dateSubmitted:"January 21st 2022",dateReviewed:"March 1st 2022",datePrePublished:"May 2nd 2022",datePublished:null,dateFinished:"April 29th 2022",readingETA:"0",abstract:"Congenital diaphragmatic hernia (CDH) is a condition characterized by a defect in the diaphragm leading to protrusion of abdominal contents into the thoracic cavity interfering with normal development of the lungs. The pathophysiology of CDH is a combination of lung hypoplasia and immaturity associated with persistent pulmonary hypertension of newborn (PPHN) and cardiac dysfunction. Prenatal assessment of lung to head ratio (LHR) and position of the liver by ultrasound are used to diagnose and predict outcomes. However, fetal therapy is indicated in cases where negative prognostic factors are detected in screening investigations (liver herniation, LHR <1.0). Immediate management at birth includes bowel decompression, avoidance of mask ventilation and endotracheal tube placement if required. The main focus of management includes gentle ventilation, hemodynamic monitoring and treatment of pulmonary hypertension followed by surgery. Although inhaled nitric oxide is not approved by FDA for the treatment of PPHN induced by CDH. Surgical treatment of CDH should be planned in election, after the achievement of hemodynamic stability. The only case in which it is acceptable to perform an emergency operation is when there are signs of ischemia of the herniated intestinal loops. Extracorporeal membrane oxygenation (ECMO) is typically considered after failure of conventional medical management for infants ≥ 34 weeks’ gestation or with weight > 2 kg with CDH and no associated major lethal anomalies. Prematurity, associated abnormalities, severity of PPHN, type of repair and need for ECMO can affect the survival of an infant with CDH. With advances in the management of CDH, the overall survival has improved.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/81570",risUrl:"/chapter/ris/81570",signatures:"Marina Sica, Carlotta Plessi and Francesco Molinaro",book:{id:"11280",type:"book",title:"Prenatal Diagnosis",subtitle:null,fullTitle:"Prenatal Diagnosis",slug:null,publishedDate:null,bookSignature:"Dr. Wei Wu, Ms. Qiuqin Tang, Prof. Panagiotis Tsikouras, Prof. Werner Rath and Prof. Georg-Friedrich Von Tempelhoff",coverURL:"https://cdn.intechopen.com/books/images_new/11280.jpg",licenceType:"CC BY 3.0",editedByType:null,isbn:"978-1-80355-841-7",printIsbn:"978-1-80355-840-0",pdfIsbn:"978-1-80355-842-4",isAvailableForWebshopOrdering:!0,editors:[{id:"178661",title:"Dr.",name:"Wei",middleName:null,surname:"Wu",slug:"wei-wu",fullName:"Wei Wu"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null,sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Classification",level:"1"},{id:"sec_3",title:"3. Pathogenesis",level:"1"},{id:"sec_4",title:"4. Antenatal management",level:"1"},{id:"sec_4_2",title:"4.1 Antenatal diagnosis",level:"2"},{id:"sec_5_2",title:"4.2 Antenatal therapies",level:"2"},{id:"sec_7",title:"5. Postnatal management",level:"1"},{id:"sec_8",title:"6. Long-term outcomes",level:"1"}],chapterReferences:[{id:"B1",body:'Lima M, editor. Pediatric Thoracic Surgery [Internet]. Mailand: Springer-Verlag; 2013 [cited 2021 Mar 27]. Available from: https://www.springer.com/gp/book/9788847052017'},{id:"B2",body:'Dingeldein M. Congenital diaphragmatic hernia. Advances in Pediatrics. 2018;65(1):241-247'},{id:"B3",body:'Leeuwen L, Fitzgerald DA. Congenital diaphragmatic hernia: Congenital diaphragmatic hernia. Journal of Paediatrics and Child Health. 2014;50(9):667-673'},{id:"B4",body:'Bloss RS, Aranda JV, Beardmore HE. Congenital diaphragmatic hernia: Pathophysiology and pharmacologic support. Surgery. 1981;89(4):518-524'},{id:"B5",body:'Kirby E, Keijzer R. Congenital diaphragmatic hernia: Current management strategies from antenatal diagnosis to long-term follow-up. Pediatric Surgery International. 2020;36(4):415-429'},{id:"B6",body:'Cordier A-G, Russo FM, Deprest J, Benachi A. Prenatal diagnosis, imaging, and prognosis in congenital diaphragmatic hernia. Seminars in Perinatology. 2020;44(1):51163'},{id:"B7",body:'Kitano Y. Prenatal intervention for congenital diaphragmatic hernia. Seminars in Pediatric Surgery. 2007;16(2):101-108'},{id:"B8",body:'Nakajima Y, Einspieler C, Marschik PB, Bos AF, Prechtl HFR. Does a detailed assessment of poor repertoire general movements help to identify those infants who will develop normally? Early Human Development. 2006;82(1):53-59'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Marina Sica",address:"sicamarina121@gmail.com",affiliation:'
'}],corrections:null},book:{id:"11280",type:"book",title:"Prenatal Diagnosis",subtitle:null,fullTitle:"Prenatal Diagnosis",slug:null,publishedDate:null,bookSignature:"Dr. Wei Wu, Ms. Qiuqin Tang, Prof. Panagiotis Tsikouras, Prof. Werner Rath and Prof. Georg-Friedrich Von Tempelhoff",coverURL:"https://cdn.intechopen.com/books/images_new/11280.jpg",licenceType:"CC BY 3.0",editedByType:null,isbn:"978-1-80355-841-7",printIsbn:"978-1-80355-840-0",pdfIsbn:"978-1-80355-842-4",isAvailableForWebshopOrdering:!0,editors:[{id:"178661",title:"Dr.",name:"Wei",middleName:null,surname:"Wu",slug:"wei-wu",fullName:"Wei Wu"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},profile:{item:{id:"228986",title:"Dr.",name:"Teresa Fina",middleName:null,surname:"Mastropietro",email:"tf.mastropietro@itm.cnr.it",fullName:"Teresa Fina Mastropietro",slug:"teresa-fina-mastropietro",position:null,biography:null,institutionString:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"1",totalEditedBooks:"0",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:null},booksEdited:[],chaptersAuthored:[{id:"59572",title:"Mesoporous TiO2 Thin Films: State of the Art",slug:"mesoporous-tio2-thin-films-state-of-the-art",abstract:"Mesoporous TiO2 thin films (MTTFs), thanks to their particularly high surface area, controlled porosity, high flexibility in composition, and surface design, are promising candidates in different application fields such as sensors, self-cleaning coatings, lithium-ion batteries (LIBs), photocatalysis, and new-generation solar cells. This chapter is focused on the synthetic and post-synthesis aspects that can affect the TiO2 mesoporous structure and consequently the MTTF properties. In particular, after a brief summary of TiO2 properties, all experimental conditions to prepare MTTFs are reviewed as well as the main characterization techniques employed to study their physicochemical and photocatalytic properties. An overview of the main applications of MTTFs is also proposed, mainly focused on the use of MTTFs in sensors and LIBs.",signatures:"Francesca Scarpelli, Teresa F. Mastropietro, Teresa Poerio and\nNicolas Godbert",authors:[{id:"228682",title:"Dr.",name:"Teresa",surname:"Poerio",fullName:"Teresa Poerio",slug:"teresa-poerio",email:"t.poerio@itm.cnr.it"},{id:"228684",title:"Dr.",name:"Nicolas",surname:"Godbert",fullName:"Nicolas Godbert",slug:"nicolas-godbert",email:"nicolas.godbert@unical.it"},{id:"228694",title:"Dr.",name:"Francesca",surname:"Scarpelli",fullName:"Francesca Scarpelli",slug:"francesca-scarpelli",email:"francesca.scarpelli@unical.it"},{id:"228986",title:"Dr.",name:"Teresa Fina",surname:"Mastropietro",fullName:"Teresa Fina Mastropietro",slug:"teresa-fina-mastropietro",email:"tf.mastropietro@itm.cnr.it"}],book:{id:"6426",title:"Titanium Dioxide",slug:"titanium-dioxide-material-for-a-sustainable-environment",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"20509",title:"Dr.",name:"Nika",surname:"Veronovski",slug:"nika-veronovski",fullName:"Nika Veronovski",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"200196",title:"Dr.",name:"Andreas",surname:"Petsas",slug:"andreas-petsas",fullName:"Andreas Petsas",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of the Aegean",institutionURL:null,country:{name:"Greece"}}},{id:"200198",title:"Dr.",name:"Maria",surname:"Vagi",slug:"maria-vagi",fullName:"Maria Vagi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"224679",title:"Dr.",name:"Sonia",surname:"Martinez-Gallegos",slug:"sonia-martinez-gallegos",fullName:"Sonia Martinez-Gallegos",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Instituto Tecnológico de Toluca",institutionURL:null,country:{name:"Mexico"}}},{id:"226906",title:"Dr.",name:"Lijia",surname:"Liu",slug:"lijia-liu",fullName:"Lijia Liu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"227893",title:"Dr.",name:"Sonia",surname:"Martinez-Gallegos",slug:"sonia-martinez-gallegos",fullName:"Sonia Martinez-Gallegos",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"227894",title:"Dr.",name:"Julio César",surname:"González-Juárez",slug:"julio-cesar-gonzalez-juarez",fullName:"Julio César González-Juárez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"227897",title:"MSc.",name:"Juan Carlos",surname:"Contreras-Ruíz",slug:"juan-carlos-contreras-ruiz",fullName:"Juan Carlos Contreras-Ruíz",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"227899",title:"Dr.",name:"José Luis",surname:"García-Rivas",slug:"jose-luis-garcia-rivas",fullName:"José Luis García-Rivas",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"227900",title:"Dr.",name:"Eduardo",surname:"Ordoñez",slug:"eduardo-ordonez",fullName:"Eduardo Ordoñez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]},generic:{page:{slug:"advertising-policy",title:"Advertising Policy",intro:"
In line with the Principles of Transparency and Best Practice in Scholarly Publishing, below is a more detailed description of IntechOpen's Advertising Policy.
",metaTitle:"Advertising Policy",metaDescription:"IntechOpen partners with third-party companies to serve ads and/or collect certain information when you visit our website. These companies may collect non-personally identifiable information (not including your name, address, email address or telephone number) during your visit to IntechOpen's website.",metaKeywords:null,canonicalURL:"/page/advertising-policy",contentRaw:'[{"type":"htmlEditorComponent","content":"
1. IntechOpen partners with third-party companies to serve ads and/or collect certain information when you visit our website. These companies may collect non-personally identifiable information (not including your name, address, email address or telephone number) during your visit to IntechOpen's website.
\\n\\n
2. All advertisements and commercially sponsored publications are independent from editorial decisions.
\\n\\n
3. IntechOpen does not endorse any product or service marked as an advertisement on IntechOpen website.
\\n\\n
4. IntechOpen has blocked all the inappropriate types of advertising.
\\n\\n
5. IntechOpen has blocked advertisement of harmful products or services.
\\n\\n
6. Advertisements and editorial content are clearly distinguishable.
\\n\\n
7. Editorial decisions will not be influenced by current or potential advertisers and will not be influenced by marketing decisions.
\\n\\n
8. Advertisers have no control or influence over the results of searches a user may conduct on the website by keyword or topic search.
\\n\\n
9. Types of advertisments:
\\n\\n
- Advertisements in the Physical Sciences, Engineering and Technology, and Social Sciences and Humanities sections of the IntechOpen website are programmatic (based on user behaviour such as web pages visited, content viewed, etc.)
\\n\\n
- Advertisements in the Life Sciences and Health Sciences sections of the IntechOpen website are programmatic as well as contextual based on the content of the respective books and chapters. IntechOpen's third party partner eHealthcare Solutions (EHS) is a unique marketing platform that specializes in connecting niche audiences with healthcare brands.
10. IntechOpen Advertising Sales department makes the decisions about the types of advertisements to include or exclude. Placement of advertising is at the discretion of IntechOpen. IntechOpen retains the right to reject and/or request modifications to the advertisement. An advertisement that is visible online, will be withdrawn from the site at any time if the Editor(s) or Author(s) request its removal.
\\n\\n
11. Users can make decisions about accepting advertisements. Users can block all the advertisements by using ad blockers. Users can send all the complaints about advertising to: info@intechopen.com.
1. IntechOpen partners with third-party companies to serve ads and/or collect certain information when you visit our website. These companies may collect non-personally identifiable information (not including your name, address, email address or telephone number) during your visit to IntechOpen's website.
\n\n
2. All advertisements and commercially sponsored publications are independent from editorial decisions.
\n\n
3. IntechOpen does not endorse any product or service marked as an advertisement on IntechOpen website.
\n\n
4. IntechOpen has blocked all the inappropriate types of advertising.
\n\n
5. IntechOpen has blocked advertisement of harmful products or services.
\n\n
6. Advertisements and editorial content are clearly distinguishable.
\n\n
7. Editorial decisions will not be influenced by current or potential advertisers and will not be influenced by marketing decisions.
\n\n
8. Advertisers have no control or influence over the results of searches a user may conduct on the website by keyword or topic search.
\n\n
9. Types of advertisments:
\n\n
- Advertisements in the Physical Sciences, Engineering and Technology, and Social Sciences and Humanities sections of the IntechOpen website are programmatic (based on user behaviour such as web pages visited, content viewed, etc.)
\n\n
- Advertisements in the Life Sciences and Health Sciences sections of the IntechOpen website are programmatic as well as contextual based on the content of the respective books and chapters. IntechOpen's third party partner eHealthcare Solutions (EHS) is a unique marketing platform that specializes in connecting niche audiences with healthcare brands.
10. IntechOpen Advertising Sales department makes the decisions about the types of advertisements to include or exclude. Placement of advertising is at the discretion of IntechOpen. IntechOpen retains the right to reject and/or request modifications to the advertisement. An advertisement that is visible online, will be withdrawn from the site at any time if the Editor(s) or Author(s) request its removal.
\n\n
11. Users can make decisions about accepting advertisements. Users can block all the advertisements by using ad blockers. Users can send all the complaints about advertising to: info@intechopen.com.
\n\n
Policy last updated: 2021-04-28
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[],filtersByRegion:[],offset:0,limit:12,total:null},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{topicId:"13"},books:[{type:"book",id:"11369",title:"RNA Viruses",subtitle:null,isOpenForSubmission:!0,hash:"52f8a3a1486912beae40b34ac557fed3",slug:null,bookSignature:"Ph.D. Yogendra Shah",coverURL:"https://cdn.intechopen.com/books/images_new/11369.jpg",editedByType:null,editors:[{id:"278914",title:"Ph.D.",name:"Yogendra",surname:"Shah",slug:"yogendra-shah",fullName:"Yogendra Shah"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11630",title:"Life in Extreme Environments - Diversity, Adaptability and Valuable Resources of Bioactive Molecules",subtitle:null,isOpenForSubmission:!0,hash:"9c39aa5fd22296ba53d87df6d761a5fc",slug:null,bookSignature:"Dr. Afef Najjari",coverURL:"https://cdn.intechopen.com/books/images_new/11630.jpg",editedByType:null,editors:[{id:"196823",title:"Dr.",name:"Afef",surname:"Najjari",slug:"afef-najjari",fullName:"Afef Najjari"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11632",title:"Updated Research on Bacteriophages",subtitle:null,isOpenForSubmission:!0,hash:"d34dfa0d5d10511184f97ddaeef9936b",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11632.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11633",title:"Pseudomonas aeruginosa - New Perspectives and Applications",subtitle:null,isOpenForSubmission:!0,hash:"a7cd19791397a27a80526be0dc54bd8a",slug:null,bookSignature:"Associate Prof. Osama Darwesh and Dr. Ibrahim Matter",coverURL:"https://cdn.intechopen.com/books/images_new/11633.jpg",editedByType:null,editors:[{id:"298076",title:"Associate Prof.",name:"Osama",surname:"Darwesh",slug:"osama-darwesh",fullName:"Osama Darwesh"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11634",title:"Mycobacterium - Epidemiology, Prevention, Diagnostic, and Management",subtitle:null,isOpenForSubmission:!0,hash:"aa972af90c14eb4ef39b6dc71911f623",slug:null,bookSignature:"Dr. Awelani Mutshembele",coverURL:"https://cdn.intechopen.com/books/images_new/11634.jpg",editedByType:null,editors:[{id:"468847",title:"Dr.",name:"Awelani",surname:"Mutshembele",slug:"awelani-mutshembele",fullName:"Awelani Mutshembele"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11635",title:"Towards New Perspectives on Toxoplasma gondii",subtitle:null,isOpenForSubmission:!0,hash:"2d409a285bea682efb34a817b0651aba",slug:null,bookSignature:"Dr. Saeed El-Ashram, Dr. Guillermo Téllez and Dr. Firas Alali",coverURL:"https://cdn.intechopen.com/books/images_new/11635.jpg",editedByType:null,editors:[{id:"209746",title:"Dr.",name:"Saeed",surname:"El-Ashram",slug:"saeed-el-ashram",fullName:"Saeed El-Ashram"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11796",title:"Cytomegalovirus - Recent Advances",subtitle:null,isOpenForSubmission:!0,hash:"4e442adc2808f68ccc1aeac17e6ae746",slug:null,bookSignature:"Dr. Seyyed Shamsadin Athari and Dr. Entezar Mehrabi Nasab",coverURL:"https://cdn.intechopen.com/books/images_new/11796.jpg",editedByType:null,editors:[{id:"139889",title:"Dr.",name:"Seyyed Shamsadin",surname:"Athari",slug:"seyyed-shamsadin-athari",fullName:"Seyyed Shamsadin Athari"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11797",title:"Clostridium difficile",subtitle:null,isOpenForSubmission:!0,hash:"4cb066b44bb8d4a8b93a627de26e3ebf",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11797.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11798",title:"Listeria monocytogenes",subtitle:null,isOpenForSubmission:!0,hash:"678ca4185133438014939804bf8a05e6",slug:null,bookSignature:"Prof. Cristina Saraiva, Dr. Sónia Saraiva and Prof. Alexandra Esteves",coverURL:"https://cdn.intechopen.com/books/images_new/11798.jpg",editedByType:null,editors:[{id:"226197",title:"Prof.",name:"Cristina",surname:"Saraiva",slug:"cristina-saraiva",fullName:"Cristina Saraiva"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11799",title:"Salmonella - Past, Present and Future",subtitle:null,isOpenForSubmission:!0,hash:"6ddb13c31fb19c6f79d19f11ceeb860e",slug:null,bookSignature:"Ph.D. Hongsheng Huang and Dr. Sohail Naushad",coverURL:"https://cdn.intechopen.com/books/images_new/11799.jpg",editedByType:null,editors:[{id:"342722",title:"Ph.D.",name:"Hongsheng",surname:"Huang",slug:"hongsheng-huang",fullName:"Hongsheng Huang"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11800",title:"Cyanobacteria - Recent Advances and New Perspectives",subtitle:null,isOpenForSubmission:!0,hash:"645b037b086ec8c36af614326dce9804",slug:null,bookSignature:"Dr. Archana Tiwari",coverURL:"https://cdn.intechopen.com/books/images_new/11800.jpg",editedByType:null,editors:[{id:"186791",title:"Dr.",name:"Archana",surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11801",title:"Roundworms - A Survey From Past to Present",subtitle:null,isOpenForSubmission:!0,hash:"5edc96349630be8bb4e67170be677d8c",slug:null,bookSignature:"Dr. Nihal Dogan",coverURL:"https://cdn.intechopen.com/books/images_new/11801.jpg",editedByType:null,editors:[{id:"169552",title:"Dr.",name:"Nihal",surname:"Dogan",slug:"nihal-dogan",fullName:"Nihal Dogan"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:38},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:13},{group:"topic",caption:"Business, Management and Economics",value:7,count:7},{group:"topic",caption:"Chemistry",value:8,count:23},{group:"topic",caption:"Computer and Information Science",value:9,count:24},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:15},{group:"topic",caption:"Engineering",value:11,count:65},{group:"topic",caption:"Environmental Sciences",value:12,count:10},{group:"topic",caption:"Immunology and Microbiology",value:13,count:16},{group:"topic",caption:"Materials Science",value:14,count:25},{group:"topic",caption:"Mathematics",value:15,count:11},{group:"topic",caption:"Medicine",value:16,count:116},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:6},{group:"topic",caption:"Neuroscience",value:18,count:4},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:9},{group:"topic",caption:"Physics",value:20,count:9},{group:"topic",caption:"Psychology",value:21,count:10},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:9},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:4}],offset:12,limit:12,total:23},popularBooks:{featuredBooks:[{type:"book",id:"10858",title:"MOOC (Massive Open Online Courses)",subtitle:null,isOpenForSubmission:!1,hash:"d32f86793bc72dde32532f509b1ec5b0",slug:"mooc-massive-open-online-courses-",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/10858.jpg",editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10195",title:"Serotonin and the CNS",subtitle:"New Developments in Pharmacology and Therapeutics",isOpenForSubmission:!1,hash:"7ed9d96da98233a885bd2869a8056c36",slug:"serotonin-and-the-cns-new-developments-in-pharmacology-and-therapeutics",bookSignature:"Berend Olivier",coverURL:"https://cdn.intechopen.com/books/images_new/10195.jpg",editors:[{id:"71579",title:"Prof.",name:"Berend",middleName:null,surname:"Olivier",slug:"berend-olivier",fullName:"Berend Olivier"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10755",title:"Corporate Governance",subtitle:"Recent Advances and Perspectives",isOpenForSubmission:!1,hash:"ffe06d1d5c4bf0fc2e63511825fe1257",slug:"corporate-governance-recent-advances-and-perspectives",bookSignature:"Okechukwu Lawrence Emeagwali and Feyza Bhatti",coverURL:"https://cdn.intechopen.com/books/images_new/10755.jpg",editors:[{id:"196317",title:"Associate Prof.",name:"Okechukwu Lawrence",middleName:null,surname:"Emeagwali",slug:"okechukwu-lawrence-emeagwali",fullName:"Okechukwu Lawrence Emeagwali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11120",title:"Environmental Impact and Remediation of Heavy Metals",subtitle:null,isOpenForSubmission:!1,hash:"9e77514288e7394f1e6cd13481af3509",slug:"environmental-impact-and-remediation-of-heavy-metals",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11120.jpg",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10901",title:"Grapes and Wine",subtitle:null,isOpenForSubmission:!1,hash:"5d7f2aa74874444bc6986e613ccebd7c",slug:"grapes-and-wine",bookSignature:"Antonio Morata, Iris Loira and Carmen González",coverURL:"https://cdn.intechopen.com/books/images_new/10901.jpg",editors:[{id:"180952",title:"Prof.",name:"Antonio",middleName:null,surname:"Morata",slug:"antonio-morata",fullName:"Antonio Morata"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11080",title:"Engineering Principles",subtitle:"Welding and Residual Stresses",isOpenForSubmission:!1,hash:"6c07a13a113bce94174b40096f30fb5e",slug:"engineering-principles-welding-and-residual-stresses",bookSignature:"Kavian Omar Cooke and Ronaldo Câmara Cozza",coverURL:"https://cdn.intechopen.com/books/images_new/11080.jpg",editors:[{id:"138778",title:"Dr.",name:"Kavian",middleName:"Omar",surname:"Cooke",slug:"kavian-cooke",fullName:"Kavian Cooke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",isOpenForSubmission:!1,hash:"742e6cae3a35686f975edc8d7f9afa94",slug:"essential-oils-advances-in-extractions-and-biological-applications",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11029",title:"Hepatitis B",subtitle:null,isOpenForSubmission:!1,hash:"609701f502efc3538c112ff47a2c2119",slug:"hepatitis-b",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/11029.jpg",editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9537",title:"Human Rights in the Contemporary World",subtitle:null,isOpenForSubmission:!1,hash:"54f05b93812fd434f3962956d6413a6b",slug:"human-rights-in-the-contemporary-world",bookSignature:"Trudy Corrigan",coverURL:"https://cdn.intechopen.com/books/images_new/9537.jpg",editors:[{id:"197557",title:"Dr.",name:"Trudy",middleName:null,surname:"Corrigan",slug:"trudy-corrigan",fullName:"Trudy Corrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11371",title:"Cerebral Circulation",subtitle:"Updates on Models, Diagnostics and Treatments of Related Diseases",isOpenForSubmission:!1,hash:"e2d3335445d2852d0b906bb9750e939f",slug:"cerebral-circulation-updates-on-models-diagnostics-and-treatments-of-related-diseases",bookSignature:"Alba Scerrati, Luca Ricciardi and Flavia Dones",coverURL:"https://cdn.intechopen.com/books/images_new/11371.jpg",editors:[{id:"182614",title:"Dr.",name:"Alba",middleName:null,surname:"Scerrati",slug:"alba-scerrati",fullName:"Alba Scerrati"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11012",title:"Radiopharmaceuticals",subtitle:"Current Research for Better Diagnosis and Therapy",isOpenForSubmission:!1,hash:"f9046d6f96148b285e776f384991120d",slug:"radiopharmaceuticals-current-research-for-better-diagnosis-and-therapy",bookSignature:"Farid A. Badria",coverURL:"https://cdn.intechopen.com/books/images_new/11012.jpg",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9974",title:"E-Learning and Digital Education in the Twenty-First Century",subtitle:null,isOpenForSubmission:!1,hash:"88b58d66e975df20425fc1dfd22d53aa",slug:"e-learning-and-digital-education-in-the-twenty-first-century",bookSignature:"M. Mahruf C. Shohel",coverURL:"https://cdn.intechopen.com/books/images_new/9974.jpg",editors:[{id:"94099",title:"Dr.",name:"M. Mahruf C.",middleName:null,surname:"Shohel",slug:"m.-mahruf-c.-shohel",fullName:"M. Mahruf C. Shohel"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4430},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10858",title:"MOOC (Massive Open Online Courses)",subtitle:null,isOpenForSubmission:!1,hash:"d32f86793bc72dde32532f509b1ec5b0",slug:"mooc-massive-open-online-courses-",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/10858.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1677,editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10195",title:"Serotonin and the CNS",subtitle:"New Developments in Pharmacology and Therapeutics",isOpenForSubmission:!1,hash:"7ed9d96da98233a885bd2869a8056c36",slug:"serotonin-and-the-cns-new-developments-in-pharmacology-and-therapeutics",bookSignature:"Berend Olivier",coverURL:"https://cdn.intechopen.com/books/images_new/10195.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1337,editors:[{id:"71579",title:"Prof.",name:"Berend",middleName:null,surname:"Olivier",slug:"berend-olivier",fullName:"Berend Olivier"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10755",title:"Corporate Governance",subtitle:"Recent Advances and Perspectives",isOpenForSubmission:!1,hash:"ffe06d1d5c4bf0fc2e63511825fe1257",slug:"corporate-governance-recent-advances-and-perspectives",bookSignature:"Okechukwu Lawrence Emeagwali and Feyza Bhatti",coverURL:"https://cdn.intechopen.com/books/images_new/10755.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1309,editors:[{id:"196317",title:"Associate Prof.",name:"Okechukwu Lawrence",middleName:null,surname:"Emeagwali",slug:"okechukwu-lawrence-emeagwali",fullName:"Okechukwu Lawrence Emeagwali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11120",title:"Environmental Impact and Remediation of Heavy Metals",subtitle:null,isOpenForSubmission:!1,hash:"9e77514288e7394f1e6cd13481af3509",slug:"environmental-impact-and-remediation-of-heavy-metals",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11120.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:847,editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10901",title:"Grapes and Wine",subtitle:null,isOpenForSubmission:!1,hash:"5d7f2aa74874444bc6986e613ccebd7c",slug:"grapes-and-wine",bookSignature:"Antonio Morata, Iris Loira and Carmen González",coverURL:"https://cdn.intechopen.com/books/images_new/10901.jpg",publishedDate:"June 15th 2022",numberOfDownloads:2273,editors:[{id:"180952",title:"Prof.",name:"Antonio",middleName:null,surname:"Morata",slug:"antonio-morata",fullName:"Antonio Morata"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11080",title:"Engineering Principles",subtitle:"Welding and Residual Stresses",isOpenForSubmission:!1,hash:"6c07a13a113bce94174b40096f30fb5e",slug:"engineering-principles-welding-and-residual-stresses",bookSignature:"Kavian Omar Cooke and Ronaldo Câmara Cozza",coverURL:"https://cdn.intechopen.com/books/images_new/11080.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:591,editors:[{id:"138778",title:"Dr.",name:"Kavian",middleName:"Omar",surname:"Cooke",slug:"kavian-cooke",fullName:"Kavian Cooke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",isOpenForSubmission:!1,hash:"742e6cae3a35686f975edc8d7f9afa94",slug:"essential-oils-advances-in-extractions-and-biological-applications",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:515,editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11029",title:"Hepatitis B",subtitle:null,isOpenForSubmission:!1,hash:"609701f502efc3538c112ff47a2c2119",slug:"hepatitis-b",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/11029.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:413,editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9537",title:"Human Rights in the Contemporary World",subtitle:null,isOpenForSubmission:!1,hash:"54f05b93812fd434f3962956d6413a6b",slug:"human-rights-in-the-contemporary-world",bookSignature:"Trudy Corrigan",coverURL:"https://cdn.intechopen.com/books/images_new/9537.jpg",publishedDate:"June 8th 2022",numberOfDownloads:2194,editors:[{id:"197557",title:"Dr.",name:"Trudy",middleName:null,surname:"Corrigan",slug:"trudy-corrigan",fullName:"Trudy Corrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11371",title:"Cerebral Circulation",subtitle:"Updates on Models, Diagnostics and Treatments of Related Diseases",isOpenForSubmission:!1,hash:"e2d3335445d2852d0b906bb9750e939f",slug:"cerebral-circulation-updates-on-models-diagnostics-and-treatments-of-related-diseases",bookSignature:"Alba Scerrati, Luca Ricciardi and Flavia Dones",coverURL:"https://cdn.intechopen.com/books/images_new/11371.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:341,editors:[{id:"182614",title:"Dr.",name:"Alba",middleName:null,surname:"Scerrati",slug:"alba-scerrati",fullName:"Alba Scerrati"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"11043",title:"Endometriosis",subtitle:"Recent Advances, New Perspectives and Treatments",isOpenForSubmission:!1,hash:"7baf1c70b11d41400bb9302ae9411ca4",slug:"endometriosis-recent-advances-new-perspectives-and-treatments",bookSignature:"Giovana Ap. Gonçalves",coverURL:"https://cdn.intechopen.com/books/images_new/11043.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"185930",title:"Associate Prof.",name:"Giovana",middleName:null,surname:"Gonçalves",slug:"giovana-goncalves",fullName:"Giovana Gonçalves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10536",title:"Campylobacter",subtitle:null,isOpenForSubmission:!1,hash:"c4b132b741dd0a2ed539b824ab63965f",slug:"campylobacter",bookSignature:"Guillermo Tellez-Isaias and Saeed El-Ashram",coverURL:"https://cdn.intechopen.com/books/images_new/10536.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"73465",title:"Dr.",name:"Guillermo",middleName:null,surname:"Téllez",slug:"guillermo-tellez",fullName:"Guillermo Téllez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10798",title:"Starch",subtitle:"Evolution and Recent Advances",isOpenForSubmission:!1,hash:"f197f6062c1574a9a90e50a369271bcf",slug:"starch-evolution-and-recent-advances",bookSignature:"Martins Ochubiojo Emeje",coverURL:"https://cdn.intechopen.com/books/images_new/10798.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11083",title:"Hazardous Waste Management",subtitle:null,isOpenForSubmission:!1,hash:"d553bd4f6f1c4b115ca69bd19faac7dc",slug:"hazardous-waste-management",bookSignature:"Rajesh Banu Jeyakumar, Kavitha Sankarapandian and Yukesh Kannah Ravi",coverURL:"https://cdn.intechopen.com/books/images_new/11083.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"218539",title:"Dr.",name:"Rajesh Banu",middleName:null,surname:"Jeyakumar",slug:"rajesh-banu-jeyakumar",fullName:"Rajesh Banu Jeyakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10848",title:"Tribology of Machine Elements",subtitle:"Fundamentals and Applications",isOpenForSubmission:!1,hash:"3c4ca4c4692ca8d4fa749b4ae81ec1fa",slug:"tribology-of-machine-elements-fundamentals-and-applications",bookSignature:"Giuseppe Pintaude, Tiago Cousseau and Anna Rudawska",coverURL:"https://cdn.intechopen.com/books/images_new/10848.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"18347",title:"Prof.",name:"Giuseppe",middleName:null,surname:"Pintaude",slug:"giuseppe-pintaude",fullName:"Giuseppe Pintaude"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10856",title:"Crude Oil",subtitle:"New Technologies and Recent Approaches",isOpenForSubmission:!1,hash:"8d0a7ca35b3de95b295dc4eab39a087e",slug:"crude-oil-new-technologies-and-recent-approaches",bookSignature:"Manar Elsayed Abdel-Raouf and Mohamed Hasan El-Keshawy",coverURL:"https://cdn.intechopen.com/books/images_new/10856.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"102626",title:"Prof.",name:"Manar",middleName:null,surname:"Elsayed Abdel-Raouf",slug:"manar-elsayed-abdel-raouf",fullName:"Manar Elsayed Abdel-Raouf"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9625",title:"Spinocerebellar Ataxia",subtitle:"Concepts, Particularities and Generalities",isOpenForSubmission:!1,hash:"365a7025fd46eb45de2549bdd9d50b98",slug:"spinocerebellar-ataxia-concepts-particularities-and-generalities",bookSignature:"Patricia Bozzetto Ambrosi",coverURL:"https://cdn.intechopen.com/books/images_new/9625.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"221787",title:"Dr.",name:"Patricia",middleName:null,surname:"Bozzetto Ambrosi",slug:"patricia-bozzetto-ambrosi",fullName:"Patricia Bozzetto Ambrosi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10905",title:"Plant Defense Mechanisms",subtitle:null,isOpenForSubmission:!1,hash:"84ad5b27dde5f01dc76087d0fd6fa834",slug:"plant-defense-mechanisms",bookSignature:"Josphert Ngui Kimatu",coverURL:"https://cdn.intechopen.com/books/images_new/10905.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"224171",title:"Prof.",name:"Josphert N.",middleName:null,surname:"Kimatu",slug:"josphert-n.-kimatu",fullName:"Josphert N. Kimatu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10686",title:"Natural Gas",subtitle:"New Perspectives and Future Developments",isOpenForSubmission:!1,hash:"581763788a6a59e653a9d1d9b5a42d79",slug:"natural-gas-new-perspectives-and-future-developments",bookSignature:"Maryam Takht Ravanchi",coverURL:"https://cdn.intechopen.com/books/images_new/10686.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"2416",title:"Dr.",name:"Maryam",middleName:null,surname:"Takht Ravanchi",slug:"maryam-takht-ravanchi",fullName:"Maryam Takht Ravanchi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10988",title:"Railway Transport Planning and Manageme",subtitle:null,isOpenForSubmission:!1,hash:"5cb54cc53caedad9ec78372563c82e2c",slug:"railway-transport-planning-and-management",bookSignature:"Stefano de Luca, Roberta Di Pace and Chiara Fiori",coverURL:"https://cdn.intechopen.com/books/images_new/10988.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"271061",title:"Prof.",name:"Stefano",middleName:null,surname:"de Luca",slug:"stefano-de-luca",fullName:"Stefano de Luca"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"1207",title:"Forensic Toxicology",slug:"forensic-toxicology",parent:{id:"220",title:"Toxicology",slug:"pharmacology-toxicology-and-pharmaceutical-science-toxicology"},numberOfBooks:1,numberOfSeries:0,numberOfAuthorsAndEditors:14,numberOfWosCitations:70,numberOfCrossrefCitations:45,numberOfDimensionsCitations:94,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"1207",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"4557",title:"Toxicology Studies",subtitle:"Cells, Drugs and Environment",isOpenForSubmission:!1,hash:"e547709cb19f12af25b2eb23aecc726d",slug:"toxicology-studies-cells-drugs-and-environment",bookSignature:"Ana Cristina Andreazza and Gustavo Scola",coverURL:"https://cdn.intechopen.com/books/images_new/4557.jpg",editedByType:"Edited by",editors:[{id:"172081",title:"Dr.",name:"Ana Cristina",middleName:null,surname:"Andreazza",slug:"ana-cristina-andreazza",fullName:"Ana Cristina Andreazza"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:1,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"48406",doi:"10.5772/59710",title:"Impact of Pesticides on Environmental and Human Health",slug:"impact-of-pesticides-on-environmental-and-human-health",totalDownloads:7379,totalCrossrefCites:25,totalDimensionsCites:62,abstract:null,book:{id:"4557",slug:"toxicology-studies-cells-drugs-and-environment",title:"Toxicology Studies",fullTitle:"Toxicology Studies - Cells, Drugs and Environment"},signatures:"Mariana Furio Franco Bernardes, Murilo Pazin, Lilian Cristina Pereira\nand Daniel Junqueira Dorta",authors:[{id:"172524",title:"Dr.",name:"Daniel",middleName:null,surname:"Dorta",slug:"daniel-dorta",fullName:"Daniel Dorta"}]},{id:"48270",doi:"10.5772/59885",title:"Estrogenic Compounds in Estuarine and Coastal Water Environments of the Iberian Western Atlantic Coast and Selected Locations Worldwide — Relevancy, Trends and Challenges in View of the EU Water Framework Directive",slug:"estrogenic-compounds-in-estuarine-and-coastal-water-environments-of-the-iberian-western-atlantic-coa",totalDownloads:1814,totalCrossrefCites:10,totalDimensionsCites:10,abstract:null,book:{id:"4557",slug:"toxicology-studies-cells-drugs-and-environment",title:"Toxicology Studies",fullTitle:"Toxicology Studies - Cells, Drugs and Environment"},signatures:"Maria João Rocha and Eduardo Rocha",authors:[{id:"172652",title:"Prof.",name:"Eduardo",middleName:null,surname:"Rocha",slug:"eduardo-rocha",fullName:"Eduardo Rocha"},{id:"172670",title:"Prof.",name:"Maria João",middleName:null,surname:"Rocha",slug:"maria-joao-rocha",fullName:"Maria João Rocha"}]},{id:"48295",doi:"10.5772/60439",title:"Tramadol Poisoning",slug:"tramadol-poisoning",totalDownloads:4094,totalCrossrefCites:6,totalDimensionsCites:8,abstract:null,book:{id:"4557",slug:"toxicology-studies-cells-drugs-and-environment",title:"Toxicology Studies",fullTitle:"Toxicology Studies - Cells, Drugs and Environment"},signatures:"Omid Mehrpour, Mohammaddavood Sharifi and Nasim Zamani",authors:[{id:"172571",title:"Dr.",name:"Omid",middleName:null,surname:"Mehrpour",slug:"omid-mehrpour",fullName:"Omid Mehrpour"}]},{id:"48230",doi:"10.5772/59719",title:"Mitochondrial Targeting for Drug Development",slug:"mitochondrial-targeting-for-drug-development",totalDownloads:6841,totalCrossrefCites:1,totalDimensionsCites:6,abstract:null,book:{id:"4557",slug:"toxicology-studies-cells-drugs-and-environment",title:"Toxicology Studies",fullTitle:"Toxicology Studies - Cells, Drugs and Environment"},signatures:"Jalal Pourahmad, Ahmad Salimi and Enayatollah Seydi",authors:[{id:"172672",title:"Prof.",name:"Jalal",middleName:null,surname:"Pourahmad",slug:"jalal-pourahmad",fullName:"Jalal Pourahmad"}]},{id:"48151",doi:"10.5772/59945",title:"Pathological Aspects with Global Impact Induced by Toxicants at Cellular Level",slug:"pathological-aspects-with-global-impact-induced-by-toxicants-at-cellular-level",totalDownloads:2100,totalCrossrefCites:1,totalDimensionsCites:3,abstract:null,book:{id:"4557",slug:"toxicology-studies-cells-drugs-and-environment",title:"Toxicology Studies",fullTitle:"Toxicology Studies - Cells, Drugs and Environment"},signatures:"Dorina E. Coricovac and Cristina A. Dehelean",authors:[{id:"141027",title:"Dr.",name:"Cristina",middleName:null,surname:"Dehelean",slug:"cristina-dehelean",fullName:"Cristina Dehelean"},{id:"173283",title:"Dr.",name:"Dorina",middleName:null,surname:"Coricovac",slug:"dorina-coricovac",fullName:"Dorina Coricovac"}]}],mostDownloadedChaptersLast30Days:[{id:"48230",title:"Mitochondrial Targeting for Drug Development",slug:"mitochondrial-targeting-for-drug-development",totalDownloads:6841,totalCrossrefCites:1,totalDimensionsCites:6,abstract:null,book:{id:"4557",slug:"toxicology-studies-cells-drugs-and-environment",title:"Toxicology Studies",fullTitle:"Toxicology Studies - Cells, Drugs and Environment"},signatures:"Jalal Pourahmad, Ahmad Salimi and Enayatollah Seydi",authors:[{id:"172672",title:"Prof.",name:"Jalal",middleName:null,surname:"Pourahmad",slug:"jalal-pourahmad",fullName:"Jalal Pourahmad"}]},{id:"48406",title:"Impact of Pesticides on Environmental and Human Health",slug:"impact-of-pesticides-on-environmental-and-human-health",totalDownloads:7379,totalCrossrefCites:25,totalDimensionsCites:62,abstract:null,book:{id:"4557",slug:"toxicology-studies-cells-drugs-and-environment",title:"Toxicology Studies",fullTitle:"Toxicology Studies - Cells, Drugs and Environment"},signatures:"Mariana Furio Franco Bernardes, Murilo Pazin, Lilian Cristina Pereira\nand Daniel Junqueira Dorta",authors:[{id:"172524",title:"Dr.",name:"Daniel",middleName:null,surname:"Dorta",slug:"daniel-dorta",fullName:"Daniel Dorta"}]},{id:"48302",title:"Forensic Toxicology",slug:"forensic-toxicology",totalDownloads:2471,totalCrossrefCites:0,totalDimensionsCites:0,abstract:null,book:{id:"4557",slug:"toxicology-studies-cells-drugs-and-environment",title:"Toxicology Studies",fullTitle:"Toxicology Studies - Cells, Drugs and Environment"},signatures:"Donata Favretto, Massimo Montisci and Rossella Snenghi",authors:[{id:"172305",title:"Prof.",name:"Donata",middleName:null,surname:"Favretto",slug:"donata-favretto",fullName:"Donata Favretto"},{id:"172775",title:"Dr.",name:"Rossella",middleName:null,surname:"Snenghi",slug:"rossella-snenghi",fullName:"Rossella Snenghi"}]},{id:"48295",title:"Tramadol Poisoning",slug:"tramadol-poisoning",totalDownloads:4094,totalCrossrefCites:6,totalDimensionsCites:8,abstract:null,book:{id:"4557",slug:"toxicology-studies-cells-drugs-and-environment",title:"Toxicology Studies",fullTitle:"Toxicology Studies - Cells, Drugs and Environment"},signatures:"Omid Mehrpour, Mohammaddavood Sharifi and Nasim Zamani",authors:[{id:"172571",title:"Dr.",name:"Omid",middleName:null,surname:"Mehrpour",slug:"omid-mehrpour",fullName:"Omid Mehrpour"}]},{id:"48270",title:"Estrogenic Compounds in Estuarine and Coastal Water Environments of the Iberian Western Atlantic Coast and Selected Locations Worldwide — Relevancy, Trends and Challenges in View of the EU Water Framework Directive",slug:"estrogenic-compounds-in-estuarine-and-coastal-water-environments-of-the-iberian-western-atlantic-coa",totalDownloads:1814,totalCrossrefCites:10,totalDimensionsCites:10,abstract:null,book:{id:"4557",slug:"toxicology-studies-cells-drugs-and-environment",title:"Toxicology Studies",fullTitle:"Toxicology Studies - Cells, Drugs and Environment"},signatures:"Maria João Rocha and Eduardo Rocha",authors:[{id:"172652",title:"Prof.",name:"Eduardo",middleName:null,surname:"Rocha",slug:"eduardo-rocha",fullName:"Eduardo Rocha"},{id:"172670",title:"Prof.",name:"Maria João",middleName:null,surname:"Rocha",slug:"maria-joao-rocha",fullName:"Maria João Rocha"}]}],onlineFirstChaptersFilter:{topicId:"1207",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:0,limit:8,total:null},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:89,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:104,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:32,numberOfPublishedChapters:318,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:12,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:141,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:105,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:2,numberOfUpcomingTopics:1,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:5,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:15,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}},{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}}]},series:{item:{id:"24",title:"Sustainable Development",doi:"10.5772/intechopen.100361",issn:null,scope:"
\r\n\tTransforming our World: the 2030 Agenda for Sustainable Development endorsed by United Nations and 193 Member States, came into effect on Jan 1, 2016, to guide decision making and actions to the year 2030 and beyond. Central to this Agenda are 17 Goals, 169 associated targets and over 230 indicators that are reviewed annually. The vision envisaged in the implementation of the SDGs is centered on the five Ps: People, Planet, Prosperity, Peace and Partnership. This call for renewed focused efforts ensure we have a safe and healthy planet for current and future generations.
\r\n
\r\n\t
\r\n
\r\n\tThis Series focuses on covering research and applied research involving the five Ps through the following topics:
\r\n
\r\n\t
\r\n
\r\n\t1. Sustainable Economy and Fair Society that relates to SDG 1 on No Poverty, SDG 2 on Zero Hunger, SDG 8 on Decent Work and Economic Growth, SDG 10 on Reduced Inequalities, SDG 12 on Responsible Consumption and Production, and SDG 17 Partnership for the Goals
\r\n
\r\n\t
\r\n
\r\n\t2. Health and Wellbeing focusing on SDG 3 on Good Health and Wellbeing and SDG 6 on Clean Water and Sanitation
\r\n
\r\n\t
\r\n
\r\n\t3. Inclusivity and Social Equality involving SDG 4 on Quality Education, SDG 5 on Gender Equality, and SDG 16 on Peace, Justice and Strong Institutions
\r\n
\r\n\t
\r\n
\r\n\t4. Climate Change and Environmental Sustainability comprising SDG 13 on Climate Action, SDG 14 on Life Below Water, and SDG 15 on Life on Land
\r\n
\r\n\t
\r\n
\r\n\t5. Urban Planning and Environmental Management embracing SDG 7 on Affordable Clean Energy, SDG 9 on Industry, Innovation and Infrastructure, and SDG 11 on Sustainable Cities and Communities.
\r\n
\r\n\t
\r\n
\r\n\tThe series also seeks to support the use of cross cutting SDGs, as many of the goals listed above, targets and indicators are all interconnected to impact our lives and the decisions we make on a daily basis, making them impossible to tie to a single topic.
",coverUrl:"https://cdn.intechopen.com/series/covers/24.jpg",latestPublicationDate:"June 28th, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:0,editor:{id:"262440",title:"Prof.",name:"Usha",middleName:null,surname:"Iyer-Raniga",slug:"usha-iyer-raniga",fullName:"Usha Iyer-Raniga",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRYSXQA4/Profile_Picture_2022-02-28T13:55:36.jpeg",biography:"Usha Iyer-Raniga is a professor in the School of Property and Construction Management at RMIT University. Usha co-leads the One Planet Network’s Sustainable Buildings and Construction Programme (SBC), a United Nations 10 Year Framework of Programmes on Sustainable Consumption and Production (UN 10FYP SCP) aligned with Sustainable Development Goal 12. The work also directly impacts SDG 11 on Sustainable Cities and Communities. She completed her undergraduate degree as an architect before obtaining her Masters degree from Canada and her Doctorate in Australia. Usha has been a keynote speaker as well as an invited speaker at national and international conferences, seminars and workshops. Her teaching experience includes teaching in Asian countries. She has advised Austrade, APEC, national, state and local governments. She serves as a reviewer and a member of the scientific committee for national and international refereed journals and refereed conferences. She is on the editorial board for refereed journals and has worked on Special Issues. Usha has served and continues to serve on the Boards of several not-for-profit organisations and she has also served as panel judge for a number of awards including the Premiers Sustainability Award in Victoria and the International Green Gown Awards. Usha has published over 100 publications, including research and consulting reports. Her publications cover a wide range of scientific and technical research publications that include edited books, book chapters, refereed journals, refereed conference papers and reports for local, state and federal government clients. She has also produced podcasts for various organisations and participated in media interviews. She has received state, national and international funding worth over USD $25 million. Usha has been awarded the Quarterly Franklin Membership by London Journals Press (UK). Her biography has been included in the Marquis Who's Who in the World® 2018, 2016 (33rd Edition), along with approximately 55,000 of the most accomplished men and women from around the world, including luminaries as U.N. Secretary-General Ban Ki-moon. In 2017, Usha was awarded the Marquis Who’s Who Lifetime Achiever Award.",institutionString:null,institution:{name:"RMIT University",institutionURL:null,country:{name:"Australia"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:11,paginationItems:[{id:"91",title:"Sustainable Economy and Fair Society",coverUrl:"https://cdn.intechopen.com/series_topics/covers/91.jpg",editor:{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo",profilePictureURL:"https://mts.intechopen.com/storage/users/181603/images/system/181603.jpg",biography:"Antonella Petrillo is a Professor at the Department of Engineering of the University of Naples “Parthenope”, Italy. She received her Ph.D. in Mechanical Engineering from the University of Cassino. Her research interests include multi-criteria decision analysis, industrial plant, logistics, manufacturing and safety. She serves as an Associate Editor for the International Journal of the Analytic Hierarchy Process. She is a member of AHP Academy and a member of several editorial boards. She has over 160 Scientific Publications in International Journals and Conferences and she is the author of 5 books on Innovation and Decision Making in Industrial Applications and Engineering.",institutionString:null,institution:{name:"Parthenope University of Naples",institutionURL:null,country:{name:"Italy"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"179628",title:"Prof.",name:"Dima",middleName:null,surname:"Jamali",slug:"dima-jamali",fullName:"Dima Jamali",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSAIlQAO/Profile_Picture_2022-03-07T08:52:23.jpg",institutionString:null,institution:{name:"University of Sharjah",institutionURL:null,country:{name:"United Arab Emirates"}}},{id:"170206",title:"Prof.",name:"Dr. Orhan",middleName:null,surname:"Özçatalbaş",slug:"dr.-orhan-ozcatalbas",fullName:"Dr. Orhan Özçatalbaş",profilePictureURL:"https://mts.intechopen.com/storage/users/170206/images/system/170206.png",institutionString:null,institution:{name:"Akdeniz University",institutionURL:null,country:{name:"Turkey"}}},{id:"250347",title:"Associate Prof.",name:"Isaac",middleName:null,surname:"Oluwatayo",slug:"isaac-oluwatayo",fullName:"Isaac Oluwatayo",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRVIVQA4/Profile_Picture_2022-03-17T13:25:32.jpg",institutionString:null,institution:{name:"University of Venda",institutionURL:null,country:{name:"South Africa"}}},{id:"141386",title:"Prof.",name:"Jesús",middleName:null,surname:"López-Rodríguez",slug:"jesus-lopez-rodriguez",fullName:"Jesús López-Rodríguez",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRBNIQA4/Profile_Picture_2022-03-21T08:24:16.jpg",institutionString:null,institution:{name:"University of A Coruña",institutionURL:null,country:{name:"Spain"}}},{id:"208657",title:"Dr.",name:"Mara",middleName:null,surname:"Del Baldo",slug:"mara-del-baldo",fullName:"Mara Del Baldo",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRLMUQA4/Profile_Picture_2022-05-18T08:19:24.png",institutionString:"University of Urbino Carlo Bo",institution:null}]},{id:"92",title:"Health and Wellbeing",coverUrl:"https://cdn.intechopen.com/series_topics/covers/92.jpg",editor:{id:"348225",title:"Prof.",name:"Ann",middleName:null,surname:"Hemingway",slug:"ann-hemingway",fullName:"Ann Hemingway",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000035LZFoQAO/Profile_Picture_2022-04-11T14:55:40.jpg",biography:"Professor Hemingway is a public health researcher, Bournemouth University, undertaking international and UK research focused on reducing inequalities in health outcomes for marginalised and excluded populations and more recently focused on equine assisted interventions.",institutionString:null,institution:{name:"Bournemouth University",institutionURL:null,country:{name:"United Kingdom"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"169536",title:"Dr.",name:"David",middleName:null,surname:"Claborn",slug:"david-claborn",fullName:"David Claborn",profilePictureURL:"https://mts.intechopen.com/storage/users/169536/images/system/169536.jpeg",institutionString:null,institution:{name:"Missouri State University",institutionURL:null,country:{name:"United States of America"}}},{id:"248594",title:"Ph.D.",name:"Jasneth",middleName:null,surname:"Mullings",slug:"jasneth-mullings",fullName:"Jasneth Mullings",profilePictureURL:"https://mts.intechopen.com/storage/users/248594/images/system/248594.jpeg",institutionString:"The University Of The West Indies - Mona Campus, Jamaica",institution:null},{id:"331299",title:"Prof.",name:"Pei-Shan",middleName:null,surname:"Liao",slug:"pei-shan-liao",fullName:"Pei-Shan Liao",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000032Fh2FQAS/Profile_Picture_2022-03-18T09:39:41.jpg",institutionString:"Research Center for Humanities and Social Sciences, Academia Sinica, Taiwan",institution:null}]},{id:"93",title:"Inclusivity and Social Equity",coverUrl:"https://cdn.intechopen.com/series_topics/covers/93.jpg",editor:{id:"210060",title:"Prof. Dr.",name:"Ebba",middleName:null,surname:"Ossiannilsson",slug:"ebba-ossiannilsson",fullName:"Ebba Ossiannilsson",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6LkBQAU/Profile_Picture_2022-02-28T13:31:48.png",biography:"Professor Dr. Ebba Ossiannilsson is an independent researcher, expert, consultant, quality auditor and influencer in the fields of open, flexible online and distance learning (OFDL) and the 'new normal'. Her focus is on quality, innovation, leadership, and personalised learning. She works primarily at the strategic and policy levels, both nationally and internationally, and with key international organisations. She is committed to promoting and improving OFDL in the context of SDG4 and the future of education. Ossiannilsson has more than 20 years of experience in her current field, but more than 40 years in the education sector. She works as a reviewer and expert for the European Commission and collaborates with the Joint Research Centre for Quality in Open Education. Ossiannilsson also collaborates with ITCILO and ICoBC (International Council on Badges and Credentials). She is a member of the ICDE Board of Directors and has previously served on the boards of EDEN and EUCEN. Ossiannilsson is a quality expert and reviewer for ICDE, EDEN and the EADTU. She chairs the ICDE OER Advocacy Committee and is a member of the ICDE Quality Network. She is regularly invited as a keynote speaker at conferences. She is a guest editor for several special issues and a member of the editorial board of several scientific journals. She has published more than 200 articles and is currently working on book projects in the field of OFDL. Ossiannilsson is a visiting professor at several international universities and was recently appointed Professor and Research Fellow at Victoria University of Wellington, NZ. Ossiannilsson has been awarded the following fellowships: EDEN Fellows, EDEN Council of Fellows, and Open Education Europe. She is a ICDE OER Ambassador, Open Education Europe Ambassador, GIZ Ambassador for Quality in Digital Learning, and part of the Globe-Community of Digital Learning and Champion of SPARC Europe. On a national level, she is a quality developer at the Swedish Institute for Standards (SIS) and for ISO. She is a member of the Digital Skills and Jobs Coalition Sweden and Vice President of the Swedish Association for Distance Education. She is currently working on a government initiative on quality in distance education at the National Council for Higher Education. She holds a Ph.D. from the University of Oulu, Finland.",institutionString:"Swedish Association for Distance Education, Sweden",institution:null},editorTwo:null,editorThree:null,editorialBoard:[{id:"320585",title:"Ph.D.",name:"Deborah",middleName:null,surname:"Young",slug:"deborah-young",fullName:"Deborah Young",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00002vZLcTQAW/Profile_Picture_2022-05-10T08:30:47.jpg",institutionString:"Empowering Communities Globally",institution:null},{id:"348038",title:"Associate Prof.",name:"Feyza",middleName:null,surname:"Bhatti",slug:"feyza-bhatti",fullName:"Feyza Bhatti",profilePictureURL:"https://mts.intechopen.com/storage/users/348038/images/system/348038.jpg",institutionString:"Girne American University",institution:{name:"Girne American University",institutionURL:null,country:{name:"Cyprus"}}},{id:"302382",title:"Dr.",name:"Gina",middleName:null,surname:"Alvarado",slug:"gina-alvarado",fullName:"Gina Alvarado",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002mZoL9QAK/Profile_Picture_2022-05-26T08:14:10.jpg",institutionString:"Landesa, Seattle",institution:null},{id:"128665",title:"Prof.",name:"Man-Chung",middleName:null,surname:"Chiu",slug:"man-chung-chiu",fullName:"Man-Chung Chiu",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bR9OrQAK/Profile_Picture_2022-03-09T08:36:59.JPG",institutionString:null,institution:{name:"Beijing Normal University",institutionURL:null,country:{name:"China"}}}]},{id:"94",title:"Climate Change and Environmental Sustainability",coverUrl:"https://cdn.intechopen.com/series_topics/covers/94.jpg",editor:{id:"61855",title:"Dr.",name:"Yixin",middleName:null,surname:"Zhang",slug:"yixin-zhang",fullName:"Yixin Zhang",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYWJgQAO/Profile_Picture_2022-06-09T11:36:35.jpg",biography:"Professor Yixin Zhang is an aquatic ecologist with over 30 years of research and teaching experience in three continents (Asia, Europe, and North America) in Stream Ecology, Riparian Ecology, Urban Ecology, and Ecosystem Restoration and Aquatic Conservation, Human-Nature Interactions and Sustainability, Urbanization Impact on Aquatic Ecosystems. He got his Ph.D. in Animal Ecology at Umeå University in Sweden in 1998. He conducted postdoc research in stream ecology at the University of California at Santa Barbara in the USA. After that, he was a postdoc research fellow at the University of British Columbia in Canada to do research on large-scale stream experimental manipulation and watershed ecological survey in temperate rainforests of BC. He was a faculty member at the University of Hong Kong to run ecological research projects on aquatic insects, fishes, and newts in Tropical Asian streams. He also conducted research in streams, rivers, and caves in Texas, USA, to study the ecology of macroinvertebrates, big-claw river shrimp, fish, turtles, and bats. Current research interests include trophic flows across ecosystems; watershed impacts of land-use change on biodiversity and ecosystem functioning; ecological civilization and water resource management; urban ecology and urban/rural sustainable development.",institutionString:null,institution:{name:"Soochow University",institutionURL:null,country:{name:"China"}}},editorTwo:null,editorThree:null,editorialBoard:null},{id:"95",title:"Urban Planning and Environmental Management",coverUrl:"https://cdn.intechopen.com/series_topics/covers/95.jpg",editor:{id:"181079",title:"Dr.",name:"Christoph",middleName:null,surname:"Lüthi",slug:"christoph-luthi",fullName:"Christoph Lüthi",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRHSqQAO/Profile_Picture_2022-04-12T15:51:33.png",biography:"Dr. Christoph Lüthi is an urban infrastructure planner with over 25 years of experience in planning and design of urban infrastructure in middle and low-income countries. He holds a Master’s Degree in Urban Development Planning from the University College of London (UCL), and a Ph.D. in Urban Planning & Engineering from TU Berlin. He has conducted applied research on urban planning and infrastructure issues in over 20 countries in Africa and Asia. In 2005 he joined Eawag-Sandec as Leader of the Strategic Environmental Sanitation Planning Group. Since 2015 he heads the research department Sanitation, Water and Solid Waste for Development (Sandec) at the Swiss Federal Institute of Aquatic Research and Technology (Eawag).",institutionString:"Swiss Federal Institute of Aquatic Science and Technology, Switzerland",institution:null},editorTwo:{id:"290571",title:"Dr.",name:"Rui Alexandre",middleName:null,surname:"Castanho",slug:"rui-alexandre-castanho",fullName:"Rui Alexandre Castanho",profilePictureURL:"https://mts.intechopen.com/storage/users/290571/images/system/290571.jpg",biography:"Rui Alexandre Castanho has a master\\'s degree in Planning, Audit, and Control in Urban Green Spaces and an international Ph.D. in Sustainable Planning in Borderlands. Currently, he is a professor at WSB University, Poland, and a visiting professor at the University of Johannesburg, South Africa. Dr. Castanho is a post-doc researcher on the GREAT Project, University of Azores, Ponta Delgada, Portugal. He collaborates with the Environmental Resources Analysis Research Group (ARAM), University of Extremadura (UEx), Spain; VALORIZA - Research Center for the Enhancement of Endogenous Resources, Polytechnic Institute of Portalegre (IPP), Portugal; Centre for Tourism Research, Development and Innovation (CITUR), Madeira, Portugal; and AQUAGEO Research Group, University of Campinas (UNICAMP), Brazil.",institutionString:"University of Johannesburg, South Africa and WSB University, Poland",institution:{name:"University of Johannesburg",institutionURL:null,country:{name:"South Africa"}}},editorThree:null,editorialBoard:[{id:"181486",title:"Dr.",name:"Claudia",middleName:null,surname:"Trillo",slug:"claudia-trillo",fullName:"Claudia Trillo",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSAZHQA4/Profile_Picture_2022-03-14T08:26:43.jpg",institutionString:null,institution:{name:"University of Salford",institutionURL:null,country:{name:"United Kingdom"}}},{id:"308328",title:"Dr.",name:"Dávid",middleName:null,surname:"Földes",slug:"david-foldes",fullName:"Dávid Földes",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00002nXXGKQA4/Profile_Picture_2022-03-11T08:25:45.jpg",institutionString:null,institution:{name:"Budapest University of Technology and Economics",institutionURL:null,country:{name:"Hungary"}}},{id:"282172",title:"Dr.",name:"Ivan",middleName:null,surname:"Oropeza-Perez",slug:"ivan-oropeza-perez",fullName:"Ivan Oropeza-Perez",profilePictureURL:"https://mts.intechopen.com/storage/users/282172/images/system/282172.jpg",institutionString:"Universidad de las Américas Puebla",institution:{name:"Universidad de las Américas Puebla",institutionURL:null,country:{name:"Mexico"}}}]}]},overviewPageOFChapters:{paginationCount:8,paginationItems:[{id:"82289",title:"Consumer Culture and Abundance of Choices: Having More, Feeling Blue",doi:"10.5772/intechopen.105607",signatures:"Ondřej Roubal",slug:"consumer-culture-and-abundance-of-choices-having-more-feeling-blue",totalDownloads:1,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"A New Era of Consumer Behavior - Beyond the Pandemic",coverURL:"https://cdn.intechopen.com/books/images_new/11581.jpg",subseries:{id:"88",title:"Marketing"}}},{id:"82405",title:"Does Board Structure Matter in CSR Spending of Commercial Banks? Empirical Evidence from an Emerging Economy",doi:"10.5772/intechopen.105589",signatures:"Bishnu Kumar Adhikary and Ranjan Kumar Mitra",slug:"does-board-structure-matter-in-csr-spending-of-commercial-banks-empirical-evidence-from-an-emerging-",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82395",title:"Toward a Better Understanding of Green Human Resource Management’s Impact on Green Competitive Advantage: A Conceptual Model",doi:"10.5772/intechopen.105528",signatures:"Hosna Hossari and Kaoutar Elfahli",slug:"toward-a-better-understanding-of-green-human-resource-management-s-impact-on-green-competitive-advan",totalDownloads:7,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82269",title:"CSR Reporting and Blockchain Technology",doi:"10.5772/intechopen.105512",signatures:"Pattarake Sarajoti, Pattanaporn Chatjuthamard, Suwongrat Papangkorn and Piyachart Phiromswad",slug:"csr-reporting-and-blockchain-technology",totalDownloads:5,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}}]},overviewPagePublishedBooks:{paginationCount:1,paginationItems:[{type:"book",id:"11392",title:"Leadership in a Changing World",subtitle:"A Multidimensional Perspective",coverURL:"https://cdn.intechopen.com/books/images_new/11392.jpg",slug:"leadership-in-a-changing-world-a-multidimensional-perspective",publishedDate:"May 11th 2022",editedByType:"Edited by",bookSignature:"Muhammad Mohiuddin, Bilal Khalid, Md. Samim Al Azad and Slimane Ed-dafali",hash:"86a6d33cf601587e591064ce92effc02",volumeInSeries:1,fullTitle:"Leadership in a Changing World - A Multidimensional Perspective",editors:[{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000038UqSfQAK/Profile_Picture_2022-05-13T10:39:03.jpg",biography:"Dr. Muhammad Mohiuddin is an Associate Professor of International Business at Laval University, Canada. He has taught at Thompson Rivers University, Canada; University of Paris-Est, France; Osnabruck University of Applied Science, Germany; and Shanghai Institute of Technology and Tianjin University of Technology, China. He has published research in Research Policy, Applied Economics, Review of Economic Philosophy, Strategic Change, International Journal of Logistics, Sustainability, Journal of Environmental Management, Journal of Global Information Management, Journal of Cleaner Production, M@N@GEMENT, and more. He is a member of CEDIMES Institut (France), Academy of International Business (AIB), Strategic Management Society (SMS), Academy of Management (AOM), Administrative Science Association of Canada (ASAC), and Canadian council of small business and entrepreneurship (CCSBE). He is currently the director of the Research Group on Contemporary Asia (GERAC) at Laval University. He is also co-managing editor of Transnational Corporations Review and a guest editor for Electronic Commerce Research and Journal of Internet Technology.",institutionString:"Université Laval",institution:{name:"Université Laval",institutionURL:null,country:{name:"Canada"}}}]}]},openForSubmissionBooks:{},onlineFirstChapters:{},subseriesFiltersForOFChapters:[],publishedBooks:{paginationCount:32,paginationItems:[{type:"book",id:"10798",title:"Starch",subtitle:"Evolution and Recent Advances",coverURL:"https://cdn.intechopen.com/books/images_new/10798.jpg",slug:"starch-evolution-and-recent-advances",publishedDate:"June 28th 2022",editedByType:"Edited by",bookSignature:"Martins Ochubiojo Emeje",hash:"f197f6062c1574a9a90e50a369271bcf",volumeInSeries:33,fullTitle:"Starch - Evolution and Recent Advances",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje",profilePictureURL:"https://mts.intechopen.com/storage/users/94311/images/system/94311.jpeg",institutionString:"National Institute for Pharmaceutical Research and Development",institution:{name:"National Institute for Pharmaceutical Research and Development",institutionURL:null,country:{name:"Nigeria"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",slug:"essential-oils-advances-in-extractions-and-biological-applications",publishedDate:"June 23rd 2022",editedByType:"Edited by",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",hash:"742e6cae3a35686f975edc8d7f9afa94",volumeInSeries:32,fullTitle:"Essential Oils - Advances in Extractions and Biological Applications",editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira",profilePictureURL:"https://mts.intechopen.com/storage/users/195290/images/system/195290.png",institutionString:"Museu Paraense Emílio Goeldi",institution:{name:"Museu Paraense Emílio Goeldi",institutionURL:null,country:{name:"Brazil"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10839",title:"Protein Detection",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10839.jpg",slug:"protein-detection",publishedDate:"June 23rd 2022",editedByType:"Edited by",bookSignature:"Yusuf Tutar and Lütfi Tutar",hash:"2f1c0e4e0207fc45c936e7d22a5369c4",volumeInSeries:31,fullTitle:"Protein Detection",editors:[{id:"158492",title:"Prof.",name:"Yusuf",middleName:null,surname:"Tutar",slug:"yusuf-tutar",fullName:"Yusuf Tutar",profilePictureURL:"https://mts.intechopen.com/storage/users/158492/images/system/158492.jpeg",institutionString:"University of Health Sciences",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10797",title:"Cell Culture",subtitle:"Advanced Technology and Applications in Medical and Life Sciences",coverURL:"https://cdn.intechopen.com/books/images_new/10797.jpg",slug:"cell-culture-advanced-technology-and-applications-in-medical-and-life-sciences",publishedDate:"June 15th 2022",editedByType:"Edited by",bookSignature:"Xianquan Zhan",hash:"2c628f4757f9639a4450728d839a7842",volumeInSeries:30,fullTitle:"Cell Culture - Advanced Technology and Applications in Medical and Life Sciences",editors:[{id:"223233",title:"Prof.",name:"Xianquan",middleName:null,surname:"Zhan",slug:"xianquan-zhan",fullName:"Xianquan Zhan",profilePictureURL:"https://mts.intechopen.com/storage/users/223233/images/system/223233.png",institutionString:"Shandong First Medical University",institution:{name:"Affiliated Hospital of Shandong Academy of Medical Sciences",institutionURL:null,country:{name:"China"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10841",title:"Hydrolases",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10841.jpg",slug:"hydrolases",publishedDate:"June 15th 2022",editedByType:"Edited by",bookSignature:"Sajjad Haider, Adnan Haider and Angel Catalá",hash:"4e868cde273d65a7ff54b1817d640629",volumeInSeries:29,fullTitle:"Hydrolases",editors:[{id:"110708",title:"Dr.",name:"Sajjad",middleName:null,surname:"Haider",slug:"sajjad-haider",fullName:"Sajjad Haider",profilePictureURL:"https://mts.intechopen.com/storage/users/110708/images/system/110708.png",institutionString:"King Saud University",institution:{name:"King Saud University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10803",title:"Reactive Oxygen Species",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10803.jpg",slug:"reactive-oxygen-species",publishedDate:"April 28th 2022",editedByType:"Edited by",bookSignature:"Rizwan Ahmad",hash:"176adcf090fdd1f93cb8ce3146e79ca1",volumeInSeries:28,fullTitle:"Reactive Oxygen Species",editors:[{id:"40482",title:null,name:"Rizwan",middleName:null,surname:"Ahmad",slug:"rizwan-ahmad",fullName:"Rizwan Ahmad",profilePictureURL:"https://mts.intechopen.com/storage/users/40482/images/system/40482.jpeg",institutionString:"Imam Abdulrahman Bin Faisal University",institution:{name:"Imam Abdulrahman Bin Faisal University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9008",title:"Vitamin K",subtitle:"Recent Topics on the Biology and Chemistry",coverURL:"https://cdn.intechopen.com/books/images_new/9008.jpg",slug:"vitamin-k-recent-topics-on-the-biology-and-chemistry",publishedDate:"March 23rd 2022",editedByType:"Edited by",bookSignature:"Hiroyuki Kagechika and Hitoshi Shirakawa",hash:"8b43add5389ba85743e0a9491e4b9943",volumeInSeries:27,fullTitle:"Vitamin K - Recent Topics on the Biology and Chemistry",editors:[{id:"180528",title:"Dr.",name:"Hiroyuki",middleName:null,surname:"Kagechika",slug:"hiroyuki-kagechika",fullName:"Hiroyuki Kagechika",profilePictureURL:"https://mts.intechopen.com/storage/users/180528/images/system/180528.jpg",institutionString:"Tokyo Medical and Dental University",institution:{name:"Tokyo Medical and Dental University",institutionURL:null,country:{name:"Japan"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10799",title:"Phenolic Compounds",subtitle:"Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",coverURL:"https://cdn.intechopen.com/books/images_new/10799.jpg",slug:"phenolic-compounds-chemistry-synthesis-diversity-non-conventional-industrial-pharmaceutical-and-therapeutic-applications",publishedDate:"February 23rd 2022",editedByType:"Edited by",bookSignature:"Farid A. Badria",hash:"339199f254d2987ef3167eef74fb8a38",volumeInSeries:26,fullTitle:"Phenolic Compounds - Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria",profilePictureURL:"https://mts.intechopen.com/storage/users/41865/images/system/41865.jpg",institutionString:"Mansoura University",institution:{name:"Mansoura University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9659",title:"Fibroblasts",subtitle:"Advances in Inflammation, Autoimmunity and Cancer",coverURL:"https://cdn.intechopen.com/books/images_new/9659.jpg",slug:"fibroblasts-advances-in-inflammation-autoimmunity-and-cancer",publishedDate:"December 22nd 2021",editedByType:"Edited by",bookSignature:"Mojca Frank Bertoncelj and Katja Lakota",hash:"926fa6446f6befbd363fc74971a56de2",volumeInSeries:25,fullTitle:"Fibroblasts - Advances in Inflammation, Autoimmunity and Cancer",editors:[{id:"328755",title:"Ph.D.",name:"Mojca",middleName:null,surname:"Frank Bertoncelj",slug:"mojca-frank-bertoncelj",fullName:"Mojca Frank Bertoncelj",profilePictureURL:"https://mts.intechopen.com/storage/users/328755/images/system/328755.jpg",institutionString:"BioMed X Institute",institution:{name:"University Hospital of Zurich",institutionURL:null,country:{name:"Switzerland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8977",title:"Protein Kinases",subtitle:"Promising Targets for Anticancer Drug Research",coverURL:"https://cdn.intechopen.com/books/images_new/8977.jpg",slug:"protein-kinases-promising-targets-for-anticancer-drug-research",publishedDate:"December 8th 2021",editedByType:"Edited by",bookSignature:"Rajesh Kumar Singh",hash:"6d200cc031706a565b554fdb1c478901",volumeInSeries:24,fullTitle:"Protein Kinases - Promising Targets for Anticancer Drug Research",editors:[{id:"329385",title:"Dr.",name:"Rajesh K.",middleName:"Kumar",surname:"Singh",slug:"rajesh-k.-singh",fullName:"Rajesh K. Singh",profilePictureURL:"https://mts.intechopen.com/storage/users/329385/images/system/329385.png",institutionString:"Punjab Technical University",institution:{name:"Punjab Technical University",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8018",title:"Extracellular Matrix",subtitle:"Developments and Therapeutics",coverURL:"https://cdn.intechopen.com/books/images_new/8018.jpg",slug:"extracellular-matrix-developments-and-therapeutics",publishedDate:"October 27th 2021",editedByType:"Edited by",bookSignature:"Rama Sashank Madhurapantula, Joseph Orgel P.R.O. and Zvi Loewy",hash:"c85e82851e80b40282ff9be99ddf2046",volumeInSeries:23,fullTitle:"Extracellular Matrix - Developments and Therapeutics",editors:[{id:"212416",title:"Dr.",name:"Rama Sashank",middleName:null,surname:"Madhurapantula",slug:"rama-sashank-madhurapantula",fullName:"Rama Sashank Madhurapantula",profilePictureURL:"https://mts.intechopen.com/storage/users/212416/images/system/212416.jpg",institutionString:"Illinois Institute of Technology",institution:{name:"Illinois Institute of Technology",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9759",title:"Vitamin E in Health and Disease",subtitle:"Interactions, Diseases and Health Aspects",coverURL:"https://cdn.intechopen.com/books/images_new/9759.jpg",slug:"vitamin-e-in-health-and-disease-interactions-diseases-and-health-aspects",publishedDate:"October 6th 2021",editedByType:"Edited by",bookSignature:"Pınar Erkekoglu and Júlia Scherer Santos",hash:"6c3ddcc13626110de289b57f2516ac8f",volumeInSeries:22,fullTitle:"Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects",editors:[{id:"109978",title:"Prof.",name:"Pınar",middleName:null,surname:"Erkekoğlu",slug:"pinar-erkekoglu",fullName:"Pınar Erkekoğlu",profilePictureURL:"https://mts.intechopen.com/storage/users/109978/images/system/109978.jpg",institutionString:"Hacettepe University",institution:{name:"Hacettepe University",institutionURL:null,country:{name:"Turkey"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Proteomics",value:18,count:4},{group:"subseries",caption:"Metabolism",value:17,count:6},{group:"subseries",caption:"Cell and Molecular Biology",value:14,count:9},{group:"subseries",caption:"Chemical Biology",value:15,count:13}],publicationYearFilters:[{group:"publicationYear",caption:"2022",value:2022,count:8},{group:"publicationYear",caption:"2021",value:2021,count:7},{group:"publicationYear",caption:"2020",value:2020,count:12},{group:"publicationYear",caption:"2019",value:2019,count:3},{group:"publicationYear",caption:"2018",value:2018,count:2}],authors:{}},subseries:{item:{id:"91",type:"subseries",title:"Sustainable Economy and Fair Society",keywords:"Sustainable, Society, Economy, Digitalization, KPIs, Decision Making, Business, Digital Footprint",scope:"
\r\n\tGlobally, the ecological footprint is growing at a faster rate than GDP. This phenomenon has been studied by scientists for many years. However, clear strategies and actions are needed now more than ever. Every day, humanity, from individuals to businesses (public and private) and governments, are called to change their mindset in order to pursue a virtuous combination for sustainable development. Reasoning in a sustainable way entails, first and foremost, managing the available resources efficiently and strategically, whether they are natural, financial, human or relational. In this way, value is generated by contributing to the growth, improvement and socio-economic development of the communities and of all the players that make up its value chain. In the coming decades, we will need to be able to transition from a society in which economic well-being and health are measured by the growth of production and material consumption, to a society in which we live better while consuming less. In this context, digitization has the potential to disrupt processes, with significant implications for the environment and sustainable development. There are numerous challenges associated with sustainability and digitization, the need to consider new business models capable of extracting value, data ownership and sharing and integration, as well as collaboration across the entire supply chain of a product. In order to generate value, effectively developing a complex system based on sustainability principles is a challenge that requires a deep commitment to both technological factors, such as data and platforms, and human dimensions, such as trust and collaboration. Regular study, research and implementation must be part of the road to sustainable solutions. Consequently, this topic will analyze growth models and techniques aimed at achieving intergenerational equity in terms of economic, social and environmental well-being. It will also cover various subjects, including risk assessment in the context of sustainable economy and a just society.
",coverUrl:"https://cdn.intechopen.com/series_topics/covers/91.jpg",hasOnlineFirst:!0,hasPublishedBooks:!1,annualVolume:11975,editor:{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo",profilePictureURL:"https://mts.intechopen.com/storage/users/181603/images/system/181603.jpg",biography:"Antonella Petrillo is a Professor at the Department of Engineering of the University of Naples “Parthenope”, Italy. She received her Ph.D. in Mechanical Engineering from the University of Cassino. Her research interests include multi-criteria decision analysis, industrial plant, logistics, manufacturing and safety. She serves as an Associate Editor for the International Journal of the Analytic Hierarchy Process. She is a member of AHP Academy and a member of several editorial boards. She has over 160 Scientific Publications in International Journals and Conferences and she is the author of 5 books on Innovation and Decision Making in Industrial Applications and Engineering.",institutionString:null,institution:{name:"Parthenope University of Naples",institutionURL:null,country:{name:"Italy"}}},editorTwo:null,editorThree:null,series:{id:"24",title:"Sustainable Development",doi:"10.5772/intechopen.100361",issn:null},editorialBoard:[{id:"179628",title:"Prof.",name:"Dima",middleName:null,surname:"Jamali",slug:"dima-jamali",fullName:"Dima Jamali",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSAIlQAO/Profile_Picture_2022-03-07T08:52:23.jpg",institutionString:null,institution:{name:"University of Sharjah",institutionURL:null,country:{name:"United Arab Emirates"}}},{id:"170206",title:"Prof.",name:"Dr. Orhan",middleName:null,surname:"Özçatalbaş",slug:"dr.-orhan-ozcatalbas",fullName:"Dr. Orhan Özçatalbaş",profilePictureURL:"https://mts.intechopen.com/storage/users/170206/images/system/170206.png",institutionString:null,institution:{name:"Akdeniz University",institutionURL:null,country:{name:"Turkey"}}},{id:"250347",title:"Associate Prof.",name:"Isaac",middleName:null,surname:"Oluwatayo",slug:"isaac-oluwatayo",fullName:"Isaac Oluwatayo",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRVIVQA4/Profile_Picture_2022-03-17T13:25:32.jpg",institutionString:null,institution:{name:"University of Venda",institutionURL:null,country:{name:"South Africa"}}},{id:"141386",title:"Prof.",name:"Jesús",middleName:null,surname:"López-Rodríguez",slug:"jesus-lopez-rodriguez",fullName:"Jesús López-Rodríguez",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRBNIQA4/Profile_Picture_2022-03-21T08:24:16.jpg",institutionString:null,institution:{name:"University of A Coruña",institutionURL:null,country:{name:"Spain"}}},{id:"208657",title:"Dr.",name:"Mara",middleName:null,surname:"Del Baldo",slug:"mara-del-baldo",fullName:"Mara Del Baldo",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRLMUQA4/Profile_Picture_2022-05-18T08:19:24.png",institutionString:"University of Urbino Carlo Bo",institution:null}]},onlineFirstChapters:{},publishedBooks:{paginationCount:6,paginationItems:[{type:"book",id:"9493",title:"Periodontology",subtitle:"Fundamentals and Clinical Features",coverURL:"https://cdn.intechopen.com/books/images_new/9493.jpg",slug:"periodontology-fundamentals-and-clinical-features",publishedDate:"February 16th 2022",editedByType:"Edited by",bookSignature:"Petra Surlin",hash:"dfe986c764d6c82ae820c2df5843a866",volumeInSeries:8,fullTitle:"Periodontology - Fundamentals and Clinical Features",editors:[{id:"171921",title:"Prof.",name:"Petra",middleName:null,surname:"Surlin",slug:"petra-surlin",fullName:"Petra Surlin",profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institutionString:"University of Medicine and Pharmacy of Craiova",institution:{name:"University of Medicine and Pharmacy of Craiova",institutionURL:null,country:{name:"Romania"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9588",title:"Clinical Concepts and Practical Management Techniques in Dentistry",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9588.jpg",slug:"clinical-concepts-and-practical-management-techniques-in-dentistry",publishedDate:"February 9th 2022",editedByType:"Edited by",bookSignature:"Aneesa Moolla",hash:"42deab8d3bcf3edf64d1d9028d42efd1",volumeInSeries:7,fullTitle:"Clinical Concepts and Practical Management Techniques in Dentistry",editors:[{id:"318170",title:"Dr.",name:"Aneesa",middleName:null,surname:"Moolla",slug:"aneesa-moolla",fullName:"Aneesa Moolla",profilePictureURL:"https://mts.intechopen.com/storage/users/318170/images/system/318170.png",institutionString:"University of the Witwatersrand",institution:{name:"University of the Witwatersrand",institutionURL:null,country:{name:"South Africa"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8202",title:"Periodontal Disease",subtitle:"Diagnostic and Adjunctive Non-surgical Considerations",coverURL:"https://cdn.intechopen.com/books/images_new/8202.jpg",slug:"periodontal-disease-diagnostic-and-adjunctive-non-surgical-considerations",publishedDate:"February 5th 2020",editedByType:"Edited by",bookSignature:"Nermin Mohammed Ahmed Yussif",hash:"0aee9799da7db2c732be44dd8fed16d8",volumeInSeries:6,fullTitle:"Periodontal Disease - Diagnostic and Adjunctive Non-surgical Considerations",editors:[{id:"210472",title:"Dr.",name:"Nermin",middleName:"Mohammed Ahmed",surname:"Yussif",slug:"nermin-yussif",fullName:"Nermin Yussif",profilePictureURL:"https://mts.intechopen.com/storage/users/210472/images/system/210472.jpg",institutionString:"MSA University",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8837",title:"Human Teeth",subtitle:"Key Skills and Clinical Illustrations",coverURL:"https://cdn.intechopen.com/books/images_new/8837.jpg",slug:"human-teeth-key-skills-and-clinical-illustrations",publishedDate:"January 22nd 2020",editedByType:"Edited by",bookSignature:"Zühre Akarslan and Farid Bourzgui",hash:"ac055c5801032970123e0a196c2e1d32",volumeInSeries:5,fullTitle:"Human Teeth - Key Skills and Clinical Illustrations",editors:[{id:"171887",title:"Prof.",name:"Zühre",middleName:null,surname:"Akarslan",slug:"zuhre-akarslan",fullName:"Zühre Akarslan",profilePictureURL:"https://mts.intechopen.com/storage/users/171887/images/system/171887.jpg",institutionString:"Gazi University",institution:{name:"Gazi University",institutionURL:null,country:{name:"Turkey"}}}],equalEditorOne:{id:"52177",title:"Prof.",name:"Farid",middleName:null,surname:"Bourzgui",slug:"farid-bourzgui",fullName:"Farid Bourzgui",profilePictureURL:"https://mts.intechopen.com/storage/users/52177/images/system/52177.png",biography:"Prof. Farid Bourzgui obtained his DMD and his DNSO option in Orthodontics at the School of Dental Medicine, Casablanca Hassan II University, Morocco, in 1995 and 2000, respectively. Currently, he is a professor of Orthodontics. He holds a Certificate of Advanced Study type A in Technology of Biomaterials used in Dentistry (1995); Certificate of Advanced Study type B in Dento-Facial Orthopaedics (1997) from the Faculty of Dental Surgery, University Denis Diderot-Paris VII, France; Diploma of Advanced Study (DESA) in Biocompatibility of Biomaterials from the Faculty of Medicine and Pharmacy of Casablanca (2002); Certificate of Clinical Occlusodontics from the Faculty of Dentistry of Casablanca (2004); University Diploma of Biostatistics and Perceptual Health Measurement from the Faculty of Medicine and Pharmacy of Casablanca (2011); and a University Diploma of Pedagogy of Odontological Sciences from the Faculty of Dentistry of Casablanca (2013). He is the author of several scientific articles, book chapters, and books.",institutionString:"University of Hassan II Casablanca",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"7",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"University of Hassan II Casablanca",institutionURL:null,country:{name:"Morocco"}}},equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7060",title:"Gingival Disease",subtitle:"A Professional Approach for Treatment and Prevention",coverURL:"https://cdn.intechopen.com/books/images_new/7060.jpg",slug:"gingival-disease-a-professional-approach-for-treatment-and-prevention",publishedDate:"October 23rd 2019",editedByType:"Edited by",bookSignature:"Alaa Eddin Omar Al Ostwani",hash:"b81d39988cba3a3cf746c1616912cf41",volumeInSeries:4,fullTitle:"Gingival Disease - A Professional Approach for Treatment and Prevention",editors:[{id:"240870",title:"Ph.D.",name:"Alaa Eddin Omar",middleName:null,surname:"Al Ostwani",slug:"alaa-eddin-omar-al-ostwani",fullName:"Alaa Eddin Omar Al Ostwani",profilePictureURL:"https://mts.intechopen.com/storage/users/240870/images/system/240870.jpeg",institutionString:"International University for Science and Technology.",institution:{name:"Islamic University of Science and Technology",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"6668",title:"Dental Caries",subtitle:"Diagnosis, Prevention and Management",coverURL:"https://cdn.intechopen.com/books/images_new/6668.jpg",slug:"dental-caries-diagnosis-prevention-and-management",publishedDate:"September 19th 2018",editedByType:"Edited by",bookSignature:"Zühre Akarslan",hash:"b0f7667770a391f772726c3013c1b9ba",volumeInSeries:1,fullTitle:"Dental Caries - Diagnosis, Prevention and Management",editors:[{id:"171887",title:"Prof.",name:"Zühre",middleName:null,surname:"Akarslan",slug:"zuhre-akarslan",fullName:"Zühre Akarslan",profilePictureURL:"https://mts.intechopen.com/storage/users/171887/images/system/171887.jpg",institutionString:"Gazi University",institution:{name:"Gazi University",institutionURL:null,country:{name:"Turkey"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.png",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}}]},submityourwork:{pteSeriesList:[],lsSeriesList:[],hsSeriesList:[],sshSeriesList:[],subseriesList:[],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:null},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"chapter.detail",path:"/chapters/65172",hash:"",query:{},params:{id:"65172"},fullPath:"/chapters/65172",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()